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Abstract 
MurA and AroA are important antibacterial targets due to their essentiality in 
microorganisms and the absence of their respective pathways within mammals. 
Although much research has focussed on these enzymes, little is known about the 
evolution of AroA and MurA. Ancestral sequence reconstruction (ASR), a 
technique used to infer sequences of ancestral proteins and study their properties 
in the laboratory, was used to study the evolution of AroA and MurA enzymes 
from Bacillus. The ancestral AroA and MurA enzymes were functionally and 
structurally characterised and their properties compared to those of contemporary 
AroA and MurA.  
AroA and MurA from the last common ancestor (LCA) of Bacillus along with 
three intermediate Bacillus MurA ancestors were inferred using ASR. The 
reconstructed AroA and MurA ancestral enzymes show comparable kinetic 
properties to the contemporary enzymes. The thermal properties of Bacillus AroA 
LCA, Bacillus MurA LCA and the remaining three MurA ancestors were found to 
be moderately thermophilic. However, the contrasting thermal profiles observed 
for AroA, MurA and LeuB ancestral enzymes from Bacillus at the same period of 
time led to the hypothesis that reconstructed ancestral enzymes provide a snapshot 
of the evolving host at a given point in time. 
The exclusive inhibition of AroA and MurA by their inhibitors glyphosate and 
fosfomycin respectively remains unchanged for AroA LCA and MurA LCA. On 
the other hand, the high affinity for PEP and increased glyphosate sensitivity 
exhibited by AroA LCA indicate AroA LCA to be intermediate between class I 
(glyphosate sensitive) and class II (glyphosate insensitive) AroA. Characterisation 
of AroA LCA in vivo resulted in AroA LCA posing a fitness cost to the cells 
carrying this enzyme on a plasmid in a aroA background. AroA LCA and MurA 
LCA remain highly structurally similar to the contemporary enzymes, with minor 
differences predominantly located on the protein surface.  
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1 Chapter 1 
Introduction  
1.1 Antibiotic Resistance and Multi-target Drug Development 
Infectious diseases are the second leading cause of death worldwide and will 
remain a dominant aspect of future health considerations (Fauci 2001). Pathogenic 
bacteria are prokaryotes with structural features and metabolic characteristics 
significantly different from eukaryotes, making it relatively simple to find and 
develop antibacterial drugs with minimal side effects (National Institutes of 
Health 2007). Antibiotics have played a critical role in the fight against infectious 
diseases caused by bacteria. However, the development of resistance against 
antibacterial drugs is becoming a global concern. Alarmingly, many strains have 
also developed resistance to multiple drugs (National Institutes of Health 2007). 
Therefore, there is a growing need to find new targets for the development of new 
antibiotics (McDevitt et al. 2002; Livermore 2004).  
Many bacterial targets have been identified and extensively evaluated, and 
research is ongoing to find promising inhibitors. Examples of some pathways of 
interest include the shikimate pathway responsible for aromatic amino acid 
biosynthesis and the peptidoglycan biosynthesis pathway (McDevitt et al. 2002; 
Amer et al. 2008). The inhibition of any enzyme involved in any of the above 
pathways may prove lethal to the organism and thus make very good antibiotic 
targets. There are many antibacterial agents that target single enzymes. However, 
it has been observed that drugs that interact with multiple molecular sites, the 
structures of which are determined by multiple genes, have a low likelihood of 
developing a high level of endogenous resistance (Silver 2007). This observation 
favours the development of multi-target drugs over single-target compounds for 
the development of novel antibiotics. This hypothesis is also supported by 
network models, suggesting that partial inhibition of a small number of targets can 
be more efficient than the complete inhibition of a single target (Csermely et al. 
2005). Many researchers have studied the shikimate pathway and peptidoglycan 
pathway, and pointed out that the respective enzymes AroA and MurA, are 
structurally and mechanistically similar to each other (Eschenburg et al. 2003; 
Oberdorfer et al. 2012). Such similarities offer the opportunity to find multi-target 
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inhibitors. Consequently, understanding the evolution of these enzymes imparts us 
with information that could be used for the design of multi-target inhibitors as 
well as understanding the origin of antibiotic resistance (Nobeli et al. 2009).  
1.2 Enolpyruvyl Transferases 
The peptidoglycan synthesis pathway and the shikimate pathway are absent from 
mammals but are essential for the survival of microorganisms (McDevitt et al. 
2002; Eschenburg et al. 2003). This makes the enzymes of these pathways good 
antibacterial targets. The enolpyruvyl transferase family is a small family of 
enzymes consisting of AroA (5-enolpyruvylshikimate-3-phosphate synthase, EC 
2.5.1.19), MurA (UDP-N-acetylglucosamine enolpyruvyl transferase, EC 2.5.1.7) 
(Eschenburg et al. 2003) and the putative enolpyruvyl transferase NikO (SCOP 
number: 55209) (Lauer et al. 2000; Oberdorfer et al. 2012). AroA is the sixth 
enzyme of the shikimate pathway (Funke 2008), MurA catalyses the first 
committed step of peptidoglycan biosynthesis (Skarzynski et al. 1996; Du et al. 
2000) and NikO is a key enzyme in the biosynthesis of nikkomycins (Oberdorfer 
et al. 2012). The characteristic reaction carried out by members of the enolpyruvyl 
transferase family is the transfer of the enolpyruvyl moiety from 
phosphoenolpyruvate (PEP) to their respective substrates (Figure 1.1). AroA and 
MurA have always been reported as the only two known members of the 
enolpyruvyl transferase family (Skarzynski et al. 1996; Eschenburg et al. 2003; 
Biery 2007) until the characterisation of NikO which showed significant sequence 
identity to AroA and MurA. For example, MurA shares ~30 % sequence identity 
with NikO (Lauer et al. 2000; Oberdorfer et al. 2012). NikO was also found to be 
inhibited by MurA’s unique inhibitor fosfomycin (Oberdorfer et al. 2012).  
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Figure 1.1: The enolpyruvyl transferase reaction catalysed by AroA and MurA  
A) The reaction mechanism of AroA. B) The reaction mechanism of MurA. 
The analysis of MurA sequences has led to the identification of two genes 
encoding for UDP-N-acetylglucosamine enolpyruvyltransferase in Gram positive 
bacteria, murA and murZ (sometimes called murA2), which possibly originated 
from a gene duplication event, whereas only one gene, murA, is found in Gram 
negative bacteria (Du et al. 2000; Blake et al. 2009). The in vitro characterisation 
of MurA and MurZ from Streptococcus pneumoniae showed that both enzymes 
catalyse the same enolpyruvyl transfer reaction from PEP to UNAG, have similar 
catalytic parameters and are both inhibited by fosfomycin (Du et al. 2000). 
However, in Staphylococcus aureus, MurA is the primary enzyme with five times 
greater expression than MurZ and a 25% reduction in peptidoglycan upon MurA 
inactivation as opposed to minimal change with MurZ inactivation (Blake et al. 
2009). 
Independent inactivation of MurA and MurZ in S. pneumoniae and S. aureus 
shows that either of them can sustain viability, however double deletions are 
unachievable showing that at least one UDP-N-acetylglucosamine 
enolpyruvyltransferse enzyme is essential to these organisms (Du et al. 2000; 
Blake et al. 2009). In contrast, MurA is an essential enzyme in Bacillus subtilis 
A) 
B) 
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and Bacillus anthracis as MurZ is unable to compensate for deletion of MurA 
(Kock et al. 2004; Kedar et al. 2008). 
The essentiality of AroA has also been tested in different pathogenic organisms. 
The deletion of the aroA gene from S. pneumoniae caused the strain to be entirely 
attenuated in terms of virulence (McDevitt et al. 2002). In 2002, Parish
 
and Stoker 
disrupted the gene that encodes shikimate kinase, aroK, and demonstrated that the 
shikimate pathway is essential for the viability of Mycobacterium tuberculosis 
(Parish & Stoker 2002). 
1.3 AroA (5-enolpyruvylshikimate-3-phosphate synthase) 
1.3.1 Pathway 
The shikimate pathway is known to be the common aromatic biosynthetic 
pathway, conserved in plants, algae, fungi and bacteria (McConkey 1999; 
Priestman et al. 2005b). In bacteria, the shikimate pathway is almost exclusively 
used for the synthesis of aromatic amino acids for protein synthesis (Herrmann 
1995b; Tzin & Galili 2010).  
The synthesis of aromatic amino acids involves two processes: (i) the synthesis of 
chorismate from PEP and erythrose-4-phosphate (called the shikimate pathway), 
and (ii) the synthesis of the three aromatic amino acids (phenylalanine, tyrosine 
and tryptophan) and p-amino and p-hydroxy benzoate from chorismate (Herrmann 
1995a; Herrmann 1995b; Parish & Stoker 2002). The shikimate pathway involves 
seven enzymes (Figure 1.2). The first step of the shikimate pathway is catalysed 
by 3-Deoxy-D-arabinoheptulosonate-7-phosphate (DAHP) synthase causing the 
condensation of PEP and erythrose-4-phosphate (Herrmann 1995a). The second 
step involves the formation of the cyclohexane derivative 3-dehydroquinate using 
divalent cations and NAD
+
 cofactors (Herrmann 1995b; Maeda & Dudareva 
2012). The last five steps are responsible for the introduction of one side chain 
and two double bonds to the ring. The first double bond is introduced through the 
dehydration of 3-dehydroquinate to 3-dehydroshikimate by 3-dehydroquinate 
dehydratase. This is followed by the reversible reduction of 3-dehydroshikimate 
into shikimate using NADPH by shikimate dehydrogenase. Shikimate kinase, 
during the fifth step of the shikimate pathway, produces shikimate-3-phosphate 
via phosphorylation of shikimate using ATP. A side chain is introduced in the 
sixth step catalysed by 5-enolpyruvyl-shikimate-3-phoshate synthase (AroA) 
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(Herrmann 1995b; Maeda & Dudareva 2012). The two most studied enzymes on 
the pathway are shikimate kinase and AroA. The final step is catalysed by 
chorismate synthase by converting 5-enolpyruvyl-shikimate-3-phoshate to 
chorismate, thereby introducing the second double bond in the ring (Priestman et 
al. 2005b; Maeda & Dudareva 2012).    
 
Figure 1.2: Flow diagram showing the steps involved in the shikimate pathway 
1.3.2 Mechanism of AroA 
Huge interest has been directed to the study of the shikimate pathway and its 
enzymes because the pathway is absent in mammals and thus make an attractive 
target for the development of new antimicrobials (McConkey 1999; McDevitt et 
al. 2002; Amer et al. 2008). 
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AroA, the sixth enzyme of the shikimate pathway, catalyses the reversible transfer 
of the intact enolpyruvyl moiety of PEP to the 5 hydroxyl group of shikimate-3-
phosphate (S3P) to produce 5-enolpyruvylshikimate-3-phosphate (EPSP) and 
inorganic phosphate (Lewendon & Coggins 1983; Steinrücken & Amrhein 1984a; 
Schönbrunn et al. 2001; Eschenburg et al. 2003) (Figure 1.1). Unlike typical PEP-
utilizing enzymes, AroA catalyses the reaction by the cleavage of the C-O bond of 
PEP instead of the high energy P-O bond (Schönbrunn et al. 2001; Eschenburg et 
al. 2003). 
A reversible addition-elimination reaction was put forward in 1964 (Levin & 
Sprinson 1964). The nucleophilic attack of the 5 hydroxyl group of shikimate-3-
phosphate on the C2 position of PEP forms a non-covalent tetrahedral 
intermediate at the active site of the enzyme. This mechanism was later 
unequivocally confirmed using NMR (Anderson et al. 1988a). The mechanism 
catalysed by AroA via its intermediate was further investigated by chemically 
synthesising both diastereomers of the tertrahedral intermediate, (R)-TI and (S)-TI 
(An et al. 2003). The conversion of (S)-TI to EPSP, PEP and S3P conclusively 
identified the tetrahedral intermediate as the (S)-ketal phosphate, thereby 
confirming the catalytic mechanism proceeds via an anti addition followed by a 
syn elimination (An et al. 2003). 
The role of the catalytic residues in the addition-elimination steps of the reaction 
was examined by a novel approach called partitioning analysis (Mizyed et al. 
2003). It was found that many amino acid residues contribute to catalysis, 
however no single residue is responsible for only addition or elimination. In the 
addition step of the overall reaction, the amino acid residue Lys22 acts as a 
general base catalyst and Glu341 acts as a general acid catalyst. The same 
residues act as general acid or general base catalysts of the tetrahedral 
intermediate breakdown in both the forward and reverse reactions (Mizyed et al. 
2003). The identification of Lys22 and Glu341 as general acid/base catalytic 
residues is backed up by a later study performed by Berti and Chindemi (2009). In 
addition to the acid/base catalysis role, they also assigned Glu341 to have an 
electrostatic catalysis role. This is because Glu341 and Asp313 stabilize the 
cationic intermediates/transition states by forming an electrostatic sandwich 
around the positive charge at C2. Mutations of Glu341 and Asp313 greatly affect 
the kcat thus confirming their importance as catalytic residues whereas mutation of 
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Lys22 mainly affects substrate binding (E.coli numbering) (Berti & Chindemi 
2009). The position of Lys22, Asp313 and Glu341 within the active site is shown 
in Figure 1.3.    
 
Figure 1.3: Positioning of catalytic residues Lys22, Asp313 and Glu341 in the active 
site of AroA enzyme 
The position of catalytic residues Lys22, Asp313 and Glu341 from E.coli AroA 
(PDB 1G6T) are shown in relation to the AroA substrate shikimate-3-phosphate (S3P) 
within the active site.  
Steady-state kinetics of B. subtilis AroA showed allosteric behaviour (Majumder 
et al. 1995). Kinetic analyses performed by site-directed mutagenesis of Pro105 
and His385 suggest that PEP has a second binding site which is non catalytic. It 
was then demonstrated that the non-catalytic PEP binding resides at His385 
(Shuttleworth & Evans 1994). It was also observed that B. subtilis AroA could be 
activated using ammonia. Mutations at Arg24 and His385 affected the ammonium 
interaction sites as they nearly eliminated the ammonia activation (Majumder et al. 
1995).  
Therefore, AroA enzymes from different species have specific characteristics and 
their mechanism and catalytic activity may be controlled differently in different 
species.        
1.3.3 Structure 
The polypeptide chain of AroA folds into two globular domains connected by a 
short hinge region. The mainchain fold of each domain is very similar with each 
other consisting of three repeats of βαβαββ motif (Skarzynski et al. 1996; 
Eschenburg et al. 2003; Funke 2008). Upon binding of the AroA substrate S3P, 
the enzyme undergoes a conformational change from an ‘open’ to ‘closed’ 
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conformation resulting from the two domains approaching each other in a screw-
like movement (Figure 1.4) (Schönbrunn et al. 2001). This leads to the formation 
of the active site in the interdomain cleft where the second substrate PEP and the 
inhibitor glyphosate bind (Eschenburg et al. 2003; Funke et al. 2009).  
 
 
Figure 1.4: Streptococcus pneumoniae AroA in its open and closed conformations 
A) S. pneumoniae AroA (PDB 1RF5) in its unliganded open conformation. 
B) S. pneumoniae AroA (PDB 1RF6) bound to S3P and glyphosate in a closed 
conformation. The figure shows the cartoon representation of the N-terminal domain 
(domain I) (red) and C-terminal domain (domain II) (blue). The protein surface 
(transparent light blue) in A) clearly shows the gap between the N- and C-terminal 
domains in open conformation in comparison to closed. S3P and glyphosate complex is 
represented with spheres in dark blue. 
A) 
B) 
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The structure of the free enzyme AroA, in the ‘open’ conformation, from E. coli 
was reported by Stallings et al. (1991). The structure consisted of two remarkably 
similar globular domains with 131 residues out of 208 in each domain equivalent 
to the other. In addition to this overall twofold topological symmetry, the structure 
also showed an additional threefold axis of symmetry in each domain. Thus each 
domain can further be divided into three more subunits with a total of six subunits 
in the entire structure (Figure 1.5). Out of these six subunits, even though only 
three subunits are formed from a continuous polypeptide chain, there is a 
possibility that the structure may have evolved from a sixfold replication of the 
gene responsible for the folding unit (Stallings et al. 1991).  
 
Figure 1.5: Cartoon representation of the two globular domains and individual 
subunits constituting the AroA enzyme  
A) The full AroA enzyme from E. coli (PDB 1G6T) showing its two domains, the N-
terminal domain (domain I) and C-terminal domain (domain II). The colour spectrum 
from dark blue to red goes from N-terminal to C-terminal. The structure consists of a total 
of six subunits, each subunit coloured differently.  B) The N-terminal domain consisting 
of three individual subunits. C) The individual subunit consisting of two  helices and 
four  strands. The subunit shown is formed from discontinuous polypeptide chain. The 
whole AroA structure consists of a six fold repetition of this  motif. 
 
A) B) 
C) 
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Stallings et al. (1991) proposed the “mushroom button” model for the overall 
structure of AroA with parallel interacting helices acting as the stem and the 
extensive domain surface covered with sheets as the cap of the mushroom. This 
model is also referred to as the ‘inside-out /-barrel’ (Stallings et al. 1991) 
(Figure 1.6).  
  
Figure 1.6: Cartoon representation of “inside-out  barrel” configuration of AroA 
enzymes 
The two domains of E. coli (PDB 1G6T) A) N-terminal domain (domain I) and B) C-
terminal domain (domain II).    
Homology among the bacterial, fungal and plant AroA sequences has been 
observed (Gasser et al. 1988) and this suggests the possibility that the three 
dimensional structure of all these AroAs may be similar to that of E. coli AroA. 
Structural information for AroA from a different species, S. pneumoniae, showed 
similar topology with six  motifs, in spite of only having 25% amino acid 
sequence identity with AroA from E. coli. It also has approaching domains for 
ligand binding and local structural changes of certain highly flexible regions from 
disordered to ordered helical structure upon binding of the ligand (Park et al. 
2004). 
The structure of AroA from S. pneumoniae showed minor differences when 
compared to E. coli AroA with the presence of an additional short helix (310-helix) 
in certain motifs. A significant decrease in the B-factor of the C-terminal domain 
in the closed conformation was observed in comparison to the open state, as a 
consequence of ligand binding which causes a highly flexible region (331-342 in 
S. pneumoniae and 406-415 in E. coli) to transition to an ordered helical structure. 
A) B) 
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Even though the overall domain closure mechanism is similar for both 
S. pneumoniae and E. coli, they differ in rotation angles and axis angles. Salt 
bridges and hydrogen bonds are responsible for the stabilization of the 
interdomain interaction (Park et al. 2004).  
Therefore, even though the overall structure of AroA from all organisms may be 
expected to be similar, each structure shows distinct variations. 
Substrate binding and reaction mechanism:  
The interdomain cleft, formed by the two domains of AroA, harbours the amino 
acid residues responsible for ligand binding (Park et al. 2004). It was proposed 
that a macrodipolar effect was responsible for attracting the approaching anionic 
ligands such as S3P, PEP, reaction products, tetrahedral intermediate and the 
inhibitor glyphosate, and guiding them to an active site near a highly positively 
charged interdomain pocket (Stallings et al. 1991). Upon comparison of 
unliganded AroA with liganded AroA, Schönbrunn et al. (2001) explained that 
positive charge accumulates at the cleft as a result of the conformational change 
from ‘open’ to ‘closed’ states initiated by S3P binding. 
Glyphosate is known to occupy the same binding site as PEP at the active site. 
The interaction of the charged residues from the two domains of E. coli, Lys22, 
Arg124, and Lys411, with glyphosate is very likely to be similar to that of PEP. 
Conservative residues from MurA which interact with PEP (Lys22, Arg120, 
Asp305, Arg331, Arg371, Arg397) were also found to correspond to the residues 
present in the glyphosate binding site of AroA (Lys22, Arg124, Asp313, Arg344, 
Arg386, Lys411) (Schönbrunn et al. 2001). The structures of S. pneumoniae AroA 
in complex with S3P and glyphosate were compared with AroA in its tetrahedral 
intermediate form in complex with S3P and F-PEP (pseudo substrate (Z)-3-fluoro-
PEP for the formation of stable tetrahedral intermediate), agreeing that PEP and 
glyphosate share a common binding site (Park et al. 2004). The PEP/glyphosate 
binding site residues common to E. coli and S. pneumoniae AroA are shown in 
Figure 1.7.   
Analysis of the PEP binding site provides more information about the residues 
involved in the catalytic reaction of AroA. One such residue, Glu341, was 
suggested to act as the proton donor for the methylene group of PEP and involved 
in the stabilisation of PEP oxocarbenium ion. The interactions of the backbone 
nitrogen of Glu341 and interactions of the Lys411 and His385 sidechains, holds 
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the side chain of Glu341 in place. His385 may act as a proton source for Glu341, 
shifting up the pKa for Glu341. We already know that the reaction mechanism 
involves the deprotonation of S3P 5 hydroxyl group to attack C2 of PEP. The 
structure shows that the S3P 5 hydroxyl group interacts with Asp313 which 
hence may act as a proton acceptor (Schönbrunn et al. 2001).  
 
Figure 1.7: The residues present in the PEP/glyphosate binding site of AroA enzyme  
The residues (red) identified at the PEP/glyphosate binding site, common to E.coli AroA 
and S. pneumoniae AroA are shown on E. coli AroA structure (PDB1G6S) (blue). 
Substrate S3P (green);inhibitor glyphosate (orange).   
The ligand binding process adopts both the lock and key model and an induced fit 
model (Park et al. 2004). The binding of S3P follows a lock and key model as the 
binding site remains unchanged irrespective of the protein conformation (Park et 
al. 2004). The N-terminal domain of the structure possesses the S3P binding site. 
NMR spectroscopy and isothermal titration calorimetry identified a stable 
conformational change of the isolated N-terminal domain upon binding with S3P 
(Stauffer et al. 2001). The residues responsible for binding PEP or glyphosate are 
equally distributed over the C- and N-terminal domain (Stauffer et al. 2001). 
Upon binding of S3P, a conformational change of the protein brings the two 
domains together, where parts of the binding site are reorganized to accommodate 
the binding of PEP or glyphosate via the induced-fit model (Park et al. 2004).  
1.3.4 Inhibition by glyphosate 
AroA is inhibited by the broad-spectrum herbicide glyphosate. The inhibition of 
AroA by glyphosate is competitive versus PEP, and noncompetitive versus S3P 
(Sun et al. 2005). AroA enzymes can be categorised into two classes based on 
their glyphosate sensitivity. Class I enzymes (e.g. from E. coli) are naturally 
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sensitive to glyphosate. The generation of class I mutants with tolerance to 
glyphosate causes a decrease in the affinity of AroA for PEP. Class II AroA 
enzymes (e.g. from B. subtilis) have a high affinity for PEP and are naturally 
tolerant to glyphosate (Sun et al. 2005). 
Glyphosate is the main ingredient of the broad-spectrum herbicide Roundup 
(Steinrücken & Amrhein 1984b; Priestman et al. 2005b). The proposed ordered 
mechanism for glyphosate binding is that S3P has to bind to the enzyme first in 
order for glyphosate to bind. This is supported by the fact that upon mutation of 
Arg27, a residue that is important in the binding of S3P, to alanine, AroA was not 
able to bind either S3P or glyphosate (Anderson et al. 1988b; Schönbrunn et al. 
2001). It was determined that the AroA structure changes its conformation from 
an open to a closed state due to the binding of S3P and that glyphosate is not 
responsible for the structural conformational change (Schönbrunn et al. 2001). 
Lys22, Arg124 and Lys411 are residues implicated in PEP binding. A comparison 
of the interaction of the carboxyl moieties of PEP and glyphosate with Lys22, 
Arg124 and Lys411, and a comparison of the PEP binding site of MurA with the 
glyphosate binding region of AroA, provides evidence that glyphosate binds at the 
same binding site as PEP (Schönbrunn et al. 2001).    
 The determination of the mechanism and residues responsible for glyphosate 
resistance is important, especially in cases where we want to achieve inhibition. 
One such modification which gave glyphosate resistance, but also maintained a 
desirable substrate affinity, was the double mutation of T97I/P101S in E. coli 
AroA (Funke et al. 2009). Similarly, substitution of Gly96 with alanine 
(numbering corresponding to E. coli), was found to confer glyphosate tolerance. 
Mutation at Pro101 made the enzymes less sensitive towards glyphosate (Padgette 
et al. 1991; Priestman et al. 2005b). It was also found that the use of shikimate as 
an alternative substrate for AroA induces a conformational change that does not 
allow efficient binding of glyphosate thus making it insensitive to glyphosate 
(Priestman et al. 2005b). 
Based on the sensitivity towards glyphosate, AroA enzymes are therefore 
classified as Class I and Class II.  Class I and Class II AroA enzymes share less 
than 30% amino acid identity (Sun et al. 2005; Funke et al. 2009; Tian et al. 2013). 
Class I AroA are found in plants and bacteria, including Escherichia coli, 
Salmonella typhimurium, Aeromonas salmonicida, Bordetella pertussis, Petunia 
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petunia, and Arabidopsis thaliana (Tian et al. 2012; Zhang et al. 2014). Class II 
AroA have been identified in Pseudomonas strain PG2982, Agrobacterium 
tumefaciens strain CP4, Streptococcus pneumoniae, Staphylococcus aureus (Sun 
et al. 2005; Funke et al. 2009; Tian et al. 2013), Bacillus cereus (Tian et al. 2013), 
Alcanivorax sp. L27 (Zhang et al. 2014), Halothermothrix orenii H168 (Tian et al. 
2012) and Bacillus subtilis (Priestman et al. 2005a).         
1.4 MurA (UDP-N-acetylglucosamine enolpyruvyl transferase) 
1.4.1 Pathway 
Peptidoglycan (also called murein), is a polymer consisting of sugars and amino 
acids which forms a mesh-like layer outside the plasma membrane to form the cell 
wall. Its biosynthesis is a complex two-stage process. The first stage occurs in the 
cytoplasm and involves a series of Mur enzymes for the formation of the building 
block UDP-N-acetylmuramyl pentapeptide (Figure 1.8). This part of the pathway 
begins with the transfer of an enolpyruvate moiety of PEP to the 3 hydroxyl 
group of UDP-N-acetylglucosamine, catalyzed by MurA. The enolpyruvate 
moiety is then reduced to D-lactate by MurB to give UDP-N-acetylmuramate. A 
stepwise addition of amino acids by MurC to MurF forms UDP-N-acetylmuramyl 
pentapeptide (Molina-López et al. 2006; Yoon et al. 2008).  
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Figure 1.8: Flow diagram showing the cytoplasmic steps of the peptidoglycan 
biosynthesis pathway involved in the formation of UDP-N-acetylmuramyl 
pentapeptide 
UDP-GlcNac: Uridine diphosphate-N-acetylglucosamine; UDP-MurNac: UDP-N-
acetylmuramic acid; DAP: diaminopimelic acid. 
The absence of the peptidoglycan biosynthesis pathway in mammals makes it a 
very good target for the development of antibacterial agents (Du et al. 2000; 
Eschenburg et al. 2005b). The inhibition of any of the enzymes MurA to MurF 
causes the bacterial cells to loose shape and integrity, and ultimately to undergo 
cell lysis and death (Molina-López et al. 2006)  
1.4.2 Mechanism of MurA 
MurA catalyses the first committed step of peptidoglycan biosynthesis which 
involves the transfer of an enolpyruvate residue from PEP to UDP-N-
acetylglucosamine (Figure 1.1)(El Zoeiby et al. 2003). The MurA reaction 
proceeds via an addition-elimination reaction (Marquardt et al. 1993) in which a 
tetrahedral intermediate is formed by the direct attack of 3-OH of UDP-N-
acetylglucosamine on the C-2 position of PEP, followed by the elimination of 
inorganic phosphate to produce UDP-N-acetylenolpyruvylglucosamine 
(Skarzynski et al. 1996). Early studies on the mechanism of MurA suggested 
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many possible intermediates. One such study suggested a mechanism which 
involves the formation of two intermediates, with a phospholactoyl-enzyme 
tetrahedral intermediate preceding a phospholactoyl-UNAG intermediate (Brown 
et al. 1994).  
It is now known that the reaction starts by the binding of UNAG followed by PEP 
in the active site of the enzyme. A proton is transferred to PEP forming an 
oxocarbenium ion which is then joined to UNAG. This gives rise to the 
tetrahedral intermediate with both substrates covalently attached to each other. 
(Gautam et al. 2011). Here the C2 of the PEP moiety assumes the tetrahedral 
configuration whereas the C3 becomes a methyl group. A proton is then removed 
from C3 and inorganic phosphate is released to yield the vinyl ether product, thus 
re-establishing the double bond between C2 and C3 (Walsh et al. 1996; 
Eschenburg et al. 2003). Unlike most PEP utilizing enzymes, MurA cleaves the 
C-O bond of PEP to achieve the transfer of the enolpyruvyl moiety instead of the 
high energy P-O bond (Walsh et al. 1996; Eschenburg et al. 2003).   
Many studies have observed that the antibiotic fosfomycin, considered as an 
analog of PEP, irreversibly inhibits MurA through its covalent bonding to a 
cysteine residue of the enzyme. Therefore it was believed that PEP may bind to 
this cysteine residue to form a stable intermediate as part of the enzymatic 
reaction (Cassidy & Kahan 1973). This cysteine residue was identified to be at 
position 115 from the amino acid sequence of MurA that had been cloned and 
overexpressed from Enterobacter cloacae (Wanke et al. 1992). To prove that 
Cys115 is essential for MurA enzyme activity, an experiment was conducted 
where all the cysteine residues with the exception of one, were changed to serine 
by site-directed mutagenesis. Out of the mutants obtained, the only mutant 
resulting in an inactive enzyme was C115S, thus demonstrating the essential role 
of Cys115 in MurA enzyme activity (Wanke & Amrhein 1993). Another variant 
of MurA, C115A, expressed in E. coli at normal levels, however it did not show 
any enzyme activity. Such evidence obtained from mutagenesis studies, along 
with a number of NMR studies, strongly indicates that Cys115 is the active site 
nucleophile responsible for the formation of a covalent phospholactyl-enzyme 
adduct derived from the substrate PEP (Brown et al. 1994). Contrary to the above 
studies, site directed mutagenesis of Cys115 to aspartate (C115D) was performed 
in E. coli and resulted in a highly active MurA enzyme, in addition to full 
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resistance to its inhibitor fosfomycin (Kim et al. 1996a). Comparing the studies 
that give inactivity upon C115S and C115A mutations and the active C115D 
suggests a role for the carboxylate side chain of aspartate in catalytic function. 
The kinetics, thermodynamics and stereochemistry of the reaction of wild type 
MurA has been previously studied in the presence of the pseudosubstrate (Z)-
FPEP (Kim et al. 1994; Kim et al. 1995a; Kim et al. 1995b). The results from 
studies on the C115D mutant suggest that Cys115 functions as an active site acid 
involved in the initial protonation of PEP as well as the active site base in the 
elimination step. It was also observed that the difference in the nucleophilicity 
between the carboxylate side chain of Asp115 and the thiolate group of Cys115 
suggests that the formation of a covalent adduct is not required for catalytic 
activity (Kim et al. 1996a).  
1.4.3 Inhibition by fosfomycin 
Peptidoglycan is essential for bacterial cell wall synthesis and thus any inhibitor 
of the enzymes involved in the peptidoglycan synthesis would make good 
antibiotic candidates. Out of the many enzymes involved in the peptidoglycan 
pathway, MurA is the only one which is inhibited by a clinically validated 
antibiotic: fosfomycin. Fosfomycin was first isolated from a Streptomyces species 
(Christensen et al. 1969; Hendlin et al. 1969). It was found that fosfomycin was 
bactericidal in action by affecting the integrity of the bacterial cell wall. Initially 
its oral administration to mice proved to be effective against Gram negative and 
Gram positive organisms. Its oral and intravenous administration in humans 
proved to be effective and non-toxic upon clinical and pharmacological trials 
marking its potential as a broad spectrum antibiotic (Hendlin et al. 1969). The 
antimicrobial action of fosfomycin, particularly against uropathogenic strains, and 
its notable tolerability makes it effective for treating urinary tract infections 
(UTIs). UTIs are the most common bacterial infection in women and the second 
most common reason for antibiotic prescription in the world (Fadda et al. 2006; 
Keating 2013). 
Fosfomycin mimics and competes with the MurA substrate PEP in a stereo-
specific manner covalently and irreversibly via formation of a thioether bond to 
Cys115 (Skarzynski et al. 1996; Fadda et al. 2006). Near this bond, a pocket 
present between fosfomycin and Arg331 and Arg371 is strongly believed to be the 
PEP binding site (Figure 1.9) because these two arginines are conserved in 
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structural alignments of AroA enzymes and MurA enzymes. Fosfomycin forms 
various bonds with the enzyme and UNAG. The phosphonate oxygen atom of 
fosfomycin forms hydrogen bonds with positively charged residues of MurA 
(Lys22, Arg120, Arg397) and with the amide nitrogen of UNAG (Figure 1.9). The 
fosfomycin hydroxyl group also forms hydrogen bonds with the C3 hydroxyl of 
the UNAG sugar ring. These hydrogen bonds ensure the tight packing of 
fosfomycin in between the enzyme and UNAG (Skarzynski et al. 1996). The 
presence of UNAG was also found to accelerate the time-dependent inactivation 
of MurA by fosfomycin. The enzyme was tested in the presence of the unreactive 
UNAG analog, 3-deoxy-UNAG, to see whether the UNAG was participating in 
the chemistry of the reaction to cause inactivation. Both UNAG and 3-deoxy-
UNAG caused acceleration of the inactivation process, although not to the same 
extant. This suggests that UNAG may not participate in the reaction, but instead, 
it may influence the conformation of the active site necessary for the inactivation 
event (Marquardt et al. 1994).  
 
Figure 1.9: The fosfomycin and PEP binding site of MurA enzyme  
A) E. coli MurA monomer (green) with UNAG (orange) and fosfomycin (blue) bound to 
it (PDB 1UAE). The structure shows the active site with residues involved in interaction 
with fosfomycin (magenta). B) The pocket that is present between fosfomycin and 
residues Arg331 and Arg371 believed to be the PEP binding site. 
A) 
B) 
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One of the major concerns with the use of fosfomycin is the rising development of 
fosfomycin resistance. Fosfomycin resistance can be obtained in two ways: 
chromosome alterations in the strains, or encoded by plasmids. The strains which 
are chromosomally altered to gain fosfomycin resistance can have impairment in 
fosfomycin uptake, low affinity MurA or overproduction of the enzyme (El 
Zoeiby et al. 2003). Fosfomycin resistance genes can also be aquired through 
plasmids, however this constitutes only a low percentage of fosfomycin-resistant 
strains (Arca et al. 1997; Castañeda-García et al. 2013). Various mutations can 
also lead to fosfomycin resistance. Mycobacterium tuberculosis is naturally 
resistant to fosfomycin. A closer look at the MurA amino acid sequence from 
Mycobacterium tuberculosis shows that the site corresponding to C115 of 
Escherichia coli is replaced by an aspartate residue in M. tuberculosis (D117). 
The replacement of D117 with cysteine reversed the resistance making the strain 
sensitive to fosfomycin (De Smet et al. 1999). A similar result was observed in 
Escherichia coli, where C115D generated an active MurA enzyme that was 
completely resistant to fosfomycin. The mutation of C115 to glutamate (C115E) 
was also resistant to fosfomycin, however much less active in comparison to 
C115D (Kim et al. 1996a). 
The rise of fosfomycin resistance has been a motivation to find new inhibitors for 
MurA. The knowledge on the mode of inhibition by fosfomycin and its interaction 
with the enzyme and substrate will help the development of new antibiotics 
against MurA.  
1.4.4 Structure 
The overall structure of MurA comprises two very similar globular domains 
linked via two strands of four amino acids each. The structure is commonly 
described as an ‘inside-out / barrel and has six repetitive  motifs with 
three in each domain. Each domain consists of six helices and three four stranded 
 sheets (Schönbrunn et al. 1996; Skarzynski et al. 1996; Eschenburg et al. 2003; 
Oberdorfer et al. 2012). Out of the six-fold subdomain repetition of the MurA 
structure, the only repetitive element in the amino acid sequence is a short Leu-
X3-Gly(Ala) motif (Marquardt et al. 1992). This motif is responsible for the 
attachment of the folding units via hydrogen bond interactions forming three 
hydrophobic pockets per domain. The two domains are connected via a hinge 
region with high degree of rigidity and a salt bridge (Schönbrunn et al. 1996). The 
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enzyme is also known to be in an ‘open’ conformation in the unliganded state and 
acquires a ‘closed’ conformation upon ligand binding with the active site situated 
at the interdomain cleft (Skarzynski et al. 1996) (Figure 1.10). 
 
 
Figure 1.10: Cartoon representation of MurA in its open and closed forms 
A) E. cloacae MurA (PDB: 1NAW) in its unliganded ‘open’ conformation and B) E. coli 
MurA (PDB: 1UAE) bound to UNAG and fosfomycin in a ‘closed’ conformation. N-
terminal domain (red); C-terminal domain (green); UNAG and fosfomycin complex 
shown in spheres (blue). The surface represented with transparency clearly shows the 
distinction between open and closed conformations. The dashed box shows the ‘lid’-like 
loop over the active site.    
A) 
B) 
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The open conformation of the unliganded MurA has been studied from 
Enterobacter cloacae. A network of water molecules has been identified in the 
interdomain cleft which is believed to be important for the catalytic mechanism of 
the enzyme (Eschenburg & Schönbrunn 2000). These water molecules stabilise 
the catalytic residues and are displaced upon ligand binding. The open 
conformation of the enzyme can be described as a resting stage for the enzyme in 
the absence of substrates and it was observed that the open state did not have a 
specific phosphate binding site suggesting that this site may arise only in the 
closed conformation (Eschenburg & Schönbrunn 2000). The open conformation 
of the enzyme is believed to be stabilised through the repulsive forces between 
lysine-arginine residue pair (Arg397 and Lys48) in the interdomain cleft. The 
repulsive force between the two domains is neutralized upon UNAG binding 
thereby allowing the two domains to move towards each other (Schönbrunn et al. 
1996).   
The structure of MurA from Escherichia coli was successfully complexed with its 
substrate UNAG and inhibitor fosfomycin by Skarzynski et al. (1996). The MurA 
substrate UNAG comprises two parts: one uridinyl ring and an N-
acetylglucosamine moiety. The specific interactions and the hydrogen bonds 
involved in the binding of the uridinyl ring in between two hydrophobic surfaces 
provide it with a good fit and specificity. Whereas, the N-acetyglucosamine 
moiety interacts with a number of water molecules present in the active site 
pocket, and makes three hydrogen bonds involving the Asn23 and Asp305 
residues of the protein (Skarzynski et al. 1996) (Figure 1.11). The residues Asn23 
and Asp305 were found to be essential active site residues with Asp305 being 
essential for binding of UNAG and Asn23 involved in the stabilization of the 
transition states (Samland et al. 2001). Fosfomycin was found to be packed in 
between the enzyme and UNAG.  
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Figure 1.11: Essential MurA active site residues interacting with UNAG 
The figure shows the interaction of UNAG (cyan) with the essential active site residues 
Asn23 and Asp305 in E. coli MurA structure (green)(PDB 1UAE). The position of 
fosfomycin (orange) with respect to these residues and UNAG are also shown. The bond 
distances are shown in yellow dashes. Colour key for atoms: red-oxygen; dark blue-
nitrogen.   
It was proposed that the enzyme recognises the substrate UNAG and its binding 
induces a conformational change of the domains from an ‘open’ to ‘closed’ states 
accompanied with a conformational change of the highly flexible loop 111-121 
which allows the required positioning of the residue C115 to react with PEP or 
fosfomycin. Ten direct interdomain hydrogen bonds were identified which 
stabilise the closed conformation of the enzyme (Schönbrunn et al. 1996; 
Skarzynski et al. 1996). It is also observed that in a ‘closed’ conformation, a 
specific shielding of regions and unspecific overall protection associated with 
reduced flexibility, protects the enzyme towards proteolytic degradation (Krekel 
et al. 1999). Two very similar structures of MurA from Haemophilus influenzae, a 
binary complex with UNAG and a ternary complex with UNAG and fosfomycin, 
however, display a half-open conformation for the active site loop (Yoon et al. 
2008). Therefore, the active site loop potentially adopts three conformations: the 
fully open, the half-open and the closed conformation (Figure 1.12). 
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Figure 1.12: Cartoon representation of the three conformations adopted by the 
active site loop of MurA 
The N-terminal domain of the three MurA structures was superimposed to show the 
different conformations. The position of UNAG (orange) and fosfomycin (magenta) are 
shown in the active site. The loop of unliganded E. cloacae MurA (PDB 1NAW) (blue) 
adopts an open conformation, the loop of liganded Haemophilus influenza MurA (PDB 
2RL2) (red) adopts a half-open conformation and the loop of liganded E. coli MurA 
(PDB 1UAE) (green) adopts a closed conformation.    
The MurA structure follows the induced-fit mechanism of substrate binding. It is 
the interaction of the UNAG sugar nucleotide with the free enzyme that triggers 
the conformational change necessary for the binding of the second substrate PEP 
(Schönbrunn et al. 1998; Gautam et al. 2011). UNAG interacts with Arg91, 
Arg120, Ser162, Val163 and Gly164 upon binding. The oxygen atoms on the 
pyrophosphate bridge of UNAG form hydrogen bonds with the nitrogen atoms of 
Val163 and Gly164, the hydroxyl oxygen of Ser162 and arginine residues Arg91 
and Arg120 (Skarzynski et al. 1996).   
All the MurA structures determined so far share many similarities such as the two 
domain topology connected by double stranded linker, and the catalytically 
important residue C115 present on the active site loop, Pro111 to Pro121 (E. coli 
numbering).  
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1.5 Similarities of AroA and MurA and significance of ASR 
study on AroA/MurA 
The structural and functional characterisations of many AroA and MurA enzymes 
have been reported and despite only sharing ~25% (Schönbrunn et al. 1996; 
Eschenburg et al. 2003) amino acid sequence identity, these two enolpyruvyl 
enzymes share many unique mechanistic and structural similarities that could 
suggest their evolution from a single common ancestor.   
The reactions catalysed by MurA and AroA both proceed via an addition-
elimination mechanism (Skarzynski et al. 1996). The stereochemical analysis of 
AroA and MurA reactions indicate that the addition-elimination steps proceed 
with opposite stereochemistry, i.e., syn/anti or anti/syn (Kim et al. 1996b). There 
are typically two reactions that PEP can undergo: P-O cleavage or C-O cleavage. 
P-O cleavage of PEP makes the PEP fulfil the dual role of being a 
phosphorylating agent and versatile biosynthone as a precursor of a carbanion 
equivalent at C3. C-O cleavage achieves the net aldol condensation of PEP and C-
O cleavage for enol ether transfer. The latter is only achieved by MurA and AroA 
(Schönbrunn et al. 1996; Walsh et al. 1996).  
The forward enolpyruvyl transfer reaction catalysed by AroA and MurA results in 
the production of phosphate and enolpyruvyl products. In the reverse reaction, 
phosphates increase the reactivity of the enolpyruvyl products for the formation of 
PEP and S3P/UNAG. Various phosphate analogues were used to study the reverse 
reaction of AroA and MurA and it was found that the same three analogues 
promoted catalysis of the AroA and MurA reverse reaction (Zhang & Berti 2006).       
In addition to their mechanistic similarities, AroA and MurA also share unique 
protein architecture. The polypeptide chain forms two similar domains with a six 
fold repetition of motif forming an “inside-out / barrel” and the two 
domains are connected with a double stranded hinge (Figure 1.9). This unusual 
structural topology is a characteristic feature of enolpyruvyl transferases 
(Schönbrunn et al. 1996; Schönbrunn et al. 2001; Oberdorfer et al. 2012).  
Both AroA and MurA follow an induced-fit mechanism of ordered substrate 
binding which allows the initial binding of S3P and UNAG respectively to trigger 
a conformation change causing the two domains to approach each other to expose 
the active site in the interdomain cleft (Eschenburg et al. 2005a). The unliganded 
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enzyme is in an ‘open conformation and the liganded enzyme is generally in a 
‘closed’ state, both enzymes protected from proteolytic degradation in the ‘closed’ 
conformational state (Krekel et al. 1999). Twelve 100% conserved residues 
(majority of them within the active site and not all catalytic residues) and 17 other 
residues conserved in 90% of the sequences were identified upon sequence 
alignment of AroA and MurA primary structures (Schönbrunn et al. 1996; 
Eschenburg et al. 2003).  
However, it should also be noted that the length and conformation of several loops 
connecting the secondary structure as well as the length and relative orientation of 
individual  strands and helices differ between the structures of AroA and MurA 
(Skarzynski et al. 1996).    
Thus the stereochemical similarity, along with mechanistic and structural 
similarity reinforces the evolutionary relationship of AroA and MurA. However, 
despite all these similarities, it is very important to note that both AroA and MurA 
are exclusively inhibited by separate molecules, i.e., AroA is not inhibited by 
fosfomycin and MurA is not inhibited by glyphosate (Schönbrunn et al. 1996; 
Eschenburg et al. 2003). Such an inhibitor specificity can be explained by 
comparing AroA and MurA active sites which shows that positioning glyphosate 
into the active site of MurA causes clashes with Arg120 and Arg371 (E. cloacae 
numbering), is sterically hindered by the N-acetyl moiety of UNAG (Figure 1.13) 
and lacks certain residues for keeping glyphosate in place Eschenburg, 2003 #43}.  
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Figure 1.13: Sterical hindrance observed upon placing glyphosate within the active 
site of MurA  
Glyphosate (cyan) from the E. coli AroA structure (PDB 1G6S) was placed onto the 
active site of E. coli MurA (green) (PDB 1UAE). The figure shows how the position of 
glyphosate within MurA active site clashes with that of UNAG (orange) and the position 
of glyphosate with respect to residues Arg120 and Arg371 (dark blue).  
The similarities of the enolpyruvyl transferase enzymes AroA and MurA and their 
essentiality for bacterial survival make the idea of designing a compound that 
could inhibit both enzymes very appealing. Bacteria will not be able to easily 
develop resistance against such an inhibitor and thus will make an invaluable 
antibiotic candidate. However, one major obstacle for the development of such an 
inhibitor is the ordered substrate binding mechanism followed by both AroA and 
MurA. Therefore, the inhibitor should either be able to disrupt the catalytic 
reaction after the binding of S3P or UNAG or it should be able to mimic these 
first substrates and disrupt domain closure (Eschenburg et al. 2003). 
The relationship between AroA and MurA has been previously noted and 
suggested to be a result of gene duplication and divergence of function (Nicholas 
et al. 2001). AroA enzyme, being present in archaea, bacteria and eukaryotes, may 
have been present in the last universal common ancestor (LUCA) (Richards et al. 
2006; Zhi et al. 2014). MurA, on the other hand, an enzyme from the 
peptidoglycan biosynthesis pathway which is absent in archaea and eukaryotes, is 
likely to have arisen more recently than AroA. This may indicate that, following 
the gene duplication of AroA and MurA from the LUCA, the MurA enzyme may 
have specialised its function only later during the evolution of bacteria. There has 
not been any experimental study on the evolution of these enzymes. However, the 
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technique of ancestral sequence reconstruction (ASR) provide us with the 
opportunity to reconstruct ancestral AroA and MurA enzymes and compare their 
structural and functional characteristics to present day AroA and MurA enzymes 
to gain insight on their evolutionary mechanism.  
1.6 Ancestral Sequence Reconstruction  
1.6.1 ASR Technique 
Ancestral sequence reconstruction (ASR) is a technique which uses the sequences 
of contemporary proteins to infer ancestral sequences (Pauling & Zuckerkandl 
1963; Thornton 2004; Harms & Thornton 2010). Such a technique is useful for 
understanding evolutionary processes and to identify functional aspects of 
ancestral proteins (Harms & Thornton 2010). 
In 1963, Pauling and Zuckerkandl hypothesised that homologous proteins 
originate from a common ancestor following a gene duplication event (Pauling & 
Zuckerkandl 1963). The daughter genes exhibit different characteristics based on 
their independent mutations. Based on this idea they suggested that it is possible 
to determine the sequence of the common ancestor by comparing sequences of 
different homologous proteins. Comparison of homologous protein sequences can 
also give information on the relative time at which the common ancestor existed 
based on their degree of difference. The amino acid differences between the 
homologous proteins can be used to determine where the mutations occurred and 
where different species diverged from the common ancestor. The identification of 
conserved residues in a protein, within distant organisms, emphasises their role in 
maintaining the function of the molecule (Pauling & Zuckerkandl 1963). 
Important questions such as how protein sequences determine the structure and 
function of proteins and how contemporary proteins develop such diversity in 
their structure and function have been examined by using site-directed 
mutagenesis to swap functional residues between family members. Such a 
‘horizontal’ approach has many limits that can be overcome by studying the 
‘vertical’ evolution of proteins from its ancestor (Harms & Thornton 2010). Such 
studies were most commonly achieved using statistical analysis of modern day 
genes to infer evolutionary patterns until the recent advances in technology led to 
the development of ASR techniques. ASR allows us to reconstruct the ancestors 
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using phylogenetics and test the ancestors in laboratories to test evolutionary 
hypotheses and study their function and structure.  
The process of inferring an ancestral protein sequence using ASR involves five 
steps (Thornton 2004; Harms & Thornton 2010; Hobbs et al. 2012). 1) Extant 
protein sequences are collected and aligned along with outgroup sequences. A 
phylogenetic tree that describes the evolutionary relationship of the extant 
sequences is inferred. A statistical model of amino acid substitution is also 
identified. Phylogenetic methods such as Maximum Likelihood (ML) are used to 
infer the sequence at any ancestral node of the phylogenetic tree which has the 
highest probability to generate the modern day protein sequences, given the 
ancestral state, model of evolution and phylogenetic tree. 2) The DNA sequence 
coding for the ancestral protein is inferred. Ambiguous sites obtained from the 
inference can be resolved by choosing the amino acids that do not incur bias 
towards any particular feature and that are least likely to contribute to any 
structural or physiochemical effects to the protein (Hobbs et al. 2012). 3) The 
DNA sequence coding for the ancestral protein is synthesised de novo. 4) The 
synthesised ancestral gene is then cloned into an expression vector and 
transformed into bacterial cells. 5) The ancestral protein is expressed and purified 
and functionally characterised using enzyme assays and/or structurally 
characterised by crystallography. The enzyme activity can also act as internal 
control for the ancestral inference because error in inference would most likely 
result in an inactive enzyme (Thornton 2004; Harms & Thornton 2010; Hobbs et 
al. 2012). A schematic of the steps involved in experimental ancestral sequence 
reconstruction studies is given in Figure 1.14. 
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Figure 1.14: Flow diagram showing the steps involved in ancestral sequence 
reconstruction studies 
1.6.2 Methods used for ASR 
Three different methods are used for ancestral sequence reconstruction: maximum 
parsimony (MP), maximum likelihood (ML) and Bayesian inference (BI) methods. 
Most of the initial ancestral sequences were inferred by MP, which was later 
superseded by ML, and then followed by BI (Hall 2006; Williams et al. 2006; 
Hanson-Smith et al. 2010; Hobbs et al. 2012).   
1.6.2.1 Maximum Parsimony Method 
The Maximum parsimony method was one of the first methods used for ASR 
studies (Hanson-Smith et al. 2010). A parsimonious evolution represents the 
ancestral relationship in which the descent to the present day character states are 
defined by a minimum number of evolutionary changes. Given a sequence 
alignment of extant species and a phylogenetic tree describing the ancestral 
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relationship, the MP method assigns the possible ancestral sequences at each node 
of the tree to be consistent with the minimum number of nucleotide replacements 
necessary for the descendant to evolve from the common ancestor (Fitch 1971).  
During the construction of a phylogenetic tree, the determination of correct 
topology and branch length is very important. However, since the principle of MP 
method is to minimize the number of changes required, the method is known to 
underestimate the number of amino acid and nucleotide substitutions and as a 
result underestimates branch lengths. This problem does not affect the reliability 
of the phylogenetic tree as long as the evolutionary distance is less than 0.2 
nucleotide substitutions per nucleotide site for each branch (Saitou 1989). The 
study of the evolution of a particular character hugely benefits from the 
knowledge obtained from character state ancestral reconstruction. The MP method 
is found to show compositional bias during such reconstruction especially in cases 
where there is an unequal proportion of taxa with different states (Collins et al. 
1994). Another major drawback of the MP method is that it cannot distinguish 
equally parsimonious reconstructions (Yang et al. 1995; Cai et al. 2004). The 
accuracy of the reconstruction was defined to be inversely proportional to the 
number of equally parsimonious pathways (Zhang & Nei 1997).     
1.6.2.2 Maximum Likelihood Method 
To infer ancestral sequences using the maximum likelihood (ML) method, we 
need an alignment of extant sequences, a phylogenetic tree showing the historical 
relationship of these sequences and a model of evolution. ML method calculates 
the likelihood of each ancestral state at each node of the phylogeny and each 
amino acid of the sequence based on the probability of obtaining all the extant 
states given that ancestral state, tree and model. The ancestral sequence 
determined by this method will be the state with the maximum likelihood 
(Hanson-Smith et al. 2010). For all the results on evolutionary characteristics and 
structural and functional properties of ancestral proteins to be reliable, it is very 
important that we are confident of the accuracy of the reconstructed ancestral 
molecule. One of the major disadvantages of the MP method was its inability to 
quantify uncertainty (Yang 2006). However, ML method can measure the 
confidence of the ancestral state inference by calculating the posterior probability 
(Yang et al. 1995).  
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Unlike MP method, another advantage of ML is that it takes into account branch 
lengths of the tree and nucleotide and amino acid substitution models to calculate 
the likelihood function (Yang 2006). However, ML fails to incorporate sample 
uncertainty. It assumes that the alignment, phylogenetic tree and model of 
evolution used for the reconstruction to be correct and rules out the possibility of 
any alternatives to the tree and parameters. As true phylogeny is seldom known 
with certainty, the fact that ML does not accommodate sampling errors in 
parameter estimates is problematic particularly in the case of small datasets (Yang 
2006; Hanson-Smith et al. 2010). 
1.6.2.3 Hierarchical Bayesian Inference Method 
Rannala and Yang (1996) proposed a Bayesian model for the estimation of 
phylogenetic trees using a birth-death process to specify the prior distribution of 
tree topologies and branch lengths of the extant species and a Markov process to 
model nucleotide substitution (Rannala & Yang 1996). Maximum likelihood is 
used to estimate the parameters of the birth-death process and substitution model. 
The tree with highest posterior probability is chosen as the best estimate of the 
evolutionary relationship among species. This process is called empirical 
Bayesian analysis. It differs from ML method as it considers topologies and 
branch lengths as random variables instead of parameters (Rannala & Yang 1996; 
Yang & Rannala 1997). However, the calculations involved in this model 
restricted the number of species that could be used for the analysis. Hierarchical 
Bayesian analysis, on the other hand, overcomes this restriction and has an 
improved model for prior distribution of trees and speciation times (Yang & 
Rannala 1997). Hierarchical Bayesian analysis, unlike ML method, incorporates 
uncertainty by summing the likelihoods over a distribution of possible trees and 
parameter values (Huelsenbeck & Bollback 2001; Hanson-Smith et al. 2010). 
Various ways of incorporating uncertainty into the Baysian method have been 
proposed such as integration of topological uncertainty (Pagel et al. 2004), 
uncertainty about the parameters of the evolutionary model (Schultz & Churchill 
1999), and uncertainty about the tree topology, branch lengths and model 
parameters (Huelsenbeck & Bollback 2001) into inference of ancestral states 
(Hanson-Smith et al. 2010).    
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1.6.3 Accuracy of ASR 
Ancestral sequence reconstruction has become a valuable tool to study the 
evolution of proteins, structurally and functionally, and for testing various 
evolutionary hypotheses. All these studies are only relevant if the reconstructions 
are accurate, and if the reconstructed ancestors are evolutionarily relevant. 
However, we do not have any way to be certain of the reconstruction accuracy as 
we do not have actual ancestral sequences to compare them against. Only a few 
studies on bacteriophages enabled such a comparison of actual ancestor versus 
inferred ancestor, although the relevance of results obtained from artificially 
accelerated bacteriophage phylogenies to biomolecules that slowly evolve over 
millions of years is not known (Hillis et al. 1992; Oakley & Cunningham 2000). 
Experimental studies of organismal phylogenetic history are limited as they 
undergo genetic differentiation and produce phylogenies over very long periods of 
time, decades to centuries. However, bacteriophages can be manipulated to 
accelerate their evolution and thus can be used to study their phylogenies. An 
experimental analysis of the ML method accuracy was conducted by Sanson et al. 
(2002) where an SSU rDNA ancestor sequence was evolved using a PCR-based 
method and the resulting ancestor and terminal sequences were determined. This 
method is an improvement over previous bacteriophage experiments as the 
mutations were allowed to occur naturally instead of using mutagenic agents. The 
ancestors inferred using ML were more than 99% accurate and the inaccuracies 
were mainly at the base of the phylogenetic tree due to insertions, deletions and 
multiple substitutions. This provided the first biochemical experimental support 
for ancestral phylogeny inference using ML method (Sanson et al. 2002). 
Due to large biases caused by the MP method, ML has become one of the most 
popular ancestral inference methods. However, ML also suffers certain limitations 
and many researchers are of the opinion that Bayesian inference methods are 
better at analyzing complex evolutionary models and large data sets as it is 
computationally faster and more efficient than ML (Krishnan et al. 2004). A 
reconstruction of primate mitochondrial cytochrome b and cytochrome oxidase 
subunit I by ML showed changes in nucleotide frequencies within the tip 
sequences in comparison to the ancestral states, whereas the BI reconstructions 
resembled the extant sequences more closely. In this study, increased 
computational speed and feasibility of incorporating more complex evolutionary 
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models was achieved by using a ‘conditional pathway’ approach, which limits the 
number of substitutions allowed per site along each branch. Krishnan et al (2004) 
suggests that such differences in the nucleotide frequency between inferred and 
actual ancestor is the influence of bias in ML ancestral reconstruction method. To 
see if such biased reconstructions would affect inferences of functional properties, 
primate mitochondrial tRNA ancestors were inferred and evaluated in silico 
resulting in the BI inferred ancestor to be more theoretically functional than the 
ML inferred ancestor. Hence, bias in ancestral reconstruction does not solely 
affect the nucleotide frequencies but can lead to inaccuracies in functional 
predictions (Krishnan et al. 2004). Therefore, it was pointed out by Krishnan et al. 
(2004) that conclusions drawn from the study performed by Gaucher et al. (2003) 
on elongation factors using ML needs to be reevaluated. They suggest that the 
thermophilic ancestors might have been obtained as a result of ML method bias 
towards the amino acids responsible for thermostability. Williams et al. (2006) 
agrees that reconstructions using MP and ML methods could generate misleading 
results and the conclusions drawn from such experiments should be reevaluated. 
He supports this by performing an in silico evolutionary simulation study based 
on a realistic phylogenetic tree obtained from RNase A sequences. The protein 
fitness was measured as the amount of time the protein remains correctly folded. 
The proteins were pre-equilibrated before the simulation started, making it easy to 
find out the consistent biases as a deviation from the equilibrium properties. Thus 
the thermodynamics of the reconstructed ancestors were compared to the actual 
ancestors and it was observed that ML overestimated thermostability whereas BI 
did not. This is because ML tends to choose the amino acids that are not 
detrimental to the protein stability (Williams et al. 2006). A similar conclusion 
regarding the preference of BI method for the reconstruction process was obtained 
from a study using a sequence evolution simulation program (Hall 2006).  
Many studies have demonstrated contradictory results to the above mentioned 
conclusions and indicate that ancestors are more accurately inferred using ML as 
opposed to BI. For instance, one of the best known advantages of BI is its 
incorporation of uncertainty about tree topology, branch lengths and model of 
evolution. This is considered an advantage over ML, as ML ignores any 
uncertainty and assumes that the datasets are correct (Hanson-Smith et al. 2010). 
Simulation based experiments were performed to study the effect of incorporating 
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phylogenetic uncertainty on ASR accuracy. The ancestors were inferred using ML 
method and BI method incorporated with topological uncertainty and the inferred 
ancestors were compared to actual ancestors. The results showed that ML 
produced slightly higher accuracy and indicate that the use of BI with topological 
uncertainty is neither necessary nor beneficial. Thus ML can produce accurate 
ancestral reconstruction and was found to be robust to phylogenetic uncertainty 
(Hanson-Smith et al. 2010). Reconstruction of ancestral sequences of elongation 
factors across two bacterial phylogenies showed that ML reconstructions are 
robust to uncertainties and potential biases associated with ancestral inference. 
The resulting theory that ancient environments cooled progressively was 
supported by an identical cooling trend exhibited by the ancient oceans inferred 
from deposition of oxygen isotopes (Gaucher et al. 2008).  
All the above studies comparing the ASR methods are theoretical and the 
accuracy of the methods can be more reliably measured by testing the 
reconstructed ancestors in vitro or in vivo. Only one such study was performed 
experimentally to compare the accuracies of ML versus BI inferred ancestors. 
Hobbs et al. (2012) reconstructed the ancestors of structurally complex core 
metabolic enzyme LeuB from Bacillus species. Any error in the ancestral 
inference could potentially generate inactive enzymes or enzymes with 
biologically unrealistic properties. Thus, enzyme activity can be used as a 
measure of ancestral inference accuracy. Therefore, to compare the BI and ML 
reconstructions, the thermodynamic and kinetic properties of the enzymes 
reconstructed by both methods were determined. It was observed that the 
ancestors reconstructed using ML method were fully functional and the ancestral 
enzyme kinetics were comparable to the contemporary LeuB, whereas BI method 
exhibited a greater number of errors in the inferred sequences with biologically 
unrealistic thermodynamic and kinetic values (Hobbs et al. 2012). This study 
highlights the accuracy of ML in comparison to BI, however, the result is based 
on a single enzyme and similar experimental trials on other enzymes need to be 
performed to strengthen this conclusion.   
The topology of the phylogenetic tree used for reconstruction of the ancestral 
sequence of its extant taxa, and the number of taxa in the phylogenetic tree are 
important factors to consider for accurate ancestral reconstruction. Depending on 
the method of reconstruction and model of evolution used for ancestral inference, 
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the number of taxa used for the phylogenetic tree can influence the accuracy of 
the reconstruction. With some trees it is better to have a subset of species rather 
than having all species (Li et al. 2008). On the other hand, MP method can give 
more accurate reconstructions with increased sampling of terminal taxa (Salisbury 
& Kim 2001; Li et al. 2008). Recombination is widespread and depending on each 
case, it is advisable that recombination is accommodated in the ancestral sequence 
inference process, as ignoring recombination can bias phylogenetic estimation 
(Arenas & Posada 2010).   
With the exception of experiments conducted on bacteriophages, the relevance of 
which is questionable, it has to be noted that all the studies comparing the 
accuracy of various methods of ASR are theoretical. Even though simulation 
provides considerable insight, it incorporates many untested evolutionary 
assumptions. Therefore, future work is necessary to find out which method 
reconstructs ancestors that represent the true biological ancestor. More laboratory 
experiments on reconstructed proteins need to be conducted as opposed to 
simulation comparisons. Based on many studies mentioned above, ML method 
proves to be reconstructing biologically realistic ancestral molecules and should 
be used for future ancestral sequence reconstructions.  
1.7 In Vivo enzyme characterisation 
At a molecular level, the evolution of proteins with respect to their sequence, 
expression, structure and biophysical properties such as stability, aggregation and 
degradation, impact organismal fitness (DePristo et al. 2005; Couñago et al. 2006). 
However, enzyme evolution is often studied by focussing on single proteins and 
by characterising the enzymes in vitro. By doing so, the complex interactions 
occurring in a cellular context are ignored. The important evolutionary processes 
are influenced by the properties of the cellular metabolic network (Vitkup et al. 
2006). There are various uncertainties that are not taken into consideration while 
solely focussing on in vitro characteristics of proteins, such as, the influence of 
other metabolites within the system, the difference in overall conditions within the 
living cells and in vitro, and the enzyme concentration (Teusink et al. 2000). 
Therefore, it is beneficial to integrate the fields of molecular evolution and 
biochemistry for a better understanding of protein evolution (Harms & Thornton 
2013; Hobbs et al. 2015 ). 
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While in some instances the protein properties determined in vitro directly reflect 
on the cell behaviour and organismal fitness, it is not always the case (Teusink et 
al. 2000; DePristo et al. 2005). For example, it has been observed that while half 
of the enzymes from yeast glycolysis described the in vivo activity satisfactorily 
using the in vitro kinetics, the rest of the enzymes showed discrepancies between 
the in vitro and in vivo kinetic characteristics of yeast glycolysis (Teusink et al. 
2000).  
Furthermore, the technique of ASR provides an opportunity to reconstruct 
ancestral enzymes. In vivo properties of reconstructed ancestral enzymes have 
been studied and it was observed that superior in vitro properties did not translate 
into organismal fitness in vivo (Hobbs et al. 2015 ). Therefore, the use of ASR for 
resurrection of ancestral enzymes and the study of their biochemical properties in 
vitro and organismal fitness in vivo, would not only provide more information on 
the protein evolution, but also help us have a better understanding of the 
relationship between organismal fitness and protein properties. 
1.8 Using ASR to study evolution of thermophily  
One of the most intriguing questions of ancient life is understanding the role of 
thermophily in the history of Earth. There are two main proposed hypotheses for 
the evolution of thermophily. One of the early hypotheses suggests that 
thermophily is a primitive trait, as all the deep branches of the eubacterial tree are 
predominantly thermophilic groups (Woese 1987; Pace 1991; Stetter 1996). The 
second hypothesis proposes a mesophilic origin of life with the present day 
prokaryotes originating from a mesophilic last common ancestor (Forterre 1995). 
A possible way to test these hypotheses is to use ASR to reconstruct ancestral 
proteins from Precambrian bacteria, and to find their thermostabilities, as it would 
give a direct estimation of the environmental temperature the bacteria lived in at 
that time (Gaucher et al. 2003). Studies on elongation factors from Escherichia, 
Thermus and Thermotoga have confirmed such a correlation between the thermal 
optima and organism growth temperature (Arai et al. 1972; Nock et al. 1995; 
Sanangelantoni et al. 1996). A theoretical analysis performed by Gromiha et al. on 
56 globular proteins from 16 different families also confirms a direct relationship 
between environment temperature of host organisms and protein melting 
temperature with a correlation coefficient of 0.91. The temperatures in this study 
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were assigned to the proteins using either the optimal growth of the species 
involved or from in vitro experiments as stated in literature (Vogt et al. 1997; 
Gromiha et al. 1999). 
Many studies have been previously done on the evolution of thermophily using 
the technique of ASR. Elongation factors EF-Tu proteins were good candidate 
proteins to perform such a study because of their very slow rates of sequence 
divergence allowing robust reconstructions (Gaucher et al. 2003). Two 
phylogenetic trees were used to support the robustness of the interpretations and 
‘most probabilistic ancestral sequences’ were reconstructed. The most recent 
common ancestor of the mesophilic lieneage was also reconstructed. The ability 
of EF-Tu proteins to bind GDP at different temperatures was used as a measure of 
the thermostabilities of the reconstructed ancestor proteins and proteins from 
representative contemporary organisms. The results suggested that the 
paleoenvironment of ancient bacteria containing these resurrected proteins was at 
approximately 65 °C. It was also inferred that the ancestor of modern mesophiles 
lived at higher temperatures (Gaucher et al. 2003). Williams et al. expressed his 
concern about this study on elongation factors, as the reconstruction was achieved 
using maximum likelihood, and conclusions drawn from such studies can be 
incorrect if ML reconstruction overestimates or underestimates thermostability 
(Williams et al. 2006). These concerns were resolved by the future work of 
Gaucher et al. on elongation factors (EF) giving results robust to uncertainties and 
potential biases. They reconstructed ancestral EF sequences using one phylogeny 
having the hyperthermophilic lineage at the base of the bacterial tree and a second 
phylogeny placing the hyperthermophilic lineage at a more derived portion of the 
tree. The thermostabilities of ancestral EF were determined across both 
phylogenies and the results showed similar temperature trends (Gaucher et al. 
2008).  
Perez-Jimenez et al. reconstructed seven Precambrian thioredoxin enzymes (Trx) 
dating back between ~1.4 and ~4 billion years (Gyr). The conserved active site 
CXXC and Trx fold marks the existence of Trx enzymes in primitive forms of life. 
The results agree with studies performed on elongation factors (Gaucher et al. 
2003; Gaucher et al. 2008) and also indicate a primitive thermophilic environment 
and adaptation to progressive cooling (Perez-Jimenez et al. 2011). 
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Study on the evolution of thermophily has also been performed on a structurally 
complex core metabolic enzyme by reconstructing four ancestors (ANC1 to 
ANC4) of 3-isopropylmalate dehydrogense (LeuB) of Bacillus species (Hobbs et 
al. 2012). The ancestral reconstruction was proved to be accurate as the enzymes 
were functional with biologically realistic kinetics. The last common ancestor of 
LeuB from Bacillus species (ANC4) and ANC1 exhibited thermophilic 
characteristics. However, the difference in the thermophily mechanism of ANC4 
and ANC1 suggests that thermophily can be readily gained and lost through 
independent evolutionary paths and that thermophily is not a strictly primitive 
trait. The fluctuating trend in thermophily observed in this study is in contrast to 
the decreasing thermophily trend proposed by Gaucher et al. (2008), however this 
could be due to lack of enough samples (Hobbs et al. 2012). The conclusions 
drawn from Hobbs et al. (2012) are based on one enzyme. Therefore, conducting 
the study on a different enzyme would be ideal to confirm the results.   
1.9 Research Objectives 
AroA and MurA are considered to be very important antibacterial targets due to 
the essentiality of their pathways to bacteria and the absence of the pathways in 
mammals. AroA and MurA, have been widely studied for the synthesis of new 
antibiotics and both being enolpyruvyl transferase enzymes, exhibit very high 
structural and mechanistic similarities. Such similarities led to the hypothesis that 
AroA and MurA originated from a common ancestor followed by a gene 
duplication and functional diversification event. Therefore, by going back in 
evolutionary time, we may be able to see characteristic features that prove such an 
origin of AroA and MurA.  
This study is the first experimental investigation of the evolution of AroA and 
MurA from Bacillus using the technique of ASR (Figure 1.15). This study aims at 
answering three major questions: 
1) How different the ancestral AroA and MurA enzymes are to their contemporary 
enzymes with respect to their kinetic, thermal, inhibitory and structural properties?  
2)  Do ancestral AroA and MurA enzymes show any evidence of promiscuous 
inhibition in contrast to their present day exclusive inhibition by glyphosate and 
fosfomycin respectively? 
3) How robust is the technique of ASR in studying the evolution of thermophily? 
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 This is achieved through the following steps: 
1) Ancestral sequence reconstruction of AroA and MurA from Bacillus ancestors 
2) Determination of kinetic parameters and inhibitory properties of both ancestral 
and contemporary AroA and MurA enzymes 
3) Studies on the thermal properties of MurA ancestors, to investigate the 
evolution of thermophily in the Bacillus genus  
4) In vivo characterisation of AroA enzyme activity  
5) Determination of the structure of AroA and MurA enzymes from the last 
common ancestor of Bacillus genus  
 
Figure 1.15: Schematic diagram depicting the aims of this thesis  
AroA: E. coli AroA (PDB 1G6S); MurA: E. coli MurA (PDB 1UAE). The respective 
substrates are shown in magenta and inhibitors shown in cyan.  
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2 Chapter 2 
Materials and Methods 
2.1 Phylogenetics 
2.1.1 Sequences and Alignment 
All the available amino acid sequences for AroA and MurA of the Bacillus genus 
were retrieved from NCBI (http://www.ncbi.nlm.nih.gov/) and the nucleotide 
sequences were obtained from GenBank. Two of the sequences from the 
Clostridium genus were also collected to act as the outgroup. The gene accession 
numbers and strain information are listed in the Appendix A. All the sequences 
were collated in Geneious version 8.0.2 (http://www.geneious.com) (Kearse et al. 
2012) and the nucleotide sequences were verified to ensure that they exactly 
matched the amino acid sequences.     
Multiple sequence alignments of the amino acid and nucleotide sequences were 
generated in Geneious using the built in ClustalW algorithm (Larkin et al. 2007). 
The protein alignment was manually checked and adjusted wherever necessary by 
moving and/or rearranging the existing gaps. The nucleotide alignment was 
adjusted to exactly match the protein alignment. For use in different programs, 
both alignments were exported from Geneious in PHYLIP format.  
2.1.2 Determination of Models of Evolution 
The most appropriate model of protein evolution was determined using the 
program ProtTest version 2.4 (Abascal et al. 2005) based on the protein alignment 
of the contemporary sequences. The most appropriate model of nucleotide 
evolution was determined using jModelTest version 0.1.1 (Posada 2008) based on 
the nucleotide alignment of the contemporary sequences. 
2.1.3 Phylogenetic Tree Construction  
2.1.3.1 Maximum Likelihood Tree  
The programme GARLI version 1.0 (Zwickl 2006) was used to build phylogenetic 
trees under the Maximum Likelihood framework. To determine the final 
phylogeny, at least five trees were generated using GARLI and the topologies of 
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the resulting trees were compared. The ancestral root position of these trees was 
defined using Geneious by rooting the node that leads only to the outgroup 
Clostridium sequences. The best tree out of all the GARLI generated trees was 
chosen based on the most consistent topology and the highest log likelihood (lnL) 
score. 
2.1.3.2 Bootstrapping  
The bootstrap percentage gives the frequency with which a given branch occurs 
within the pseudoreplicate datasets and allows the reliability of each branch within 
the phylogenetic tree to be estimated. The phylogenetic tree generated by GARLI 
was bootstrapped by running GARLI version 1.0 (Zwickl 2006) and setting the 
field of ‘bootstraprep’ to 1024. The output file, containing 1024 trees, was opened 
in Geneious and a consensus tree was generated using a 50 % support threshold 
and 10 % burn-in. The bootstrap percentages were transposed onto the branches 
of the ‘best’ tree if those branches exist. 
2.1.4 Ancestral Sequence Inference 
2.1.4.1 Phylogenetic Analysis by Maximum Likelihood (PAML) 
PAML was used to perform the ancestral inference under the maximum likelihood 
criterion. The protein alignment was saved with an .aa extension and the 
nucleotide alignment was saved as a .nuc file. The ‘best tree’ obtained as in 
section 2.1.3.1 was exported from Geneious in Nexus format, manually edited 
into the Newick format and saved as a .tre file.  
CODEML performs ancestral inference based on amino acid and codon 
information whereas BASEML uses nucleotide information for the same. For this 
purpose, the ‘best tree’ along with the protein alignment was used by CODEML 
for the amino acid inference, while nucleotide alignment was used by CODEML 
for codon inference and by BASEML for nucleotide inference. The configuration 
files for CODEML and BASEML were edited to mainly contain the protein 
alignment filename, the best tree filename, output filename, and model of 
evolution. The program was run using command prompt and the output ‘rst’ file 
was saved for later use. 
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2.1.4.2 Generating Consensus Ancestral Sequences      
The ‘rst’ files from each of the inference runs were opened in a text editing 
program for analysis. The tree description given in the ‘rst’ file was copied into a 
new file with .tre extension. This tree file was then opened in Geneious and the 
node numbers assigned by PAML for each ancestral node was displayed. The 
ancestral sequences corresponding to the node numbers given in the tree were 
obtained from the amino acid, codon and nucleotide inference ‘rst’ files and 
Geneious was used to analyse them. The overall posterior probabilities (a measure 
of confidence of the ancestral state), also given in the ‘rst’ files, were noted down 
to confirm the choices of ancestral nodes. 
The ancestral nodes that were reconstructed were chosen based on the position of 
the node in the tree, the bootstrap percentage and posterior probabilities of the 
nodes, and sequence identity between the node and the extant sequences. Once the 
node of interest was chosen, the inferred sequences corresponding to that node 
from the three inference methods were translated into protein sequences in 
Geneious and compared to generate the final ancestral sequence. Ambiguous sites 
within the inference were resolved as described below. 
2.1.4.3 Resolving Sequence Inference Ambiguities 
The three versions of each sequence were compared to resolve sequence 
ambiguities between the three inference methods. The sites that are identical for 
amino acid and nucleotide methods but different from the codon method, and the 
sites that are chosen differently by all the three methods, were considered as 
ambiguous sites and certain criteria were followed to resolve the ambiguities. If 
the amino acid and nucleotide methods chose the same sites but differed from the 
codon method, then generally the original alignment was considered to find out 
the amino acid which is most conserved in that particular site. In cases where all 
three methods chose a different amino acid, the following criteria were used: 
(i) The distributions of the amino acids in the original alignment were 
considered and the amino acid present in the majority of the sequences 
was used. If not, the amino acid present in a functional extant protein 
was used. 
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(ii) Amino acids with conserved physicochemical characteristics between 
different contemporary species were chosen. 
(iii) The structures of the extant proteins were considered and the implication 
of each ambiguous amino acid in the structural environment was 
analysed.  
In all cases of ambiguous site determination, sequence bias from contemporary 
species branching close to the node of interest and sequence bias with respect to 
thermal adaptation was avoided. 
2.1.5 Aging Ancestral Nodes 
The programme r8s version 1.71 (Sanderson 2003) was used to estimate the age 
of each node of the tree and to convert the phylogram into a chronogram. 
Calibration points were taken from the literature (Battistuzzi et al. 2004). The 
chronogram for prokaryotic evolution, from which these calibration points were 
taken, was generated using 32 protein sequences, and molecular data and geologic 
calibration points were used to estimate their phylogenetic relationship and 
divergence times (Battistuzzi et al. 2004). To select calibration points, the node 
where two species of interest diverged was traced back and the timescale along 
the bottom of the tree was used to determine the calibration point for divergence 
of these two species. In this case, using the chronogram for prokaryotic evolution 
(Battistuzzi et al. 2004), the point of divergence of Bacillus subtilis and Bacillus 
halodurans, and the point of divergence of the Bacillus and Clostridium genera 
were determined as the calibration points. R8s fixed these calibration points to 
estimate the ages of the remaining nodes and the resulting chronogram was 
opened as a .tre file in FigTree version 1.3.1 (Rambaut 2009). Further image 
editing was performed in CorelDraw.  
2.2 Cloning 
2.2.1 Gene Synthesis  
The genes encoding for the Bacillus AroA LCA, Bacillus MurA ancestors and 
Bacillus coagulans MurA were synthesised by GeneArt (Life Technologies). The 
genes were codon optimized for expression in Escherichia coli and the restriction 
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sites BamHI and XhoI were incorporated on the 5 and 3 ends of the genes, 
respectively.   
2.2.2 Contemporary Genes 
Genomic DNA from Bacillus subtilis Marburg 168 was provided by Joel 
McMillan (University of Waikato) and used for the amplification of B. subtilis 
murA and aroA. 
2.2.2.1 Polymerase Chain Reaction (PCR)                                                                                                                                                                                                                                                                                                                                                                                                                                                
Amplification primers were designed to be 28 to 38 bp long and included the 
appropriate restriction sites at the 5 and 3 ends for the subsequent steps of 
cloning (Table 2.1). The primers were supplied by Integrated DNA Technologies 
(USA) and primer stocks were made up to 100 pmol/µl with ultrapure water. 
Table 2.1: Primer sequences 
Primer Primer Sequence 
Bacillus 
subtilis 
AroA 
F 5-TGGAAGGATCCAAACGAGATAAGGTGCAG-3 
R 5-AATCCTCGAGTAAAACTTCAGGATTTTTTCGAAAGC-3 
Bacillus 
subtilis 
MurA 
F 5-CATGCCATGGAATTGGAAAAAATCATCGTCCGCGGCG-3 
R 5-AACTGCAGTTATGCATTTAAGTCAGAAACGACT-3 
pPROEX 
F 5-AGCGGATAACAATTTCACACA -3 
R 5-TATCAGGCTGAAAATCTTCTC-3 
 *F – Forward primer; R – Reverse primer 
Genes aroA and murA were amplified from the genomic DNA of B. subtilis 
Marburg168 using iProof High-Fidelity PCR Kit (Bio-Rad) according to the 
manufacturer’s instructions. The reactions were set up to 15 l or 50 l final 
volume.  
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The following are the PCR cycling conditions and reaction concentrations: 
Steps Temperature Time 
Initial Denaturation 98 °C 2 minutes 
Denaturation 98 °C 10 seconds  
29 cycles Annealing 62 °C 30 seconds 
Elongation 72 °C 45 seconds 
Final Elongation 72 °C 5 minutes 
 
DNA template 50-250 ng 
Forward primer 0.5 M 
Reverse primer 0.5 M 
Deoxynucleotide triphosphate mix 0.2 mM 
MgCl2 1 mM 
Reaction buffer 1x 
iPROOF DNA Polymerase 1 U 
The PCR products were purified using the Qiaquick PCR Product Purification Kit 
(Qiagen) according to manufacturer’s instructions. 
2.2.3 DNA Quantification 
The Nanodrop ND-1000 spectrophotometer (Nanodrop Technologies) was used to 
measure the concentration of DNA samples at 260 nm absorbance. 
2.2.4 Agarose Gel Electrophoresis 
Agarose gel electrophoresis was used to separate DNA fragments. The agarose 
gels (1 % w/v) were made up using 1x TAE buffer (Appendix E1) and stained 
with 1x SYBR Safe DNA gel stain (Invitrogen). The DNA samples were mixed 
with 10x DNA loading dye (Invitrogen) prior to loading onto the gel. The DNA 
fragments were separated by running the gels at 100 V for 40 minutes and 
visualised on a blue light box. The DNA size was determined by comparison with 
a 1kb-Plus DNA ladder (Invitrogen).    
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2.2.5 Plasmid Preparation 
The expression plasmid pPROEX HTb (Invitrogen) was isolated from DH5cells 
which were grown overnight in LB media at 37 °C in the presence of antibiotic 
ampicillin at a final concentration of 100 g/ml. The QIAprep Spin Miniprep Kit 
(Qiagen) was used to isolate the plasmid from the cells. 
2.2.6 Restriction Digestion 
The GeneArt genes and the B. subtilis AroA gene amplified by PCR were 
digested with BamHI and XhoI. The PCR product for B. subtilis MurA was 
digested with NcoI and PstI. Restriction digestion was followed by a purification 
step using the Qiaquick PCR Product Purification Kit (Qiagen).  
The plasmid pPROEX HTb was digested with either BamHI and XhoI or NcoI and 
PstI and run on an agarose gel to separate the digested fragment from the rest of 
the plasmid. The band corresponding to the linearised plasmid was then excised 
from the gel using a scalpel and purified using the QIAquick Gel Extraction Kit 
(Qiagen). These restriction sites were used to allow an N-terminal His tag to the insert.   
2.2.7 Ligation         
Ligation reactions contained a 3:1 molar ratio of insert to plasmid, 1 U of T4 
DNA ligase, and 1x ligase buffer in a 20 l total volume (Invitrogen). The 
reaction was incubated at 16 °C overnight. 
A negative control was also set up in the same way as described above that 
contained digested plasmid.  
2.2.8 Transformation                                                                                  
2.2.8.1 Electrocompetent Cell Preparation 
DH5cells were grown on a LB agar plate in the absence of antibiotic at 37 °C 
overnight. A single colony from this plate was used to set up a 10 ml inoculum 
culture in LB broth in the absence of antibiotic at 37 °C overnight in an incubator 
shaking at 200 rpm. One litre of LB broth was inoculated with the 10 ml inoculum 
and the growth of the culture was monitored using a spectrophotometer at 600 nm 
until the optical density (O.D.) reached between 0.5 and 0.7. The flask containing 
the grown cells was cooled on ice for 20 minutes then pelleted using a Heraeus 
Multifuge 3SR Plus centrifuge at 4000 g for 20 minutes at 4 °C. The supernatant 
Chapter 2: Materials and Methods 
  47 
 
was discarded and the cells resuspended in 1 L of cold, sterilised 10 % glycerol 
and centrifuged again. This step was repeated with decreasing volumes (500 ml, 
20 ml and 2 ml) of 10 % glycerol. The final amount to resuspend the cells was 
determined based on the cell density of the initial culture. Aliquots of 50 l of the 
cell suspension were transferred into microcentrifuge tubes and immediately 
stored at -80 °C. 
2.2.8.2 Electroporation  
Electroporation cuvettes (Bio-Rad Laboratories, cuvette path length = 0.2 cm) 
were chilled on ice before transferring 20 l of the ligation reaction, 50 l of 
electrocompetent DH5 cells and 30 l of 10 % glycerol into them. 
Transformation of the ligation products was achieved by electroporation using the 
Bio-Rad Gene Pulser (Bio-Rad Laboratories) with 2.5 kV at 25 μF capacitance 
and 200 Ω resistance. One millilitre of LB broth was added to the cells 
immediately after electroporation and left to incubate at 37 °C for one hour 
shaking at 200 rpm. The cells were then plated onto LB agar plates containing the 
required antibiotic and incubated overnight at 37 °C. 
2.2.8.3 Screening of Transformants    
The number of colonies on the ligation plates was compared with the number of 
colonies on the negative control plate. If it was considerably different, with more 
colonies on the ligation plate than the control plate, the following procedures were 
used to screen the transformants: 
(i) Plasmid Restriction digestion or PCR 
A number of colonies selected from the ligation plates were grown in 5 ml of LB 
broth along with the respective antibiotic overnight at 37 °C shaking at 200 rpm. 
The plasmid from the cultures was purified as described in section 2.2.5. 
The plasmids were either digested (section 2.2.6) or a diagnostic PCR using Taq 
polymerase was performed as per the manufacturer’s instructions using pPROEX 
primers (Table 2.1) which flank either side of the multiple cloning sites. The 
reaction was run onto an agarose gel to check for the presence of the insert. 
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(ii) Colony PCR 
Colonies from the ligation plates after transformation were selected and 
resuspended in a dilute solution of the appropriate antibiotic. The resuspended 
colony acted as the DNA template in the Taq DNA polymerase PCR reaction 
using pPROEX primers. The PCR was performed with an annealing temperature 
of 52.5 °C due to the Tm of the pPROEX primers. The colonies of positive 
transformants were then grown overnight at 37 °C with appropriate antibiotic and 
the plasmid-insert complex was purified as described in section 2.2.5.  
The presence of the insert of interest in the purified plasmids was confirmed by 
sequencing using either gene primers or pPROEX HTb primers (Table 2.1).  
2.2.8.4 Glycerol Stocks 
Glycerol stocks were made up by combining 900 l of culture grown from 
positive transformants with 100 l of 80 % glycerol. The glycerol stocks were 
then stored at -80 °C. 
2.3 Protein Purification and In Vitro Enzyme Characterisation 
2.3.1 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Protein samples were analysed by separating them on a 15 % SDS-
polyacrylamide gel (Appendix E4). The protein samples were mixed with 4x SDS 
loading dye (Appendix E1) and incubated at 95 °C for 5 minutes prior to loading 
10 l of the mix onto the gel. To determine the protein size, 10 l of protein 
ladder, Precision Plus Protein Unstained Ladder (Bio-Rad Laboratories), was run 
alongside the samples. The SDS-PAGE gels were run in 1x SDS-PAGE running 
buffer (Appendix E1) at 15 mA until the samples passed the stacking gel layer, 
and at 30 mA through the resolving gel layer until the dye reached the bottom of 
the gel. 
After running, the gels were visualised by staining with Coomassie stain. The gels 
were transferred into containers, covered with Coomassie stain (Appendix E1) 
and microwaved for 30 seconds. Gels were then transferred onto a shaker and left 
shaking at room temperature (RT) for about 30 minutes. The stain was decanted 
and replaced with a destain solution of 10 % v/v acetic acid. After microwaving 
for 30 seconds, the gels were left to destain until the bands were well defined.  
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2.3.2 Measurement of Protein Concentration (Bradford Assay) 
The concentration of AroA and MurA proteins were measured using the Bio-Rad 
Protein Assay (Bio-Rad Laboratories). The Bio-Rad reactions were set up in a 96 
well microplate (Greiner Bio-One) and contained 5 l of protein sample, 40 l of 
Bio-Rad protein assay dye (Bio-Rad Laboratories). The buffer in which the 
protein is stored was added last into the Bio-Rad reaction to make up the reaction 
volume to 200 l. The absorbance was read at 600 nm using a Multiskan GO 
microplate spectrophotometer (Thermo Scientific) immediately after mixing the 
buffer in.  
A standard curve was generated using bovine serum albumin (BSA). Ten dilutions 
of BSA ranging from 0 to 1 mg/ml were made up and the absorbance measured as 
mentioned above immediately after the addition of MQ water instead of buffer. A 
standard curve was generated using the absorbance data and this curve provided a 
relative measurement of protein concentration. 
2.3.3 Small-scale Protein Expression Trial 
The glycerol stocks made up after successful cloning were used to grow 1 ml 
inocula of the strains in LB broth with appropriate antibiotic at 37 °C overnight 
shaking at 200 rpm. The inocula were used to inoculate 100 ml LB broth 
containing appropriate antibiotic and were incubated at 37 °C with shaking at 
200 rpm until the OD600nm reached between 0.5 and 0.7. A Heλios 
spectrophotometer (Thermo Fisher Scientific) was used to measure the OD600nm at 
various intervals. Samples were taken from this main culture for the following 
methods of protein expression analysis. 
2.3.3.1 Protein Expression Trial: Effect of time and pH  
One control sample of 10 ml volume was taken from the above mentioned culture 
once it reached the appropriate OD and was pelleted by centrifuging the cells at 
4500 rpm at 4 °C for 20 minutes. The supernatant was discarded and the pellet 
stored at -80 °C. Protein expression was induced in the remaining culture by the 
addition of IPTG to a final concentration of 1 mM and incubated at 37 °C with 
shaking of 200 rpm. Samples of 10 ml volume were taken periodically from the 
culture and treated in the same way as the control sample. After collecting all the 
samples, the cell pellets were defrosted and resuspended in 300 l of Lysis Buffer 
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(50 mM Tris-HCl pH 7.5, 300 mM NaCl, 20 mM imidazole). The resuspended 
cells were transferred into microcentrifuge tubes and sonicated on ice using the 
Ultra sonic processor XL 2020 sonicator (Misonix incorporation) (micro tip, 
setting 5, 4 x 15 seconds bursts with 30 second interval in between). The 
sonicated cells were centrifuged at 13,000 rpm at 4 °C for 20 minutes to separate 
the soluble and insoluble fractions. The protein concentration present in the 
supernatant was measured using a Nanodrop ND-1000 and approximately 10 g 
of total protein was loaded onto a 15 % SDS-PAGE gel along with 1 l of the 
insoluble pellet diluted with Lysis Buffer for analysis. 
This method of protein expression testing was also used to perform a lysis buffer 
screen. Instead of taking samples periodically, seven samples of 10 ml volume 
were taken from the main culture after incubating the culture overnight and 
pelleted as previously described. Each of these pellets were resuspended with lysis 
buffers of different pHs (Appendix E2) and then treated in the same way as the 
time course samples.  
2.3.3.2 Ni2+-Sepharose Bead Protein Expression Trial 
Ni
2+
-sepharose beads were used to test for the expression and his-tag binding 
affinity of the proteins. A pellet from a 10 ml sample taken from a culture grown 
overnight (post induction with IPTG) was resuspended with 300 l of Lysis 
Buffer. The cells were sonicated as previously mentioned and centrifuged at 
13,000 rpm at 4 °C for 20 minutes. The Ni
2+
-sepharose high performance beads 
(GE Healthcare) were equilibrated with Lysis Buffer by mixing the beads with the 
buffer, allowing the beads to settle down and then centrifuging at 3000 rpm at RT 
for 30 seconds. The buffer supernatant was removed and the beads were loaded 
with 300 l of the supernatant from the centrifuged cell lysate. The beads with the 
load were incubated in an Eppendorf ThermoMixer comfort at 22 °C with shaking 
at 1000 rpm for 15 minutes. The beads were then allowed to settle before 
centrifuging for 30 seconds at RT at 3000 rpm. The supernatant was removed and 
kept aside. The beads were then washed with 1 ml Lysis Buffer three times. For 
the analysis of the protein expression, the pellet obtained after sonication (pellet), 
the supernatant used as the load (load), the supernatant after the incubation with 
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the beads (flowthrough), the first wash (wash 1) and the Ni
2+
-sepharose beads 
(beads) were loaded onto a 15 % SDS-PAGE gel.  
2.3.4 Large-scale Protein expression  
The glycerol stocks of the strains of interest were used to grow inoculum cultures 
in 10 ml LB broth in the presence of appropriate antibiotic overnight at 37 °C. The 
inocula were used to inoculate 1 L of LB broth in the presence of antibiotic and 
left to grow in a shaking incubator at 200 rpm at 37 °C until the OD600nm reached 
between 0.5 and 0.7. Once the cultures reached the right OD, protein expression 
was induced with the addition of IPTG at a final concentration of 1 mM. AroA 
protein expression was achieved overnight at 37 °C while MurA protein 
expression was achieved overnight at 18 °C (Du et al. 2000).The cells were then 
pelleted by centrifugation at 4 °C at 4500 rpm for 20 minutes. The pellets were 
stored at -80 °C. 
2.3.5 Immobilised Metal Affinity Chromatography (IMAC)  
Cell pellets obtained from the large-scale protein expression were thawed, 
resuspended in 20 ml of Lysis Buffer and sonicated on ice using a microtip 
(setting 5) for 6x 15 second bursts with 30 seconds interval in between. The 
insoluble protein fraction was separated out by centrifugation at 4 °C for 20 
minutes at 13,000 rpm. A 5 ml HisTrap FF nickel affinity column (GE Healthcare) 
was washed with four column volumes (CV) of MQ water and primed with four 
CV of Lysis Buffer.  The supernatant from the lysed cells was filtered through 1.2, 
0.45 and 0.2 μm Minisart filters (Sartorius AG) prior to being loaded onto the 
HisTrap column which was in turn attached to an ÄKTA Prime, ÄKTA Basic or 
ÄKTA Purifier FPLC system (GE Healthcare). Unbound protein was removed by 
washing the column with Lysis Buffer at a flow rate of 1 ml/min until the 
absorbance at 280 nm dropped to baseline. Bound proteins were eluted with a 
gradient from 0-100 % elution buffer (50 mM Tris-HCl pH 7.5, 300 mM NaCl 
and 1 M imidazole) at a flow rate of 1 ml/min over 50 ml and collected in 2 ml 
fractions. The fractions corresponding to the peak/s at 280 nm on the resulting 
chromatogram were analysed using SDS-PAGE for the protein of interest (section 
2.3.1). 
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2.3.6 Size Exclusion Chromatography (SEC) 
Size exclusion chromatography was used to further purify proteins following 
nickel affinity chromatography. The size exclusion column to be used, either a 
Superdex 200 10/300 or a Superdex 75 10/300, depending on the size of the 
protein (GE Healthcare), was equilibrated with SEC buffer (50 mM Tris-HCl 
pH 7.5 and 300 mM NaCl). The protein fractions from the nickel purification 
were concentrated by centrifugation in 2 ml or 20 ml Vivaspin concentrators 
(Sartorius AG) with a 10 kDa cut off at 4 °C at 3300 rpm and passed through a 
0.2 m filter prior to loading onto the size exclusion column. Proteins were eluted 
from the size exclusion column with SEC buffer at a flow rate of 0.5 ml/min. 
Fractions of 0.5 ml were collected and fractions corresponding to the peak/s at 
280 nm on the resulting chromatogram were analysed using SDS-PAGE for the 
protein of interest (section 2.3.1). 
2.3.7 Enzyme Assays 
2.3.7.1 Standard Malachite Green Assay 
Malachite green assay reactions were set up in 96 well microplate (Greiner 
Bio-One) (Baykov et al. 1988). The reaction mixture consisting of the substrates 
and assay buffer (50 mM Tris-HCl pH 7.5 for MurA and 300 mM Tris-HCl 
pH 7.5 for AroA) was pre-equilibrated by incubating the plates at the reaction 
temperature for 10 minutes. Reactions were started with the addition of enzyme, 
thus making the total volume of 100 l, and incubated at the reaction temperature 
for a set reaction time before being stopped by the addition of 30 l of stop 
solution (9.4 % (w/v) malachite green, 13 % (v/v) sulphuric acid, 1.5 % (w/v) 
ammonium molybdate and 0.16 % Tween 80). Colour development was achieved 
by incubating the plates at RT for 5-10 minutes and the absorbance at 620 nm 
measured using a Multiskan GO microplate spectrophotometer (Thermo 
Scientific). All the reactions were performed in triplicate along with blank 
reactions containing no protein. 
2.3.7.2 Phosphate Standard  
A 10 mM stock of KH2PO4 was prepared and diluted to make a working stock of 
100 M. The working stock was diluted serially six times in assay buffer in a 1:1 
ratio to give a concentration range of 50 M, 25 M, 12.5 M, 6.25 M, 3.13 M 
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and 1.56 M in a total volume of 100 l. The standard solutions were prepared in 
duplicate and the malachite green assay was performed as described in section 
2.3.7.1. The absorbance measured at 620 nm for 100 l of assay buffer (Blank: 
0 M KH2PO4 concentration) was subtracted from the absorbance measured for 
the phosphate samples. The resulting data were plotted in Excel and a standard 
curve was generated. 
2.3.7.3 Time Course Assay 
A time course assay was performed to determine the reaction time, which is the 
time for which the reaction was allowed to proceed before adding the stop 
solution. A master mix was prepared in a microcentrifuge tube which consisted of 
a non-limiting amount of substrate (Substrate KM of MurA enzyme was taken 
from Blake et al (2009) and substrate KM of AroA enzyme was taken from 
Priestman et al (2005)) and assay buffer. The reaction mix was incubated at 37 °C 
for 10 minutes before adding the enzyme. Samples (100 l) were taken at 
different time points ranging from 0-10 minutes, stopped with 30 l of stop 
solution and absorbance measured at 620 nm. A graph of absorbance at 620 nm 
versus time was plotted in Excel and the reaction time was determined manually 
from the graph. 
2.3.7.4 Michaelis-Menten Kinetics 
Preliminary trials were performed to determine the appropriate enzyme 
concentration and concentration range of the substrates for the determination of 
Michaelis-Menten kinetics using the malachite green assay. Stock solutions of 
substrates were prepared in assay buffer and enzymes were diluted to appropriate 
concentration for the assays and stored in SEC buffer. The AroA and MurA 
enzymes catalyse reactions in the presence of two substrates. Hence, to determine 
the KM for each of the substrates, the concentration of one of the substrates was 
maintained in excess while altering the concentration of the other. The total 
reaction volume was maintained at 100 l and the malachite green assay was 
performed as explained section 2.3.7.1.  
The Michaelis-Menten kinetics were initially determined at 37 °C and the KM 
obtained for each substrate was used as a reference to determine how much excess 
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(generally 5x KM or 10x KM whenever possible) should be added in assays 
performed at higher temperatures.  
The optimum temperature for enzyme activity (Topt) was measured as below in 
section 2.3.7.5. The Michaelis-Menten kinetics were also measured at the Topt of 
each enzyme, to obtain comparable data between enzymes. Graphpad Prism 
version 5.01 (Graphpad Software) was used to fit the Michaelis-Menten equation 
to the data and determine the KM and Vmax values. The Vmax generated by Prism, in 
absorbance/s format, was converted to concentration/s format using the phosphate 
standard curve generated in section 2.3.7.2 prior to calculating kcat of the reaction.  
2.3.7.5 Determination of Optimum Temperature (Thermoactivity Topt)  
The optimum temperature of enzyme activity was determined by performing the 
AroA/MurA reactions at different temperatures and their activity measured using 
malachite green assay as described in section 2.3.7.1. The reactions were set up 
with non-limiting amounts of substrate based on the Michaelis-Menten kinetics 
measured at 37 °C. Initial trials were performed at a broad temperature range from 
20 °C to 80 °C at 10 °C intervals. A narrower temperature range was then 
investigated. Blank reactions were set up for every temperature to eliminate any 
contribution of temperature to free phosphate. The optimum temperature of 
enzyme activity was obtained by plotting the reaction rate at each temperature. 
The assays were repeated multiple times to confirm the validity of the results. 
2.3.7.6 Half Maximal Inhibitory Concentration (IC50) 
The AroA/MurA enzyme reactions in the presence of their respective inhibitors 
were set up and enzyme activity was quantified using the malachite green assay to 
measure the amount of inhibitor needed to inhibit the enzyme reaction by 50 %. 
Inhibitor stocks were made up in assay buffer and serially diluted to provide 
stocks of varying concentrations. The 100 l reaction was set up with constant 
amounts of substrates, varying concentrations of the inhibitor and assay buffer. 
The enzyme was added last to start the reaction. The concentration of enzyme 
added was kept constant at approximately 6 g/ml in all the IC50 assays. Graphpad 
Prism version 5.01 (Graphpad Software) was used to plot the log inhibitor 
concentration against enzyme activity and found the IC50 using the ‘log(inhibitor) 
vs. response -- Variable slope’ function in Prism.  
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2.3.8 Determination of Thermostability 
2.3.8.1 Differential Scanning Calorimetry (DSC) 
Thermostabilities of enzymes were measured by differential scanning calorimetry 
(DSC) in a TA Instruments Nano DSC at the University of Canterbury, 
Christchurch. The sample and reference cells were loaded with their respective 
samples and the system was set to ramp up from 20 °C to 90 °C at 1 °C/min. For 
the blank runs, both the sample and reference cells were loaded with the buffer the 
protein was stored in. For the sample runs with protein, 0.5 mg/ml of enzyme was 
loaded in to the sample cell and its respective buffer in the reference cell. The 
NanoAnalyze software was used to set the baseline and find the peak representing 
the Tm in power input for each enzyme. The raw data were exported to Excel and 
a graph was plotted after subtracting the baseline data from the analysis data.  
2.3.8.2 Protein Melt Analysis 
The estimation of Tm was also achieved for some enzymes using a 
RotorGene-6000 Real-time PCR machine (Corbett Research). To prepare the real-
time melt reaction mixtures, buffer solutions of different pHs ranging from pH 4 
to pH 10 were prepared (Appendix E2).  The 5000x SYPRO orange protein stain 
dye (Sigma Aldrich) was diluted to 300x using each different pH buffer. A 
volume of 7.5 l diluted dye was transferred into PCR tubes. Protein was added to 
the dye at a final concentration of 0.1 mg/ml, 0.2 mg/ml or/and 0.4 mg/ml in total 
volume of 25 l and the reaction was made up to the total volume with the 
appropriate buffers. Blanks were set up containing dye and buffer of different pH 
at a volume of 25 l.  
The tubes were placed into a 36-tube rotor in the RotorGene-6000 Real-time PCR 
machine. The run was set up to increase the temperature from 25 °C to 99 °C with 
an increment of 0.2 °C with 5 seconds delay between each increment. The 
fluorescence of the samples at an excitation wavelength of 470 nm and an 
emission wavelength at 555 nm was monitored. The resulting data were exported 
from the RotorGene software version 1.7 (Corbett Research) to an Excel 
spreadsheet, blank data subtracted from sample data and fluorescence vs. 
temperature data plotted.  The first derivative of each dataset was taken and 
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plotted using Prism. The Tm was then determined manually to be the middle of the 
peak, which is equivalent to the inflection point of the original melt slope. 
2.3.9 HPLC Purification of S3P 
The column used for the HPLC purification of shikimate-3-phosphate (S3P) was a 
DiscoveryBIO wide pore C18 HPLC column (Sigma-Aldrich). The column was 
maintained at 40 °C with a flow rate of 1 ml/min. The injection volume was 
200 l and S3P was monitored at 215 nm. Multiple mobile phases were attempted: 
0.1 % trifluoroacetic acid (TFA), 0.1 % TFA in the presence of an ion pairing 
reagent (5 mM tetramethylammonium bromide) and 10% acetonitrile (ACN).  
2.4 In Vivo Enzyme Characterisation 
The parent strain E. coli K-12 BW25113 and its ΔaroA derivative were obtained 
from the Keio collection (Baba et al. 2006). Electrocompetent cells were made 
using the protocol described in section 2.2.8.1. The plasmid pPROEX HTb 
containing the Bacillus AroA LCA gene and pPROEX HTb with B. subtilis AroA 
gene were transformed into the ΔaroA strain as described in section 2.2.8. As 
controls, the empty pPROEX HTb plasmid was transformed into the parent strain 
and the ΔaroA strain. 
To test the complementation of the ΔaroA strain by B. subtilis aroA and Bacillus 
LCA aroA, the strains were grown in 1 ml of LB broth with appropriate antibiotic 
at 37 °C shaking at 200 rpm.  A final concentration of 100 g/ml of ampicillin and 
30g/ml of kanamycin was added to all the cells except the parent strain with 
empty pPROEX HTb which was grown in absence of kanamycin. The cells were 
pelleted by centrifugation at 4 °C for 10 minutes at 4000 rpm and the supernatent 
discarded. The cells were washed with 1 ml of M9 minimal media (Appendix E3) 
in the presence of antibiotic. Finally, the cells were pelleted again and 
resuspended in 1 ml of M9 minimal media to remove all the residual LB.  
The cells were serially diluted to 1/10, 1/100, 1/1000 and 1/10,000 concentrations 
using M9 minimal media containing appropriate antibiotic, a final concentration 
of 1 mM IPTG and glucose as the sole carbon source. The undiluted culture and 
each dilution was spotted onto an M9 agar plate containing antibiotic, a final 
concentration of 1 mM IPTG and glucose as the carbon source. Each culture was 
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spotted by pipetting 20 l drops onto the plates. The plates were grown for 24 to 
36 hours at 37 °C and the growth monitored.   
2.5 Protein Crystallography 
2.5.1 Determination of Initial Crystallisation Conditions 
For the purpose of laying down crystal trays to determine the initial crystallisation 
conditions for the protein, purified protein after size exclusion chromatography 
was concentrated to approximately 200 l. Four sets of crystallisation screens, 
PEGRx HT - HR2-086, Crystal Screen HT - HR2-130, Index HT - HR2-134, and 
SaltRx HT - HR2-136 (Hampton Research), were used to test for the best 
condition by the sitting drop method. Each screen contained 96 crystallisation 
conditions and 100 l of each of these solutions was transferred into the reservoirs 
of four 96-2 low profile Intelli-Plate protein crystallisation plates (Hampton 
Research). A Mosquito crystallisation robot (TTP LabTech Ltd.) was used to 
pipette 100 nl of protein and 100 nl of mother liquor before dispensing onto the 
sitting drop wells of the Intelli-Plate. The plates were sealed using a ClearSeal 
film (Hampton Research) and incubated at 18 °C. The drops were checked 
regularly for crystal growth. 
2.5.2 Fine Screening to Optimize Crystallisation Conditions        
2.5.2.1 Standard Fine Screens 
The hanging drop vapour diffusion method of crystallisation was used to optimise 
the crystallisation conditions. The top of each well of a 24-well VDX plates 
(Hampton Research) was greased using glissealN grease (Borer Chemie) and 
based on the crystallisation conditions that grew the best crystals among the four 
robot screens, 500 l of mother liquor varying in pH, and concentration of other 
components were added to the wells. One microlitre of protein was laid onto the 
center of a 22 mm siliconised cover slip (Hampton Research) and mixed with 1 l 
of mother liquor taken from each respective well. The cover slip was then inverted 
over the pre-greased well containing the mother liquor and pressed down to seal. 
Fine screens plates were incubated at 18 °C and checked for crystal growth as for 
robot screens.  
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2.5.2.2 Additive Fine Screens 
Once an optimised crystallisation condition had been determined, a screen of 14 
different additives was performed by adding each additive to the crystallisation 
condition and setting up the drops as described in section 2.5.2.1. The additives 
used and their final concentration are given in (Table 2.2). 
Table 2.2: Additives used in additive screens 
Additive Final Concentration 
Co(II)Cl2.6H2O 0.01 M 
MgCl2.6H2O 0.01 M 
Ni(II)Cl2.6H2O 0.01 M 
CsCl2 0.1 M 
Glycine 0.1 M 
EDTA 0.01 M 
Glucose 3 % 
Sucrose 3 % 
Glycerol 3 % 
PEG 400 5 % 
Ethanol 3 % 
Methanol 3 % 
Acetonitrile 4 % 
Butanol 0.7 % 
2.5.2.3 Trypsin treatment 
Purified protein was mixed with trypsin (1 mg/ml stock) at a 1:500 mass ratio and 
immediately used for the hanging drop diffusion method (section 2.5.2.1). The 
drops were set up by mixing 1 l of protein-trypsin mixture with 1 l of mother 
liquor from respective wells.  
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2.5.2.4 Seeding 
The batch seeding method was used to improve the quality of the crystals. A fine 
screen drop containing crystals or microcrystals was transferred into a 
microcentrifuge tube, mixed with 18 l of mother liquor, thus diluting it 10-fold, 
and thoroughly vortexed to produce a seed stock. The seed stock was then serially 
diluted to make stocks of 1:10, 1:100 and 1:1000. Finally, the seed stock and the 
diluted stocks were mixed with protein in a 1:1 ratio and placed over the reservoir 
for hanging drop diffusion method (section 2.5.2.1). 
2.5.3 Data Collection 
Cryo-protectant solutions of the mother liquor containing 5 %, 10 %, 15 % and 
20 % (v/v) glycerol were prepared. Protein crystals were picked up from their 
original drops using a cryo-loop (Hampton research) and soaked through each of 
these cryo-protectants or directly into the mother liquor containing 20 % (v/v) 
glycerol. The cryo-protectant soaked crystals were snap frozen using liquid 
nitrogen and transferred into pucks. 
X-ray diffraction data were collected at the Australian Synchrotron, Melbourne, 
Australia using the MX1 or MX2 beam line. An ADSC Quantum 210r detector 
(Area Detector Systems Corp.) was used to measure reflections. The strategy 
function of MOSFLM (Leslie & Powell 2007) was used in certain cases to assist 
optimal data collection. As the data was collected, each dataset was auto processed 
at the Australian Synchrotron.  
2.5.4 Data Processing     
The X-ray diffraction data collected were indexed using XDS and scaled using 
Aimless (Evans & Murshudov 2013) at the Australian Synchrotron. The resulting 
log file was examined for the completeness, mosaicity and resolution of the 
collected dataset. Once these parameters were verified, the .mtz file was directly 
used for the following steps. 
2.5.4.1 Truncate 
The programme Truncate (French & Wilson 1978) in the CCP4 suite (Winn et al. 
2011) was used to ensure unique data and to generate a FreeR set for 5 % of the 
data. 
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2.5.4.2 Matthews Coefficient 
The output file from Truncate was used to determine the number of monomers 
present in the asymmetric unit using MATTHEWS_COEF programme (Matthews 
1968) in the CCP4 suite (Winn et al. 2011). The programme calculated the solvent 
occupancy of the unit cell which was used to determine the number of monomers 
in the asymmetric unit.   
2.5.4.3 Molecular Replacement 
Molecular replacement was performed using Phaser (McCoy et al. 2007) within 
the CCP4 suite (Winn et al. 2011). Suitable models for molecular replacement 
were obtained by finding structural homologues via NCBI BLAST (Johnson et al. 
2008). Molecular replacement for Bacillus MurA LCA structure was performed 
using the structure of Bacillus anthracis MurA (PDB 3SG1) and molecular 
replacement for Bacillus AroA LCA structure was performed using the structure 
of Bacillus halodurans AroA (PDB 3RMT). For datasets with high Rmerge, a 
resolution cutoff was set up during this step.     
2.5.4.4 Model Building and Refinement 
Automated model building was achieved using Buccaneer (Cowtan 2006) in the 
CCP4 suite (Winn et al. 2011) for Bacillus MurA LCA and using Autobuild 
(Terwilliger et al. 2008) within PHENIX (Adams et al. 2010) for Bacillus AroA 
LCA. Iterative rounds of manual building was performed using COOT (Emsley & 
Cowtan 2004) with electron density maps contoured to 1 Model refinement was 
achieved using refmac5 (Murshudov et al. 2011) in CCP4 suite (Winn et al. 2011) 
and/or PHENIX Refine (Afonine et al. 2012) within PHENIX (Adams et al. 2010). 
2.5.4.5 Structural Analysis 
All structural images illustrated in this thesis were generated using PyMOL 
version 2.5.4 (Schrödinger 2010). The average B factors and total number of 
atoms in the structure were obtained using the Baverage programme in the CCP4 
suite (Winn et al. 2011). PDBePISA (Krissinel & Henrick 2007) was used to 
determine the interface interaction between two subunits involved in an 
oligomeric formation. PDBsum (Laskowski 2001) was used to determine the 
bonds involved in the protein-substrate interaction. The closest structural 
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homologues from the PDB archive were identified using PDBeFOLD (Krissinel 
& Henrick 2004). 
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3 Chapter 3 
 MurA 
3.1 Introduction 
Many studies have focused on exploring the structure and function of the MurA 
enzyme as it is a very attractive antibiotic target. In spite of all these studies, very 
little is known about the evolution of MurA. I chose ancestral sequence 
reconstruction (ASR), as a powerful tool to study protein evolution of MurA. This 
has previously been used for the reconstruction of ancestral enzymes such as -
lactamases (Risso et al. 2013) and structurally complex core metabolic enzymes 
such as LeuB (Hobbs et al. 2012).  
Comparing the structural and functional properties of ancestral MurA enzymes 
reconstructed by ASR to those of MurA contemporary enzymes can provide 
insight into the evolution of MurA. Functional characterisation of the MurA 
enzymes includes determination of the enzyme’s kinetic parameters, inhibitory 
properties and thermal properties such as thermostability and thermoactivity. The 
most common way of determining such properties for MurA is by monitoring the 
inorganic phosphate released by the MurA reaction. This can be done using either 
a MurA-MurB coupled assay (Biery 2007), continuous spectroscopic assay using 
purine nucleoside phosphorylase (PNP) and 2-amino-6-mercapto-7-methylpurine 
riboside (MESG)  (Molina-López et al. 2006; Blake et al. 2009) and/or the most 
commonly used method, the malachite green assay (Lanzetta et al. 1979; Du et al. 
2000; Baum et al. 2001; Jin et al. 2009). Due to its simplicity, effectiveness and 
sensitivity, a modified malachite green method was used to characterise the MurA 
enzymes (Baykov et al. 1988).        
The thermal properties of MurA enzymes also provide information on the host 
organism growth temperature (Gromiha et al. 1999). Such a correlation can be 
exploited to study the evolution of thermophily using ancestral MurA enzymes 
reconstructed by ASR. The Bacillus genus is an ideal model to study the evolution 
of thermophily as the contemporary species live in a wide range of thermal 
habitats. Furthermore, ancestral reconstruction was found to have been previously 
successful using the Bacillus genus (Hobbs et al. 2012). Therefore Bacillus MurA 
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ancestral and contemporary enzymes were used as the candidates for the 
evolutionary study of MurA. 
This chapter describes the kinetic, inhibitory and thermal properties of ancestral 
Bacillus MurA in comparison to selected contemporary Bacillus MurA enzymes 
to shed some light on the evolution of MurA. Additionally, the thermal properties 
of reconstructed ancestral MurA enzymes are used to study the evolution of 
thermophily.    
3.2 Results and Discussion 
3.2.1 Phylogenetic Analysis and ASR 
3.2.1.1 Sequence Alignment 
All the amino acid and nucleotide sequences of Bacillus species available as at 
November 2011 were collected from online databases (Accession numbers, 
species and strain details are provided in Appendix A). A total of 20 MurA 
sequences from Bacillus species, inhabiting mesophilic and moderately 
thermophilic environments, were retrieved. The alignment of these sequences, 
along with two Clostridium MurA sequences (outgroup sequences) has an overall 
33.3 % of identical sites. The exclusion of the Clostridium MurA outgroup 
sequences from the alignment revealed that the Bacillus MurA sequences are well 
conserved (50.2 % identical sites). The inclusion of the outgroup in the alignment 
only decreases identical sites by 16.9 %, thus proving that the outgroup chosen is 
appropriate by being close enough to the ingroup sequences to provide a robust 
alignment but at the same time distant enough to be a clear outgroup (Salemi & 
Vandamme 2003). Out of the 20 sequences used for the alignment, seven MurA 
sequences were taken from Bacillus species that inhabit a temperature range of 
25-30 °C, four sequences from 45-50 °C and nine sequences from 37 °C.  
Various conserved residues found in MurA have been identified in the literature. 
The Bacillus MurA alignment showed the presence of many universally 
recognised conserved residues (the alignment given in Appendix B). For example, 
Arg401 contributes to the phosphate binding site, Asp50 is involved in a salt 
bridge in E. coli MurA (Skarzynski et al. 1996) and Leu34 forms a hydrophobic 
pocket with other residues to connect two of the MurA structural subunits 
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(Schönbrunn et al. 1996). Many conserved residues that have been identified to be 
involved in ligand binding interactions such as Lys22, Arg124, Asp373, Leu374, 
Cys119 and Asp309 (Schönbrunn et al. 1996; Skarzynski et al. 1996; Takahata et 
al. 2010; Shahab et al. 2014) are also conserved among Bacillus MurA sequences 
(numbering corresponds to the sequence alignment in Appendix B).  
The high sequence identity between the Bacillus MurA sequences implies a 
higher accuracy for the phylogeny that is inferred from them (Kumar & Filipski 
2007). This also confirms that these sequences have evolved from a common 
ancestor and phylogenetic analysis based on these sequences will result in a 
biologically relevant phylogenetic tree (Brown 2002). 
3.2.1.2 Phylogenetic Analysis 
The characterisation of protein evolution requires the determination of an 
appropriate model of evolution which gives the probability of change from one 
amino acid to another. ProtTest version 2.4 was used to choose the best model of 
amino acid evolution for MurA sequences based on the alignment of the MurA 
sequences (Abascal et al. 2005). ProtTest chose the LG model as the best model 
for evolution, which is a sophisticated model that incorporates evolutionary rate 
variability across sites in the matrix estimation (Le & Gascuel 2008). 
The model of evolution and amino acid alignment were used in GARLI 1.0 
(Zwickl 2006) to generate five phylogenetic trees based on the ML criterion. Each 
phylogenetic tree was rooted with Clostridium sequences as the outgroup. Four 
out of the five phylogenetic trees had equal log likelihood score of -6055 with 
identical positions of tree branches, suggesting it to be the most plausible 
branching pattern and therefore phylogeny. 
The phylogeny of Bacillus MurA was confirmed with the help of bootstrap 
percentages and by comparison to other Bacillus phylogenetic trees from the 
literature (Nakamura & Jackson 1995; Fritze & Pukall 2001; Nogi et al. 2005; 
Alcaraz et al. 2010; Hobbs et al. 2012). Bootstrapping was achieved as described 
in section 2.1.3.2. The bootstrap values ≥50% are displayed in Figure 3.1.  
The MurA phylogenetic tree (Figure 3.1) reproduced the previously observed 
phylogenetically conserved clades: the soil clade, the pathogenic clade and the 
halophile clade (Alcaraz et al. 2010). The positions of species in the MurA 
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phylogenetic tree are consistent with phylogenetic trees constructed by Alcaraz et 
al. (2010) and Hobbs et al. (2012). The phylogenetically conserved clades were 
identified in both Bacillus MurA and LeuB phylogenetic trees (Figure 3.1 and 
Figure 3.2).  Bacillus atrophaeus is very closely associated with Bacillus subtilis 
and is therefore grouped within the soil clade (Fritze & Pukall 2001). Bacillus 
cereus and Bacillus thuringiensis are grouped together and the position of 
Bacillus mycoides in the pathogenic clade is consistent with previous taxonomic 
classifications (Nakamura & Jackson 1995). Based on 16s rRNA analysis, 
Bacillus pseudofirmus has been shown to be part of the halophile clade along with 
Bacillus halodurans and Bacillus clausii (Nogi et al. 2005).   
Four ancestors were chosen from the phylogenetic tree (Figure 3.1) for sequence 
reconstruction with each ancestor progressively going back in evolutionary time. 
LCA represents MurA from the last common ancestor of the Bacillus genus. 
ANC3 was chosen to be reconstructed as it only differs from ANC2 by the 
presence of Bacillus selenitireducens, yet it is more distant from ANC2 and closer 
to LCA. Therefore, analysis of the properties of ANC3 would not only provide 
information on the evolution of MurA, but allows us to determine any bias 
imposed by the B. selenitireducens branch. The absence of such bias would also 
concur with realistic ancestral reconstruction.  
The age of the nodes was determined by converting the phylogram to a 
chronogram. Unlike a phylogram, in which branch lengths represent the number 
of amino acid changes per site, the branch lengths in a chronogram represent 
evolutionary time. The program R8s version 1.71 (Sanderson 2003) was used to 
generate the chronogram. Fixing one or more time nodes, based on information 
obtained from fossils or other sources, allows R8s to generate absolute rates and 
ages (Sanderson 2003). The chronogram depicting the timescale of prokaryote 
evolution (Battistuzzi et al. 2004) was used as a reference to find the node times 
necessary to fix in R8s program. The divergence point of Clostridium and 
Bacillus was fixed to be 2650 myr and B. halodurans and B. subtilis diverge at 
950 myr. Fixing these two node times allowed R8s to estimate age of the 
remaining nodes (Figure 3.1). 
Comparing the MurA ancestral nodes to the reconstructed LeuB ancestors (Hobbs 
et al. 2012), MurA LCA (950 myr) can be considered to occupy a temporally and 
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phylogenetically equivalent position to the LeuB4 (Figure 3.2). MurA ANC2 
could also be considered to occupy a phylogenetically similar position to LeuB3 
as they both represent the pathogenic clade, soil clade and Bacillus megaterium. 
The high bootstrap percentages of 100 % and 92 % for MurA LCA and MurA 
ANC2 also suggest the robustness of these phylogenies.  
The optimal growth temperatures of each Bacillus species in the MurA tree were 
taken from the literature (Gordon 1977; Nakamura 1998; Fritze & Pukall 2001; 
Denizci et al. 2004; Nogi et al. 2005; Cerritos et al. 2008; Ju et al. 2009) and are 
represented by coloured circles as in Figure 3.1. It was observed that, in the 
phylogenetic tree, species with the same growth temperature are not grouped 
together but instead species with different growth temperatures are dispersed 
evenly throughout the phylogenetic tree.   
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Figure 3.1: ML chronogram of Bacillus species based on MurA amino acid 
sequences.  
The phylogenetic tree was rooted with Clostridium sequences as outgroup. The 
reconstructed ancestral enzymes are indicated by black circles. The coloured circles next 
to each Bacillus species relates to their optimal growth temperatures: 45-50 °C (orange), 
37 °C (yellow) and 25-30 °C (green). The phylogenetically conserved clades are 
indicated in boxes: the pathogenic clade (solid line), the soil clade (dotted line) and the 
halophile clade (dashed line) (Alcaraz et al. 2010). The bootstrap values ≥ 50%, assessed 
from 1,024 bootstrap replicates are also shown. 
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Figure 3.2: ML chronogram of Bacillus species based on LeuB amino acid sequences 
(Hobbs et al. 2012). 
The reconstructed ancestral enzymes are indicated by black circles. LeuB1-LeuB4 were 
named as ANC1-ANC4 in the LeuB study (Hobbs et al. 2012). The coloured circles next 
to each Bacillus species relates to their optimal growth temperatures: 60-80 °C (red), 45-
50 °C (orange), 37 °C (yellow), 25-30 °C (green) and 20 °C (blue). The phylogenetically 
conserved clades are indicated in boxes: the pathogenic clade (solid line), the soil clade 
(dotted line) and the halophile clade (dashed line) (Alcaraz et al. 2010).  
The generation of an ML chronogram for MurA was succeeded by the inference 
of the sequences corresponding to MurA ancestral nodes. 
3.2.1.3 Ancestral Inference 
Inference of sequences for the four ancestral nodes was performed by the ML 
criterion. Inference was achieved using three methods: amino acid, nucleotide and 
codon inference methods. The most appropriate model of nucleotide evolution 
was determined by jModelTest (Posada 2008). The best model was chosen to be 
the general time reversible model (GTR model) of nucleotide substitution for the 
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nucleotide inference (Tavaré 1986) and the Jones amino acid rate file was 
employed for amino acid and codon inference (Jones et al. 1992).  
The ancestral inference was performed using PAML version 4.3 (Yang 2007). 
Geneious was used to translate the sequences inferred by the codon and nucleotide 
methods and together with sequence from the amino acid inference, the three 
amino acid sequences were then aligned using ClustalW (Larkin et al. 2007). For 
all the four nodes, the three inference methods were in agreement for ≥89% of 
sites, and for a further 7-10% of sites two out of the three methods were in 
agreement. Any remaining ambiguous sites, which accounted for ≤8 sites, were 
resolved as per the criteria employed by Hobbs et al. (2012), by 1) considering the 
distribution of amino acids in the original alignment and choosing the amino acid 
present in majority of the sequences, or the amino acid present in a functional 
extant protein, 2) choosing amino acids with conserved physico-chemical 
characteristics between different contemporary species and by 3) considering the 
structure of extant proteins and analysing the implication of each ambiguous 
amino acid within the structural environment (section 2.1.4.3). The average 
posterior probability at each site from the amino acid method for all the ancestral 
sequences was >0.95. An alignment of the inferred ancestral sequences is given in 
Figure 3.3.  
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Figure 3.3: Alignment of inferred ancestral MurA sequences 
The different shades indicate the percentage similarity at each position in the alignment. 
Black = 100% similar, dark grey = 80 to 100% similar, light grey = 60 to 80% similar and 
white = less than 60% similar. 
The pairwise identities of the above inferred ancestral sequences to the extant 
protein sequences are given in Table 3.1. As expected from the phylogenetic tree, 
ANC1 and ANC2 are more similar to each other than they are to ANC3 and LCA 
and vice versa.  The sequence identities between the ancestral sequences and the 
contemporary sequences range from 76 % to 90 %. Even though the similarities 
are high, the fact that the ancestral sequences are not significantly more similar to 
one contemporary sequence than the others suggests that there is no bias on any of 
the ancestral nodes by extant sequences. It was also noted that ANC3 is most 
similar to Bacillus cellulosilyticus and not to B. selenitireducens, thus suggesting 
that ANC3 is not biased by the B. selenitireducens branch. The high percentage 
identity of ancestral sequences to the extant sequences suggests a structural and 
functional conservation and therefore greater chances of resulting in functional 
ancestral proteins. 
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Table 3.1: Pairwise sequence identities (%) between extant and ancestral protein 
sequences. 
 ANC1 ANC2 ANC3 LCA 
ANC1 ------- 98 89 87 
ANC2 98 ------- 91 89 
ANC3 89 91 ------- 98 
LCA 87 89 98 ------ 
Bacillus amyloliquefaciens 87 85 79 78 
Bacillus anthracis 86 88 82 80 
Bacillus atrophaeus 87 85 79 78 
Bacillus cellulosilyticus 80 82 89 90 
Bacillus cereus 86 88 82 80 
Bacillus clausii 78 78 81 82 
Bacillus coagulans 83 82 78 76 
Bacillus coahuilensis 84 83 78 76 
Bacillus cytotoxicus 88 89 82 81 
Bacillus halodurans 79 79 83 85 
Bacillus licheniformis 87 86 80 78 
Bacillus megaterium 89 88 81 80 
Bacillus mycoides 86 87 81 80 
Bacillus pseudomycoides 86 87 81 80 
Bacillus pseudofirmus 78 78 83 84 
Bacillus pumilus 86 84 79 77 
Bacillus selenitireducens 76 78 84 84 
Bacillus subtilis 87 85 79 78 
Bacillus thuringiensis 86 88 82 80 
Bacillus weihenstephanensis 86 87 81 79 
Blue cell: Highest pairwise identity between ancestral and extant sequences 
Green cell: Lowest pairwise identity between ancestral and extant sequences 
The high posterior probability and low number of ambiguous sites of the ancestral 
sequences indicate a higher confidence in the ancestral inference given the model 
of evolution used. Furthermore, the high sequence identity between ancestral 
sequences and contemporary sequences suggest slow evolutionary rates and 
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therefore, a higher chance for the successful reconstruction of active ancestral 
MurA enzymes. Therefore, the process of characterising the ancestral enzymes 
was initiated by cloning the genes encoding these ancestral proteins followed by 
their expression and purification. 
3.2.2 Cloning, Protein Expression and Purification 
3.2.2.1 Cloning 
The genes encoding for Bacillus MurA ANC1, ANC2, ANC3, LCA and Bacillus 
coagulans MurA proteins were cloned into pPROEX HTb using the restriction 
sites BamHI and XhoI, resulting in expression of the protein with an N-terminal 
His-tag. B. subtilis MurA gene was amplified from genomic DNA of B. subtilis 
168 and cloned into pPROEX HTb using the restriction sites NcoI and PstI. 
pPROEX HTb containing the gene of interest was used to transform either E.coli 
DH5or BL21 cells and screened for  positive transformants as described in 
section 2.2.8. 
3.2.2.2 Small-scale Protein Expression 
The small scale expression trial of Bacillus MurA LCA (Lysis Buffer: 50 mM 
Tris-HCl pH 7.5, 300 mM NaCl, 20 mM imidazole) showed that the protein 
expressed but most was found in the insoluble fraction rather than the soluble 
fraction (Figure 3.4). A range of different buffers at a variety of pHs tested did not 
increase the solubility of the expressed MurA LCA protein. However, the amount 
of soluble protein obtained was enough to perform the enzyme characterisation 
assays. An increase in the amount of protein expressed with time was observed in 
trials performed for Bacillus MurA ANC1, ANC2, ANC3, LCA and Bacillus 
coagulans MurA (Figure 3.4). The expression of B. subtilis MurA was confirmed 
via an expression trial and subsequent Ni
2+
-sepharose pull down (Figure 3.4) 
(section 2.3.3.2).    
Protparam (Gasteiger et al. 2005) predicted the molecular weight of the 
monomeric form of each of the six MurA enzymes to be approximately 47.0 KDa. 
This molecular weight was used as a reference while analysing the SDS-PAGE 
gel bands. 
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Figure 3.4: SDS-PAGE gels of small-scale expression trials for MurA enzymes. 
A) Bacillus MurA LCA soluble and insoluble expression trial B) MurA ANC1 and ANC2 
soluble and insoluble expression trial C) MurA ANC3 and Bacillus coagulans MurA 
soluble and insoluble expression trial D) Bacillus subtilis MurA Ni
2+
-sepharose bead 
expression trial. White boxes indicate the expected band size. Labels for A), B) and C): 
C - control sample taken prior to induction; Numbered lanes indicate the number of hours 
after which the samples were taken post induction (3, 4, 6 and 20 hours). Labels for D): 
FT- flow through. 
3.2.2.3 Protein Purification 
Large scale protein expression of Bacillus MurA enzymes was achieved overnight 
at 18 °C. All the Bacillus MurA proteins were purified using Ni
2+
 affinity 
chromatography (IMAC). The bound MurA proteins were eluted using a gradient 
of increasing concentrations of elution buffer (50mM Tris, 300mM NaCl, 1M 
imidazole pH 7.5). All the six MurA proteins started eluting at around 14 % of 
elution buffer (140 mM imidazole). The fractions corresponding to the 
chromatographic peaks were run on an SDS-PAGE gel to confirm the size and 
purity of the proteins. A representative UV trace and SDS-PAGE gel for Ni 
column purification of MurA proteins is given in Figure 3.5.  
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Figure 3.5: IMAC purification of a recombinant Bacillus MurA enzyme 
A) The chromatogram shows the UV absorbance at 280nm. The peak represents the 
elution of His-tagged Bacillus MurA LCA from the IMAC column. B) SDS-PAGE gel 
demonstrates the size and purity of Bacillus MurA LCA. The SDS-PAGE gel shows the 
insoluble pellet, the column load, flow through (FT) and the MurA LCA fractions eluted 
during IMAC. MurA LCA fractions are indicated by the red bar. 
All the MurA proteins were successfully over expressed in large scale cultures, 
mostly soluble protein with minimal amount of impurities.  
Size exclusion chromatography (SEC) was used to further purify the enzymes (50 
mM Tris-HCl pH 7.5 and 300 mM NaCl) and separate the protein monomers and 
other oligomers. The chromatographic separation for SEC column S200 10/300 
(GE Healthcare) using reference samples of different molecular weights, elutes  
proteins with a molecular weight of 75 KDa at ~13 ml and 44 KDa at 15 ml, 
A) 
B) 
Chapter 3: MurA 
  75 
 
which is comparable to the dimeric and monomeric forms of MurA protein 
respectively (Protparam predicted a MW of approximately 47.0 KDa for 
monomeric MurA enzymes). Fractions corresponding to each SEC peak were run 
on an SDS-PAGE gel to confirm the presence of MurA protein and its purity 
(Figure 3.6 and Figure 3.7). One example SDS-PAGE gel showing the purity of 
protein is given in Figure 3.7.  
 
Figure 3.6: Size exclusion chromatography (SEC) purification of recombinant 
MurA enzymes. 
The chromatogram depicts the UV absorbance at 280nm for MurA proteins and the red 
bar represents their elution position as well as the fractions run on SDS-PAGE gel to 
confirm their size and purity.  
B. subtilis MurA expression was not codon optimised for expression in E. coli, 
which can help explain its low yield in comparison to the other MurA proteins. 
Initial purification of B. subtilis MurA using the generic purification buffers 
resulted in highly aggregated protein (Figure 3.7) Therefore, 5 % glycerol was 
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incorporated in all the purification buffers which drastically reduced protein 
aggregation (Figure 3.7). 
 
 
 
Figure 3.7: Size exclusion chromatography (SEC) purification of Bacillus subtilis 
MurA enzyme and SDS-PAGE gel 
A) SEC of Bacillus subtilis MurA without glycerol in the purification buffers. B) SEC of 
Bacillus subtilis MurA in the presence of 5 % glycerol in purification buffers to reduce 
protein aggregation. The red arrow indicates the monomeric peak of Bacillus subtilis 
MurA which increases approximately 2-folds with the addition of 5 % glycerol. The red 
bar represents the elution position of the protein as well as the fractions run on SDS-
PAGE gel to confirm their size and purity. C) The SDS-PAGE gel demonstrates the size 
and purity of Bacillus MurA LCA. The SDS-PAGE gel shows MurA LCA fractions 
eluted during SEC. The SDS-PAGE gel relatively corresponds to the fractions indicated 
by the red bar in SEC chromatograms. 
The purified proteins were quantified using a Bradford assay (section 2.3.2) prior 
to enzyme characterisation assays. 
3.2.3 Enzyme Characterisation 
The evolution of organisms to adapt to new environments involves evolutionary 
changes to their core metabolic enzymes, in order for their necessary metabolic 
processes to remain functional (Hobbs et al. 2012). Therefore, such evolutionary 
A) B) 
C) 
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changes can be studied by measuring the kinetic parameters of reconstructed 
ancestral enzymes and thus grant insight into the evolution of enzymatic catalysis. 
The structural and functional aspects of enzyme activity are so complex that any 
error in the ancestral inference may result in either inactivity or biologically 
unrealistic properties of the enzyme. Therefore, enzyme activity could also be 
used as a proxy for accurate ancestral inference (Hobbs et al. 2012).  
The enzyme reaction catalysed by MurA converts the substrates PEP and UNAG 
to the product enolpyruvyl UDP-N-acetyl glucosamine and inorganic phosphate. 
For the biochemical characterisation of MurA enzymes, the production of 
inorganic phosphate was measured using a modified malachite green assay 
(Baykov et al. 1988). The complex formed during the reaction between malachite 
green, molybdate and free phosphate, results in an absorbance band between 600 
and 660nm, which can be measured using a spectrophotometer. 
3.2.3.1 Activity assay 
Various preliminary tests were performed to optimize the malachite green assay 
conditions. As the assay is highly sensitive, it was important to determine the 
contribution of reaction components to free phosphate in order to differentiate it 
from the free phosphate generated by the reaction. Therefore, the assay buffer 
only, assay buffer + enzyme, and substrates + buffer were tested using the 
malachite green assay. It was observed that the assay buffer and enzyme did not 
add to the free phosphate, whereas, the substrates’ contribution to the free 
phosphate in the reaction is high. Therefore, to ensure the kinetics obtained for 
MurA were entirely due to the activity of MurA, a control/blank reaction was 
carried out for all the substrate concentrations tested which was subtracted from 
the MurA reaction readings to measure the free phosphate generated by MurA. 
Among the SEC purifications of the six MurA enzymes, B. coagulans MurA and 
Bacillus subtilis MurA UV traces show two distinctive peaks corresponding to the 
monomeric and dimeric forms of MurA protein (Figure 3.6 and Figure 3.7) 
(section 3.2.2.3). Therefore, activity tests were performed to verify which 
peak/protein state, is active or whether there is any difference in activity between 
them. It was observed that, for all the ancestral enzymes, both the dimer and 
monomer, were equally active. Whereas, for the contemporary enzymes B. subtilis 
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MurA and B. coagulans MurA, the monomer peak was found to be much more 
active than the dimer . Therefore, for consistency, fractions from the monomeric 
peak were selected for all the enzymes for characterisation assays. The activity 
tests were generally performed with 1mM of PEP and 1mM UNAG final 
concentration in assay buffer 50mM Tris pH 7.5 at 37 °C. Due to the high 
sensitivity of malachite green assay, activity assays with various concentrations of 
enzymes were performed to find out an optimum enzyme concentration which 
would not result in precipitation.  
3.2.3.2 Time course assay 
A time course assay was performed as described in section 2.3.7.3 and a graph 
with absorbance at 620 nm versus time was plotted to determine the most 
appropriate duration for the assays (Figure 3.8). 
 
Figure 3.8: Time course assay from which the reaction time was manually 
determined to be ≤5 minutes. 
3.2.3.3 Phosphate standard 
A phosphate standard curve was generated as explained in section 2.3.7.2 using 
KH2PO4. An example for one such phosphate standard is given in Figure 3.9. The 
standard curve was used to calculate the amount of free phosphate produced 
during the MurA reactions.  
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Figure 3.9: Standard curve obtained for 0 μM - 50 μM KH2PO4.   
3.2.3.4 Michaelis-Menten kinetics determination   
The malachite green assay was used to perform kinetic analysis of MurA enzymes. 
For PEP KM measurements, UNAG was maintained at a constant concentration of 
200 M. Once the PEP KM was determined, five to ten times the PEP KM was 
added for measurements of the UNAG KM. Therefore, kcat values were calculated 
from UNAG KM values at Vmax (more reliable than the Vmax from PEP KM with 
UNAG being rate limiting). In cases where ten times the PEP KM was not added 
during a UNAG KM determination, the apparent Vmax was calculated, that is, the 
Vmax which would have been obtained had there been ten times the PEP KM.  
The substrate affinity represented by the Michaelis Menten kinetic constant KM, 
typically increases with an increase in temperature (Griffith et al. 2001). Therefore 
the KM for each substrate, PEP and UNAG, were initially determined at 37 °C 
(Table 3.2) so that the temperature optima of the enzymes (Topt), and KM of 
substrates at the enzymes respective Topt, could be accurately determined at 
saturating amounts of substrate. 
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Table 3.2: Kinetic constants for contemporary and ancestral MurA enzymes at 37°C. 
Enzyme PEP KM 
(M) 
UNAG KM 
(M) 
kcat 
(sec
-1
) 
kcat/KM (UNAG)  
(sec
-1
M
-1
) 
B. subtilis 430 ± 90 170 ± 20 5.7 ± 0.2 3.4 (±0.4)x10
4
 
B. coagulans 40 ± 10 130 ± 30 4.5 ± 0.3 3.0 (±1.0) x10
4
 
ANC1 240 ± 60 150 ± 20 3.8 ± 0.1 2.5 (±0.5) x10
4
 
ANC2 90 ± 10 110 ± 10 6.0 ± 0.2 5.5 (±0.9) x10
4
 
ANC3 50 ± 10 80 ± 20 4.7 ± 0.3 6.0 (±2.0) x10
4
 
LCA 120 ± 10 150 ± 20 1.58 ± 0.06 1.1 (±0.2)x10
4
 
The kinetic values were obtained from three technical replicates.  
The errors represent the standard error of the mean.  
It was observed that the PEP KM of B. subtilis MurA measured at 37 °C is >6-fold 
higher than previously reported PEP KM of 66 M from Bacillus subtilis MurA 
measured at 25 °C (Biery 2007). The UNAG KM from the study performed by 
Biery et al (2007) is comparable to the above measured UNAG KM. By 
comparison, data reported for Staphylococcus aureus MurA (no incubation 
temperature specified) only shows a 4-5 fold difference in kcat (1.13 sec
-1
) (Blake 
et al. 2009). Differences may be expected between different assays as seen with 
the catalytic efficiency, kcat/KM (UNAG), measured for S. aureus MurA using a 
MurA-MurB coupled assay (12 sec
-1
M
-1
) (Biery 2007) differs by 750 fold from 
the kcat/KM (UNAG) of S. aureus MurA obtained using a PNG assay (9000 sec
-1
M
-
1
) (Blake et al. 2009).   
The optimum temperature of enzyme activity (Topt) was measured as described in 
section 2.3.7.5 and the kinetic parameters PEP KM, UNAG KM, kcat and kcat/KM 
were determined at each enzyme’s respective Topt (Table 3.3; Figure 3.10 and 
Figure 3.11). The Topt data is described in section 3.2.5. 
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Table 3.3: Kinetic constants for contemporary and ancestral MurA enzymes at their 
respective optimal temperatures (Topt). 
Enzyme PEP KM 
(M) 
UNAG KM 
(M) 
kcat 
(sec
-1
) 
kcat/KM (UNAG)  
(sec
-1
M
-1
) 
Topt 
(°C) 
B. subtilis 390 ± 70 490 ± 60 6.0 ± 0.3 1.2 (±0.2) x10
4
 42 
B. coagulans 320 ± 60 190 ± 40 32 ± 2 17.0 (±4.0) x10
4
 59 
ANC1 150 ± 20 100 ± 40 6.2 ± 0.7 6.0 (±3.0) x10
4
 62 
ANC2 100 ± 20 200 ± 30 72 ± 3 36.0 (±7.0) x10
4
 62 
ANC3 400 ± 100 240 ± 30 58 ± 2 24.0 (±4.0) x10
4
 62 
LCA 220 ± 20 140 ± 20 7.1 ± 0.3 5.1 (±0.7) x10
4
 58 
The kinetic and thermoactivity values were obtained from three technical replicates.  
The errors represent the standard error of the mean. 
The kcat values obtained for B.  subtilis MurA at 37 °C (Table 3.2) and at its Topt 
temperature of 42 °C (Table 3.3) were found to be very similar as the temperature 
difference is minimal. B. coagulans MurA was found to have >2-fold higher 
affinity for UNAG than B.  subtilis MurA. B. coagulans MurA is also 5-fold faster 
than B. subtilis MurA with more than 12-fold its catalytic efficiency. It was also 
observed that the measured kcat for B. subtilis MurA (6.7 sec
-1
) was found to be 
comparable with previously reported kcat for E. coli MurA (8.9 sec
-1
) at 37 °C (Dai 
et al. 2002). 
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Figure 3.10: Michaelis-Menten plots for contemporary MurA enzymes at their 
respective Topt values 
Results are the mean of three technical replicates, the error bars representing the standard 
error of the mean (SEM). 
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Figure 3.11: Michaelis-Menten plots of ancestral MurA enzymes at their respective 
Topt values 
Results are the mean of three technical replicates, the error bars representing the SEM. 
All four ancestral MurA enzymes were catalytically active and their kinetic 
parameters were observed to be proportionate with those of the contemporary 
enzymes (Table 3.3). It should be noted that in comparison to the other ancestral 
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and contemporary enzymes, MurA ANC2 displays the highest kcat and catalytic 
efficiency, with more than twice the catalytic efficiency of contemporary B. 
coagulans. It was also observed that Bacillus MurA LCA showed very similar 
kinetic values to that of MurA ANC1.  
Another characteristic property of MurA is its susceptibility to the antibiotic 
fosfomycin. Therefore, the inhibitory properties of selected MurA enzymes were 
measured using the malachite green assay. 
3.2.4 IC50 determination 
MurA, being an important antibiotic target, has been focussed on for the 
development of new inhibitors and for identification of evolutionary aspects 
leading to inhibitor resistance, such as Cys-Asp single mutation (Kim et al. 1996a; 
De Smet et al. 1999) leading to fosfomycin resistance. Therefore, studying the 
inhibitory properties of ancestral MurA in comparison to contemporary MurA 
enzymes may also provide insight into the evolution of MurA. 
3.2.4.1 Inhibition by Fosfomysin 
Fosfomycin is the only clinically available antibiotic which inhibits MurA (Chang 
et al. 2014). However, many microorganisms have evolved to be resistant to 
fosfomycin. Therefore, finding the difference in IC50 for fosfomycin of Bacillus 
MurA LCA and contemporary B. subtilis MurA would allow us to determine how 
much of the evolution of MurA has been affected by its inhibitory properties. The 
IC50 for fosfomycin measured as described in section 2.3.7.6 are given in Table 
3.4 and the corresponding dose-response curves are given in Figure 3.12.  It was 
observed that IC50 of fosfomycin for B.  subtilis MurA is slightly lower than that 
of Bacillus MurA LCA. However, the values are still in a comparable range.  
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Figure 3.12: The IC50 dose-response curves obtained for different concentration of 
fosfomycin  
Results are the mean of three technical replicates, the error bars representing the SEM 
The IC50 for fosfomycin measured for B. subtilis MurA (Table 3.4) was observed 
to be >30-fold higher than that previously observed for B. subtilis MurA (3.8±0.9 
M) (Biery 2007). However, the values better compared with fosfomycin IC50 
measured for Haemophilus influenza MurA (40 M) (Jin et al. 2009). Both 
studies by Biery et al. (2007) and Jin et al (2009) were performed at 25 °C, 
whereas, the IC50 values here were measured at 37 °C. The increase in 
temperature can drastically increase IC50 values (Beavis & Powers 2004). This 
may explain the difference between the measured and previously reported IC50 
values. 
3.2.4.2 Inhibition by Glyphosate 
As outlined in chapter 1 (section 1.5), MurA and AroA are known to be 
exclusively inhibited by fosfomysin and glyphosate respectively. However, the 
structural and functional similarities of MurA and AroA lead us to hypothesise 
that MurA and AroA might have originated from a common ancestor. Glyphosate 
specifically interacts with active site residues of AroA to cause inhibition 
(Eschenburg et al. 2003). The difference in amino acid composition and spatial 
arrangement between AroA and MurA makes it impossible for glyphosate to 
specifically inhibit MurA. Glyphosate could inhibit MurA only if appropriate 
conformational changes occurred in order to avoid any distance clashes, steric 
interference and to allow proper positioning of glyphosate molecule (Eschenburg 
et al. 2003). Therefore, measuring the IC50 of glyphosate for Bacillus MurA LCA 
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and Bacillus subtilis MurA would provide us with information on whether any 
such changes have occurred to the ancestral enzyme.  
The glyphosate IC50 graphs show that inhibition of MurA occurs with very high 
concentrations of glyphosate (Figure 3.13). However, such high concentrations of 
glyphosate suggest that it does not specifically inhibit Bacillus MurA LCA and B. 
subtilis MurA (Table 3.4). The IC50 of glyphosate for Bacillus MurA LCA is 
almost 2-fold higher than that of B. subtilis MurA. However, considering 
nonspecific inhibition, the difference between the IC50 values is still comparable.  
Table 3.4: Fosfomycin and glyphosate IC50 values for Bacillus subtilis MurA and 
Bacillus MurA LCA 
 B. subtilis MurA Bacilus MurA LCA 
Fosfomycin 150 M 270 M 
Glyphosate 2800 M 4800 M 
 
  
Figure 3.13: The IC50 dose-response curves obtained for different concentration of 
glyphosate 
Results are the mean of three technical replicates, the error bars representing the SEM 
The IC50 measurements for fosfomycin indicate that both LCA of Bacillus genus 
and contemporary Bacillus MurA enzymes are sensitive to fosfomycin to 
relatively the same extent. Fosfomycin, mimics the MurA substrate PEP and 
competes with it to form an irreversible thioether bond to Cys115 (E.coli 
numbering) (Skarzynski et al. 1996; Fadda et al. 2006). Upon binding of 
fosfomycin, several hydrogen bonds are made between fosfomycin and UNAG as 
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well as between fosfomycin and the polypeptide chain, among which, Lys22, 
Arg120 and Arg397 provide strong electrostatic interactions (in E. coli MurA) 
(Skarzynski et al. 1996). All the above amino acids which are identified in 
binding of fosfomycin are conserved within the MurA LCA. Such a conservation 
of residues, along with comparable IC50 values obtained from MurA LCA and B. 
subtilis MurA, may suggest that the amino acids and respective conformational 
changes involved in the fosfomycin inhibition of B. subtilis MurA, remains the 
same within MurA LCA. 
The glyphosate IC50 for B. subtilis MurA suggests that the enzyme cannot be 
specifically inhibited by glyphosate as might be expected for ancestral enzymes. 
Glyphosate targets the PEP binding site in AroA enzymes (Eschenburg et al. 
2003). The PEP binding site involves the residues Lys22, Arg124, Asp313, 
Arg344 and Arg386 in AroA (E. coli numbering); and Lys22, Arg120, Asp305, 
Arg331, and Arg371 in MurA (Enterobacter cloacae numbering), which are also 
conserved within MurA LCA. The interaction of these residues observed with the 
PEP moiety of the tetrahedral intermediate, are identical within AroA and MurA 
enzymes (Eschenburg et al. 2003). However, the residues Lys22, Arg124/Arg120 
and Arg344/Arg331 exhibit geometrical deviations, causing distortions within the 
PEP binding site. Therefore, these distortions in the PEP binding site between 
MurA and AroA, as well as the substantial differences in MurA and AroA binding 
sites due to the variation in size, shape, polarity and charge of UNAG and S3P, 
may explain why glyphosate cannot inhibit MurA, in spite of glyphosate targeting 
the PEP binding site in a similar way as fosfomycin (Eschenburg et al. 2003). 
Therefore, the lack of specific inhibition of MurA LCA by glyphosate suggests 
that the ancestral enzyme does not possess any structural changes that could allow 
the correct positioning of glyphosate to allow inhibition. 
Another characteristic feature involved in the study of evolution of MurA 
enzymes involves determining their thermal properties such as thermoactivity and 
thermostability. The next section describes the evolutionary significance of MurA 
enzymes’ thermal properties as well as the significance of these thermal 
characteristics in the evolution of thermophily.  
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3.2.5 Evolution of Thermophily 
Thermophily is believed to be a primitive trait. The study on elongation factors 
(EF-Tu) by Gaucher et al. (2008) suggested that evolution shows a gradual 
decrease in thermophily from that of the last common ancestor. On the other hand, 
a temporal fluctuation in respect to thermophily was observed with Bacillus genus 
from the ancestral LeuB enzymes reconstructed using ASR (Hobbs et al. 2012). 
However, the sampling involved in both studies differ and the fluctuations in the 
temporal trend in thermophily observed by Hobbs et al. (2012) may have been 
obtained from the period that was not sampled in the study on EF-Tu (Gaucher et 
al. 2008). These findings are based on the data obtained from a single enzyme. It 
is not known whether the reconstructions of a different protein would result in the 
same temporal trend in thermophily. Therefore, this could be addressed by 
repeating the study on the evolution of thermophily within the Bacillus genus 
using a different enzyme, such as MurA.      
As organisms adapt to new environments via evolutionary selection pressures 
such as temperature changes, core metabolic enzymes, such as MurA, adapt 
accordingly to maintain their function (Hobbs et al. 2012). The MurA 
phylogenetic tree was built using sequences from Bacillus species inhabiting 
different thermal environments and hence may prove to be ideal to investigate the 
evolution of thermophily within Bacillus genus. The study of the evolution of 
thermophily using ASR exploits the correlation between the organism growth 
temperature and the enzyme thermoactivity (Topt) and thermostability (Tm) 
(Gromiha et al. 1999; Akanuma et al. 2013). The Topt and Tm of reconstructed 
enzymes were used to represent their thermal adaptation (Hobbs et al. 2012). 
Using MurA to study evolution of thermophily with the Bacillus genus would not 
only provide information on thermal properties of ancestral MurA, but also help 
us to test the robustness of using ASR as a tool to study the evolution of 
thermophily.   
Thermoactivity of MurA enzymes (Topt): 
The thermoactivity measured for mesophilic B. subtilis MurA and moderately 
thermophilic B. coagulans MurA is consistent with their growth temperature and 
hence confirms the correlation (Figure 3.14; Table 3.5).  
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Figure 3.14: Thermoactivity profiles for contemporary and ancestral MurA 
enzymes 
Thermoactivity data for A) contemporary and B) ancestral MurA enzymes shown are the 
mean of at least three replicates and are expressed as a proportion of the highest activity 
(at Topt). 
It was observed that the Topt obtained for B. subtilis MurA was slightly higher than 
its growth temperature, however, such a trend is common in mesophilic organisms 
(Georlette et al. 2004; Hobbs et al. 2012). 
Thermostability of MurA enzymes (Tm): 
It was observed that the measured thermostability is consistent with 
thermoactivity of MurA enzymes (Figure 3.15; Table 3.5). The thermoactivity and 
thermostability of ancestral MurA enzymes shows that the temporal trend is 
consistently moderately thermophilic. However, this trend differs from the 
fluctuating trend in thermal evolution observed for LeuB (Hobbs et al. 2012). The 
finer resolution thermostability data provided by DSC for ancestral MurA 
enzymes also indicate a slight decrease in thermophily from ANC1 through to 
LCA (Figure 3.15; Table 3.5). This contradicts the trend observed by Gaucher et 
al. (2008) and Perez-Jimenez et al. (2011) which show a general increase in 
thermophily with increasing evolutionary time.  
 
A) B) 
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Figure 3.15: Thermostability profiles for contemporary and ancestral MurA 
enzymes 
Thermostability data for A) contemporary and B) ancestral MurA enzymes shown are 
processed DSC power inputs expressed as a proportion of the peak value which equates 
to the Tm.  
Table 3.5: Thermoactivities and/or thermostabilities of contemporary and ancestral 
MurA and LeuB enzymes along with their respective ages 
Enzyme Age (Myr) Topt (°C) Tm (°C) 
MurA B.subtilis - 42 55.4 
B.coagulans - 59 63.9 
ANC1 550 62 64.2 
ANC2 600 62 63.8 
ANC3 910 62 61.1 
LCA 950 58 59.7 
LeuB B. psychrosaccharolyticus - 47 - 
B. subtilis - 53 - 
B. caldovelox - 69 61.0 
LeuB1 670 73 64.7 
LeuB2 820 49 47.6 
LeuB3 850 60 55.5 
LeuB4 950 70 65.3 
It must be noted that there is a difference of 11 °C between the Topt of MurA and 
LeuB from B. subtilis (Table 3.5). This suggests that even though the correlation 
A) B) 
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between Topt and Tm with organism growth temperature exists, the Topt and Tm 
properties are protein dependent. Therefore, for accurate comparison of thermal 
trends between proteins, the temperatures need standardization using the enzyme 
temperatures from the common contemporary species B. subtilis (Figure 3.16). 
Standardization was achieved by subtracting the temperature of B. subtilis from 
all other temperatures. All MurA ancestors are moderately thermophilic with a 
<5 °C difference between ancestors in Topt and Tm with a slight temporal decrease, 
while LeuB ancestors show a fluctuating trend in thermophily as it goes back in 
time (Figure 3.16 and Table 3.5). MurA ancestors are more clustered around time 
periods 550-600myr (ANC1 and ANC2) and 910-950myr (ANC3 and LCA). The 
LeuB ancestor responsible for the prime fluctuation in LeuB thermal trend is 
LeuB2 (820myr), the temperature of which cannot be confirmed as there is no 
MurA ancestor equivalent in age. In terms of age, LeuB3 (850myr) could be 
considered to be approximately the same age as MurA ANC3 (910myr) with 
similar thermal properties. LeuB1 (670myr) and MurA ANC2 (600 myr) differ in 
their thermoactivity by 11 °C but is consistent with its thermostability. In terms of 
phylogenetic equivalence, LeuB3 could be considered equivalent to MurA ANC2, 
both consisting of the pathogenic and soil clades, showing similar moderate 
thermophily. However, it was observed that MurA LCA and LeuB4, both aged 
950myr, do not agree on their thermal adaptation. Even though both MurA LCA 
and LeuB4 agree that the Bacillus LCA is thermophilic, there is a considerable 
difference in the range of thermophily displayed by the Topt of both enzymes.  
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Figure 3.16: Comparison of age versus thermal adaptation data for LeuB and MurA 
Data shown are age estimates for ancestral nodes against either Tm or Topt values for each 
ancestral enzyme. A) Topt data for MurA and LeuB B) Tm data for LeuB and MurA and C) 
standardised data obtained after subtracting value for B. subtilis enzyme from LeuB Topt 
and MurA Topt. Thermal data for contemporary enzymes are shown for comparison at age 
0 Myr.  
As previously mentioned, thermoactivity and thermostability is protein dependent 
and does not solely depend on the organism growth temperature. This may be one 
explanation for the temperature differences between MurA and LeuB ancestors of 
a similar age. Another explanation for such differences in thermal trends is the 
hypothesis that each reconstructed ancestral enzyme may only represent a 
snapshot of the evolving host organism at a particular period of time. Our present 
day Bacillus genus includes a wide variety of species adapted to different 
environment conditions. Similarly, it is logical to assume that a reconstructed 
ancestral enzyme from Bacillus species may give information pertaining to a 
single member of the species consortium present at that particular point of time. 
This explanation is in agreement with the evolutionary model proposed by Woese, 
C) 
A) B) 
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in which the universal ancestor is not a discrete entity but a community (Woese 
1998). The observations made in this study also support the hypothesis made by 
Hobbs et al. (2012) that the thermal profiles obtained for the ancestral enzymes 
are most likely to reflect changes of the host microenvironments rather than 
representing a global temperature.  
The main differences between MurA and LeuB lie in the set of contemporary 
species used in the study as well as the phylogenetic tree topology. However, both 
MurA and LeuB ancestral inference was achieved using the same method based 
on ML criteria. The reconstructed MurA enzymes were all active and showed 
comparable catalytic constants as the contemporary MurA enzymes, therefore 
their thermal properties are also to be trusted and hence the thermal trends they 
imply. One source of error associated with ML inference is the overestimation of 
thermophily (Williams et al. 2006) of reconstructed ancestral proteins, which is 
not supported by MurA as the data does not indicate any considerable increase in 
thermophily nor does it show a trend of increasing thermophily with evolutionary 
time. The thermal properties of the MurA ancestors show a consistent moderate 
thermophily, with a slight decrease in thermal properties with increasing 
evolutionary time, considering the absolute values measured. It was also noted 
that B. selenitireducens branch (OGT of 26 °C) in the phylogenetic tree did not 
influence the ANC3 temperature as ANC3 remains thermophilic. There is also 
confidence in the thermal properties of the ancestral LeuB enzymes reconstructed 
by Hobbs et al. (2012) as their thermal properties do not simply represent 
averages of their extant descendants. Therefore, it is clear that the two core 
metabolic enzymes, MurA and LeuB, from the same genus show different thermal 
profiles. This suggests that the choice of protein candidate may influence the 
ancestral inference. 
Overall, all the ancestors of Bacillus inferred using MurA sequences are 
consistently moderately thermophilic. Thermostability and thermoactivity of an 
enzyme is correlated to the host organism growth temperature, however, the 
absolute Topt and Tm are protein dependant.  The temporal differences in 
thermophily observed by different enzymes may either be explained by the 
hypothesis that the reconstructed ancestors only represent a single snapshot of the 
evolving host  at a given point of time, or the choice of protein candidate may 
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influence biological conclusions. Further, as the reconstructed MurA ancestors 
demonstrate rather similar properties as that of the contemporary MurA enzymes, 
it may be necessary to go back further in time in the reconstruction of ancestors to 
be able to see some differences which in turn would facilitate the study of MurA 
evolution. 
The functional characterisation of ancestral and contemporary AroA enzymes was 
studied in a similar way as MurA and is described in chapter 4.
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4 Chapter 4 
AroA 
4.1 Introduction 
The enzyme AroA, otherwise also known as 5-enolpyruvylshikimate-3-phosphate 
synthase (EPSPS), is an attractive antibiotic target, and is the target of the 
herbicide glyphosate. Although most studies on AroA focus on genetic 
modifications to synthesise glyphosate tolerant or sensitive strains, there is an 
increased interest to design novel inhibitors for their use as broad-spectrum 
antibiotics as the pathogenicity of many microorganisms depend on a functional 
AroA enzyme and other shikimate pathway enzymes (Funke et al. 2007). Similar 
to that of MurA, previous studies focused on the function and structure of AroA, 
yet there is little information available on the evolution of AroA. Studying the 
evolution of AroA could contribute to better inhibitor design. Therefore, the 
evolution of AroA could be explored in a similar way as MurA, by using ASR to 
reconstruct the LCA of the Bacillus genus using AroA and compare its functional 
and structural properties to contemporary AroA. 
AroA catalyses a similar reaction as MurA, involving the transfer of the 
enolpyruvyl moiety to its substrate accompanied by the release of inorganic 
phosphate. Therefore, the kinetic, inhibitory and thermal properties of AroA could 
also be determined using the malachite green assay. The AroA substrate, 
shikimate-3-phosphate (S3P), although commercially available, is high-priced 
which limits the efficiency with which the experiments could be carried out. 
Therefore, it was necessary to synthesize S3P in the laboratory for its use in AroA 
characterisation. In addition to the in vitro properties, the behavior of ancestral 
AroA in vivo in contrast to contemporary AroA was also examined using 
knockout strains. 
This chapter describes the reconstruction of Bacillus AroA LCA and compares the 
in vitro and in vivo characteristics of AroA LCA against the in vitro and in vivo 
characteristics of contemporary Bacillus subtilis AroA enzyme. The process 
involved in the synthesis of the AroA substrate S3P, necessary for AroA in vitro 
characterisation, is also described in this chapter.    
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4.2 Results and Discussion 
4.2.1 Phylogenetic Analysis and ASR 
4.2.1.1 Sequence Alignment 
The AroA amino acid and nucleotide sequences were collected from the same 20 
Bacillus species as for MurA, along with AroA from the same two Clostridium 
species as outgroup sequences (Accession numbers, species and strain details are 
given in Appendix A). The amino acid alignment of Bacillus AroA sequences 
along with the two outgroup sequences has an overall 14.3% of identical sites. 
Overall, the protein alignment without the Clostridium sequences has 35.0% 
identical sites. The low percentage of identical sites may suggest a high rate of 
evolutionary change from the LCA of Bacillus AroA to contemporary Bacillus 
species, which may be reflected in the in vitro and in vivo properties of the 
enzyme measured in this chapter. 
Various catalytically important residues and conserved residues have been 
previously identified for AroA. The active site residues reported from E. coli 
include Lys22, Arg124, Asp313, Glu341, Arg344, Arg386 and Lys411 (E. coli 
numbering) (Eschenburg et al. 2003). His385 from E. coli has been suggested to 
provide a proton to Glu341, which in turn acts as proton donor for PEP 
(Schönbrunn et al. 2001). These catalytically important and conserved residues 
were also identified in the Bacillus AroA alignment, except for Lys411 which is 
replaced by Valine in all the Bacillus AroA sequences at that position. The 
numbering of the above residues from E. coli corresponds to the numbering in the 
AroA alignment as follows: Lys22  Lys25, Arg124  Arg131, Asp313  
Asp334, Glu341  Glu362, Arg344  Arg365, His385  His407, Arg386  
Arg408 and Lys411  Val434 (shown in AroA alignment in Appendix B). The 
conservation of these residues observed in the alignment may suggest that it 
would be very likely that these residues will also be conserved in the ancestral 
AroA sequence that is inferred from these Bacillus sequences.     
4.2.1.2 Phylogenetic Analysis 
The model of evolution was identified using ProtTest version 2.4 (Abascal et al. 
2005) as performed for MurA. Similar to MurA, the LG model was chosen to be 
the most suitable model of amino acid evolution. Five phylogenetic trees were 
then generated using GARLI 1.0 (Zwickl 2006) based on ML criterion, each tree 
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rooted with the outgroup Clostridium AroA sequences. All five phylogenetic trees 
had equal log likelihood scores of -9718 with identical clade groupings as well as 
branch positions. Therefore, this generated phylogram may define the 
evolutionary relationship between the Bacillus species in the best possible way.  
The Bacillus AroA phylogenetic tree was bootstrapped to provide confidence for 
the clades in the phylogenetic tree. The bootstrap values ≥50% are displayed in 
Figure 4.1. The phylogeny for Bacillus AroA also shows the presence of distinct 
phylogenetically conserved clades: the soil clade, the pathogenic clade and the 
halophilic clade (Alcaraz et al. 2010) (Figure 4.1). The topology of these 
conserved clades in Bacillus AroA phylogram is also consistent with that of the 
Bacillus LeuB phylogram (Hobbs et al. 2012) (Figure 3.2). Yet, it was observed 
that in the AroA phylogram, Bacillus megaterium, a non-pathogenic Bacillus 
species, was categorised within the pathogenic clade. However, Bacillus 
megaterium shares a phylogenetic relationship to Bacillus anthracis and Bacillus 
cereus (Dib et al. 2003; Ramasamy et al. 2013). The halophile clade described by 
Alcaraz et al (2010) is comprised of Bacillus halodurans and Bacillus clausii. In 
addition to these species, the halophile clade in the Bacillus AroA phylogenetic 
tree includes Bacillus selenitireducens, Bacillus cellulosilyticus and Bacillus 
pseudofirmus which are also halophilic species (Nielsen et al. 1995; Blum et al. 
1998; Nogi et al. 2005).  
AroA from the last common ancestor (LCA) of the Bacillus genus was chosen for 
sequence reconstruction. The AroA phylogram was converted to a chronogram in 
the same manner as was done for MurA, by fixing time nodes at 2650 myr and 
950 myr corresponding to the divergence point of Clostridium and Bacillus and 
Bacillus halodurans and Bacillus subtilis respectively using R8s version 1.71 
(Sanderson 2003) (Figure 4.1). The optimal growth temperatures of each Bacillus 
species indicated in Figure 4.1 remains the same as shown in MurA chronogram 
(Figure 3.1).  
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Figure 4.1: ML chronogram of Bacillus species based on AroA amino acid sequences.  
The phylogenetic tree was rooted with Clostridium sequences as outgroup. The 
reconstructed ancestral enzyme is indicated by a black circle. The coloured circles next to 
each Bacillus species relates to their optimal growth temperatures: 45-50 °C (orange), 
37 °C (yellow) and 25-30 °C (green). The phylogenetic conserved clades are indicated in 
boxes: pathogenic clade (solid line), soil clade (dotted line) and halophile clade (dashed 
line) (Alcaraz et al. 2010). The bootstrap values ≥ 50%, assessed from 1,024 bootstrap 
replicates are also shown.       
4.2.1.3 Ancestral Inference 
The inference of the ancestral sequence for Bacillus AroA LCA was achieved 
using amino acid, nucleotide and codon inference methods by ML criterion. The 
nucleotide model of evolution for the nucleotide inference was determined by 
jModelTest version 0.1.1 (Posada 2008) to be the general time reversible model 
(GTR model) of nucleotide substitution (Tavaré 1986) and the Jones amino acid 
rate file was employed for amino acid and codon inference. 
PAML version 4.3 (Yang 2007) inferred the AroA LCA sequence for the three 
methods and ClustalW (Larkin et al. 2007) was used to align the three translated 
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sequences. The three inference methods were in agreement for 90% of the sites 
and two out of three methods were in agreement for a further 9% of sites. The 
remaining 8 ambiguous sites were resolved as per the criteria employed by Hobbs 
et al. (2012) and as performed for MurA ancestral inference (section 2.1.4.3, 
section 3.2.1.3). The posterior probability at each site from the amino acid method 
for Bacillus AroA LCA sequence was 0.92. The inferred ancestral sequence is 
provided below: 
LCA 
MKEKTINTAEKGLNGTIRIPGDKSISHRAVMFGAIAEGTTTVKNFLPGEDCLSTI
ACFRKLGVEIEQNGDDVTINGKGLDGLKEPKDVLDVGNSGTTIRLMLGILANRPF
HSTIIGDESIAKRPMKRVTDPLREMGAQIDGREDGKFTPLSIRGGNLKGIDYNSP
VASAQVKSAILLAGLQAEGTTTVTEPHKSRDHTERMLEAFGVKVEEEGQTVSIEG
GQTLKGTDIEVPGDISSAAFFLVAGAIVPNSRIVLKNVGLNPTRTGIIDVLKKMG
ANLEIDQVREEGAEPYGDLTIETSSLKGIEIGGDLIPRLIDEIPIIALLATQAEG
TTVIKDAEELKVKETNRIDTVVSELKKLGANIEATDDGMIIHGKTTLKGGATVDS
HGDHRIGMMLAIASCIAEGEVEIEDTDAVSVSYPKFFEHLESLKK 
The conserved and catalytically important residues mentioned in section 4.2.1.1 
were also identified in the LCA sequence (highlighted residues in the above 
sequence).  
The pairwise identity of Bacillus AroA LCA to the extant Bacillus sequences 
shows that the LCA shares the highest pairwise sequence identity of 82% to 
Bacillus cytotoxicus and the lowest of 64% to B. cellulosilyticus (Table 4.1). This 
shows that AroA LCA is not disproportionately affected by the deep-branching B. 
cytotoxicus. As the ancestral sequence is not significantly more similar to one 
contemporary sequence than the others, it is improbable that any extant sequence 
would pose bias on the ancestral node.  
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Table 4.1: Pairwise sequence identities (%) between extant and ancestral protein 
sequences. 
 LCA 
Bacillus amyloliquefaciens 77 
Bacillus anthracis 75 
Bacillus atrophaeus 75 
Bacillus cellulosilyticus 64 
Bacillus cereus 76 
Bacillus clausii 71 
Bacillus coagulans 67 
Bacillus coahuilensis 65 
Bacillus cytotoxicus 82 
Bacillus halodurans 73 
Bacillus licheniformis 75 
Bacillus megaterium 76 
Bacillus mycoides 75 
Bacillus pseudomycoides 74 
Bacillus pseudofirmus 74 
Bacillus pumilus 80 
Bacillus selenitireducens 67 
Bacillus subtilis 77 
Bacillus thuringiensis 75 
Bacillus weihenstephanensis 75 
Blue cell: Highest pairwise identity between ancestral and extant sequences 
Green cell: Lowest pairwise identity between ancestral and extant sequences 
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The reconstruction of Bacillus AroA LCA resulted in high posterior probability as 
well as a low number of ambiguous sites. This indicates a high probability of 
reconstructing a functional ancestral enzyme. Therefore, as performed for MurA, 
the process of characterising Bacillus AroA LCA, for its comparison with a 
contemporary AroA enzyme, was started by cloning the genes encoding these 
proteins followed by their expression and purification. 
4.2.2  Cloning, Protein expression and purification 
4.2.2.1 Cloning 
Bacillus AroA LCA gene was obtained from GeneArt (Life Technologies) and 
B. subtilis AroA was amplified from B. subtilis 168 genomic DNA using gene 
specific primers (section 2.2.2.1). Both Bacillus AroA LCA and B. subtilis AroA 
genes were then cloned into pPROEX HTb vector with an N-terminal His-tag 
using BamHI and XhoI restriction sites. pPROEX HTb containing the gene was 
used to transform either E. coli DH5or BL21 cells and screened for  positive 
transformants as explained in section 2.2.8. 
4.2.2.2 Small-Scale Protein Expression 
Small-scale expression of Bacillus AroA LCA protein (Lysis buffer: 50 mM Tris-
HCl pH 7.5, 300 mM NaCl, 20 mM imidazole) resulted with part of the protein in 
the soluble fractions and majority of protein remaining in the insoluble fraction. 
An overall increase in protein expression was observed with increase in time 
(Figure 4.2). A lysis buffer screen was performed to improve the solubility of 
protein and did not result in increased protein solubility.  
The expression of B. subtilis AroA in either E. coli DH5or BL21 cells grown in 
LB media resulted in very low protein expression in soluble and insoluble 
fractions. Therefore, the E. coli cells with B. subtilis AroA were grown and 
protein expressed in terrific broth (TB media) (Appendix E3) to increase the total 
amount of expressed protein obtained from cultures. A Ni
2+
 bead affinity test 
confirmed the Ni affinity to the N-terminal His tag and protein expression of 
B. subtilis AroA in TB media (Figure 4.2). The molecular weight of the 
monomeric form of Bacillus AroA LCA and B. subtilis AroA were predicted to be 
45.9 KDa and 45.2 KDa respectively by Protparam (Gasteiger et al. 2005) and 
was used as reference while analysing the SDS-PAGE gel bands.   
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Figure 4.2: SDS-PAGE gels of small-scale expression trials for AroA enzymes.  
A) Bacillus AroA LCA soluble and insoluble expression trial B) B. subtilis AroA Ni
2+
-
sepharose bead expression trial. White boxes indicate the expected band size. Labels for 
A): C - control sample taken prior induction; Numbered lanes indicate the number of 
hours after which the samples were taken post induction (3, 4, 6 and 20 hours). Labels for 
B): FT- flow through. 
4.2.2.3 Protein Purification 
Protein expression of Bacillus AroA LCA was scaled up to 1 L LB cultures and 
was initially purified using Ni affinity chromatography. Protein was eluted at 
16 % of  the elution buffer (50 mM Tris, 300 mM NaCl, 1 M imidazole pH 7.5), 
that is approximately 160 mM imidazole. Fractions corresponding to the peak 
were then run on an SDS-PAGE gel to confirm the size of the Bacillus AroA LCA 
protein (Figure 4.3).  
B. subtilis AroA, unlike Bacillus AroA LCA, was not codon optimized for E. coli 
protein expression and therefore expressed in low quantities even when scaled up 
(Figure 4.3). The optimum procedure to produce as much B. subtilis AroA protein 
as required for enzyme characterisation assays, was to grow the cells in 500 ml 
cultures of TB media and then pooling together protein purified using Ni affinity 
chromatography from two such cultures for further SEC purification. B. subtilis 
AroA protein was found to be eluted at 34 % of elution buffer (50 mM Tris, 300 
mM NaCl, 1 M imidazole pH 7.5) at 340 mM imidazole (Figure 4.3). The region 
indicated with a red bar on the B. subtilis AroA chromatogram corresponds to the 
fractions in which B. subtilis AroA protein is present (Figure 4.3). 
A) B) 
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Figure 4.3: IMAC purification of recombinant AroA enzymes.  
The IMAC chromatograms and corresponding SDS-PAGE gels for A) Bacillus subtilis 
AroA and B) Bacillus AroA LCA. The chromatograms show the UV absorbance at 
280 nm. The SDS-PAGE gel demonstrates the size and purity of AroA enzymes. The 
SDS-PAGE gel shows the insoluble pellet, the column load, flow through (FT) and AroA 
fractions eluted during IMAC. The white box indicates Bacillus subtilis AroA protein. 
The fractions and their elution position are indicated by the red bar. 
The fractions of AroA proteins obtained from Ni affinity purification were further 
purified using size-exclusion chromatography (SEC) to separate the protein 
monomers and other oligomers. It was observed that Bacillus AroA LCA had a 
prominent peak, whereas, B. subtilis AroA resulted in a chromatogram with 
multiple peaks (Figure 4.4). The fractions corresponding to peaks on the 
chromatogram were run on an SDS-PAGE gel to identify the protein fractions and 
their purity (Figure 4.4).   
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Figure 4.4: Size-exclusion chromatography (SEC) purification of recombinant AroA 
enzymes.  
The SEC chromatograms and corresponding SDS-PAGE gels for A) B. subtilis AroA and 
B) Bacillus AroA LCA. The chromatogram shows the UV absorbance at 280 nm. The 
SDS-PAGE gel demonstrates the size and purity of AroA enzymes. The SDS-PAGE gel 
shows the AroA fractions eluted during SEC. The white box indicates the two pure B. 
subtilis AroA fractions used for enzyme characterisation assays, which corresponds to the 
peak indicated in the chromatogram by the red arrow. The fractions and their elution 
position in the chromatogram are marked by the red bar. 
A Bradford assay was performed to quantify AroA protein (section 2.3.2). The 
purified AroA protein was then used for respective enzyme characterisation 
assays. However, before the enzyme assays were performed, the AroA enzyme 
substrate shikimate-3-phosphate (S3P) was required to be synthesised in the 
laboratory due to the high costs of buying the substrate. The synthesis of substrate 
S3P is described in the following section. 
4.2.3 S3P synthesis 
Shikimate-3-phosphate is one of the substrates utilized by AroA onto which the 
enolpyruvyl moiety from PEP is transferred. AroA’s preceding step is the 
formation of shikimate-3-phosphate by shikimate kinase from shikimate. This 
reaction mechanism can be utilized for the enzymatic synthesis of shikimate-3-
phosphate and its further purification.  
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4.2.3.1 Shikimate kinase preparation and preliminary S3P synthesis tests  
Shikimate kinase cloning, protein expression and purification: 
The gene encoding shikimate kinase II (aroL), was obtained from GeneArt (Life 
Technologies), and was cloned into an in-house modified pET28b-PstI using the 
restriction sites PstI and XhoI with a C-terminal His-tag. The cloned aroL was 
used to transform E. coli BL21 cells as explained in section 2.2.8. A Ni
2+ 
bead 
small scale expression trial in shikimate kinase lysis buffer (50 mM Tris-HCl 
pH 7.5, 5 mM MgCl2, 50 mM KCl, 20 mM imidazole) (Akiyama et al. 1999; 
Oliveira et al. 2001) was performed to confirm the expression of shikimate kinase 
in LB media at 37 °C overnight (Molecular weight: 19.2 kDa) (Figure 4.5). 
Shikimate kinase was then expressed in large scale cultures with LB media at 
37 °C and nucleic acids precipitated from the culture supernatant by the addition 
of 1% w/v streptomycin sulfate (final concentration) (Oliveira et al. 2001; 
Oliveira et al. 2003). Shikimate kinase was then purified using Ni-affinity 
chromatography (Shikimate kinase lysis buffer: 50 mM Tris-HCl pH 7.5, 5 mM 
MgCl2, 50 mM KCl, 20 mM imidazole; shikimate kinase elution buffer: 50 mM 
Tris-HCl pH 7.5, 5 mM MgCl2, 50 mM KCl, 1 M imidazole) and size exclusion 
chromatography (Shikimate kinase SEC buffer: 50 mM Tris-HCl pH 7.5, 5 mM 
MgCl2, 50 mM KCl). The fractions containing shikimate kinase protein were 
identified using SDS-PAGE (Figure 4.5). The purified protein was quantified 
using Nanodrop ND-1000 spectrophotometer (Nanodrop Technologies, USA).  
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Figure 4.5: Shikimate kinase expression trial and purification. 
A) Shikimate kinase Ni
2+ 
bead expression trial. B) Shikimate kinase Ni affinity 
purification chromatogram showing UV absorbance at 280 nm along with SDS-PAGE gel 
demonstrating the size and purity of shikimate kinase. C) SEC purification chromatogram 
of shikimate kinase enzyme showing absorbance at 280 nm and the SDS-PAGE gel 
confirming the size and purity of the shikimate kinase fractions. Fractions and their 
elution positions are marked with the red bar. White boxes indicate the expected band 
size. Label for A) and B): FT- flowthrough. 
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Shikimate kinase activity assay: 
The activity of shikimate kinase was assayed at room temperature using a three 
reaction coupled assay , with shikimate dependant oxidation of NADH monitored 
at 340 nm (Millar et al. 1986). The reactions are as follows: 
 
Shikimate  +  ATP  S3P  +  ADP 
 
PEP  +  ADP  Pyruvate + ATP 
 
Pyruvate + NADH Lactate + NAD
+
 
The tests were carried out with 50 mM Tris pH 7.0, 50 mM KCl, 5 mM MgCl2, 
2.5 mM shikimate, 0.125 mM ATP, 2.5 mM PEP, 0.25 mM NADH, 0.006 mg/ml 
pyruvate kinase, 0.007 mg/ml lactate dehydrogenase and 0.125 mg/ml shikimate 
kinase final concentration in 400 l final volume reaction mixture. The reaction 
cascade was started with the addition of shikimate and compared to a blank 
reaction lacking the presence of shikimate. Shikimate kinase activity was 
confirmed by monitoring the decrease in absorbance at 340 nm as NADH gets 
oxidised to NAD
+
 (Figure 4.6).  
 
Figure 4.6: Shikimate kinase activity monitored at 340 nm. 
The shikimate dependant activity of shikimate kinase in a three reaction coupled assay is 
illustrated through the decrease in absorbance at 340 nm as NADH gets oxidised to NAD
+
 
(Blue). The blank reaction with no shikimate shows a constant absorbance at 340 nm 
(Red).    
Shikimate 
kinase 
Pyruvate 
kinase 
Lactate 
dehydrogenase 
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S3P reaction activity tests using HPLC: 
Preparation of S3P and its purification has previously been successful using 
HPLC (Akiyama et al. 1999; Okunuki et al. 2003). Therefore, preliminary 
attempts for the synthesis and purification of S3P were based on these previous 
procedures. The reaction mixtures were set up by modifying the reaction used for 
the shikimate kinase activity test (Millar et al. 1986). The S3P reaction mixture 
contained a final concentration of 50 mM Tris pH 7.0, 50 mM KCl, 5 mM MgCl2, 
1.6 mM shikimate, 2.5 mM ATP and 0.2 mg/ml shikimate kinase enzyme in a 
final volume of 400 l; while the control reaction was set up with no shikimate 
kinase enzyme. The mixtures were left overnight at 25 °C followed by 
deproteination using a protein concentrator with a 5 KDa or 10 KDa molecular 
weight cutoff. Attempts to purify S3P were performed using a DiscoveryBIO 
wide pore C18 HPLC column (Sigma-Aldrich) (Figure 4.7) (section 2.3.9). Albeit 
the differences between the S3P reaction and control reaction chromatograms, the 
resolution of the chromatographic separation was too low to purify S3P from the 
reaction. The difference in HPLC columns, with the DiscoveryBIO wide pore C18 
HPLC column used in this attempt versus the TSK gel CARBON-500 column 
(Tosoh Co.) used in the previously mentioned papers, may have been one of the 
reasons for poor separation of the reaction components.  
Multiple tests were performed to identify each peak and to confirm the presence 
of S3P in the reaction. Individual runs of each component separately resulted in 
peaks at the following retention times: ATP: 3.1 and 3.3 minutes, ADP: 3.3 and 
3.5 minutes, Shikimate: 3.675 minutes. Therefore, Figure 4.7 suggests the 
disappearance of shikimate and ATP to produce ADP and S3P, as the reaction is 
meant to proceed. Although the chromatograms of S3P reaction and control 
reaction suggest the presence of S3P in the reaction, the poor separation of the 
components makes it inconclusive. 
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Figure 4.7: HPLC purification of S3P reaction and control reaction. 
The HPLC chromatograms of S3P reaction run (red) and control reaction run (green) are 
shown in the figure. The peak labels were assigned according to the retention time of the 
peaks obtained from HPLC runs of individual components. The chromatograms suggest a 
successful reaction between ATP and shikimate producing S3P and ADP, with the S3P 
peak as labelled, however, inconclusive.    
4.2.3.2 MonoQ 
Synthesis of S3P was achieved by optimising and modifying enzymatic S3P 
synthesis protocols (Funke 2008; Pedroso et al.). Shikimate kinase protein was 
expressed and purified as previously described (section 4.2.3.1) and the protein 
was thoroughly dialysed against 300 mM Tris pH 7.6, 100 mM KCl and 5 mM 
MgCl2 (S3P buffer) post SEC purification.  
For large scale synthesis of S3P, 2 ml reactions were set up containing a final 
concentration of 50 mM ATP, 50 mM shikimate, 0.2 mg/ml shikimate kinase 
enzyme and S3P buffer. The pH of the reaction was adjusted to 6.6 by adding 
10 M sodium hydroxide and the reaction was left overnight at 25 °C. A control 
reaction was also set up with no shikimate kinase enzyme. Prior to the MonoQ 
purification, S3P reactions were deproteinated by passing the mixture though a 
protein concentrator with 10 KDa molecular weight cutoff. 
S3P was purified by anion exchange with a MonoQ 4.6/100 PE column (GE 
Healthcare Life Sciences) using a gradient ranging from 0-0.5 M NH4HCO3 
pH 9.0. Each run was carried out by loading 1 ml of deproteinated S3P reaction 
ADP Shikimate 
ATP S3P 
S3P run 
Blank run 
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mixture. An overlay of the S3P reaction and control reaction chromatograms 
showing UV absorbance at 254 nm indicates a successful reaction as observed 
from the decrease in ATP and shikimate and increase in ADP (Figure 4.8).  
 
Figure 4.8: Overlay of MonoQ purification of S3P reaction and control reaction 
chromatograms. 
The chromatogram shows absorbance at 254 nm. The black bars identify the respective 
positions of shikimate, ADP and ATP as determined from separate MonoQ purifications 
of individual reaction components. The high amounts of ATP and ADP in the reactions 
have resulted in wide peaks in addition to surpassing the absorbance detection range. 
Although the separation between each individual component is not very clear, there is a 
clear decrease in ATP and increase in ADP illustrated by the peak shifts between control 
(blue) and S3P (red) reactions.  
The presence of S3P in the fractions was detected by catalytic activity of AroA 
using the malachite green assay. The fractions containing S3P, were pooled and 
freeze dried. The purity and identity of the sample was inspected using NMR and 
UV spectroscopy methods.  
4.2.3.3 NMR 
The identity of S3P was reconfirmed by performing an NMR analysis. A sample 
of the freeze dried S3P was dissolved in deuterated water (D2O) to perform 
1
H 
and 
31
P (coupled) NMR analysis on Bruker Avance III spectrometers. The 
1
H 
NMR spectra (400.14 MHz) was referenced internally using the residual protio 
solvent resonance relative to tetramethylsilane ( 0) and 31P (161.97 MHz) 
externally to 85% H3PO4 ( 0). Although inconclusive, the 
1
H spectrum obtained 
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suggested the possible presence of shikimate, ADP as well as shikimate-3-
phosphate in the sample. The 
31
P NMR analysis identified two peaks for ADP of 
shift -6.2169 ppm and -10.6805 ppm from the  and  phosphates of ADP 
respectively (Figure 4.9, Table 4.2). This observed shift for ADP peaks is 
consistent with the literature (Mascaros et al. 2011; Yu et al. 2013). The minor 
difference in shift from the  phosphate of ADP measured by Mascaros et al. 
(2011) may be due to difference in pH of the sample. The presence of ADP in the 
sample was expected as S3P co-eluted with ADP, similar to the S3P purification 
performed by Funke et al. (2008). Another peak was found at a shift of 
4.3989 ppm which corresponds to the phosphate from S3P (Figure 4.9, Table 4.2). 
This is consistent with the literature which reports S3P showing a chemical shift 
of ~4.5 ppm (Ge et al. 2010) and AroA enzyme bound S3P (3 ppm) (Jakeman et 
al. 1998) to be 2 ppm upfield from unbound S3P (5 ppm) (Christensen & Schaefer 
1993). Minor shift differences may be a result of pH differences of samples. 
Although the presence of S3P was established using the catalytic activity of AroA, 
NMR analysis aimed to ensure the same, as well as estimate the purity of the 
sample by determining the different species present in the sample. Therefore, the 
S3P stocks used for AroA enzyme characterisation contained ADP and possibly 
shikimate.  
Table 4.2: 
31
P NMR peak properties 
 No: of peaks Shift (ppm) Multiplicity Coupling constant 
S3P 1 4.3989 Doublet 9 Hz (P-H) 
ADP 2 
-6.2169 Doublet 22 Hz (P-P) 
-10.6805 Doublet 22 Hz (P-P) 
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Figure 4.9: The 161.97 MHz 
31
P NMR spectra of S3P and ADP.  
The sample is freeze dried S3P dissolved in D2O. The 
31
P chemical shift of S3P is 
4.3989 ppm and the 
31
P chemical shift of  and  phosphate of ADP are -6.2169 ppm 
and -10.6805 ppm respectively. The shift reference is 85% H3PO4 ( 0) (external).  
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4.2.3.4 Concentration and purity 
The purity and concentration of S3P within the stock was further examined using 
AroA enzymatic reaction. As the amount of inorganic phosphate produced is 
proportional to the amount of initial S3P present in the reaction, the absolute 
amount of S3P present in freeze dried powder was determined by allowing the 
AroA reaction to reach completion and calculating the amount of inorganic 
phosphate produced using a phosphate standard graph (section 2.3.7.2). This was 
in turn used to estimate that the S3P in the freeze dried ‘S3P powder’ was 12.7% 
pure. The AroA enzymatic reaction was used to determine the exact concentration 
of S3P in every stock solution used for the AroA enzyme characterisation assays. 
4.2.4 Enzyme characterisation 
4.2.4.1 Activity test and Time course assay 
Similar to MurA enzymatic assays, preliminary tests were performed to optimize 
the assay conditions. To eliminate the contribution of substrates towards the 
inorganic phosphate within the reaction, AroA reactions were carried out with 
control/blank reactions for all the substrate concentrations and temperatures. 
Fractions from the prominent peak of Bacillus AroA LCA SEC purification and 
the purest fractions from the B. subtilis AroA SEC purification were chosen for 
enzymatic characterisation assays (Figure 4.4). These fractions, based on the 
reference chromatograms for SEC column S200 10/300 and S75 10/300 (GE 
Healthcare) were found to correspond to the molecular weight of a dimeric AroA 
protein. A time course assay was performed and a reaction time of 2 minutes, ie. 
time for which the reaction was allowed to proceed before adding stop solution, 
was manually confirmed from the graph to remain within the linear phase of the 
reaction.  
4.2.4.2 Michaelis Menten kinetics 
The malachite green assay was used to determine the kinetic properties of 
ancestral and contemporary AroA enzymes. The substrates were added in the 
most feasible ways to determine the results as accurately as possible.  
Whenever possible, the substrate maintained at a constant concentration was 
added at ten times its KM to ensure non-limiting amounts of substrate during KM 
determinations. Otherwise, the maximum amount of substrate possible was added. 
All the assays were initially performed at 37 °C to accurately determine the Topt 
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and KM of substrates at the enzyme’s Topt with non-limiting amounts of substrate 
(Table 4.3). It was observed during PEP KM assays that increased concentrations 
of PEP exhibited substrate inhibition. It has previously been proposed that 
substrate inhibition may occur as a result of competitive binding of PEP at the 
S3P binding site (Gruys et al. 1992). Therefore, assays were performed 
considering the factor of substrate inhibition. All kcat values were calculated using 
Vmax from S3P KM. Under circumstances where non-limiting amounts of PEP were 
not added in S3P KM assays due to substrate inhibition factors, the apparent Vmax 
was used for kcat determination.   
Table 4.3: Kinetic constants for contemporary and ancestral AroA enzymes at 37°C 
Enzyme PEP KM 
(M) 
S3P KM 
(M) 
kcat 
(sec
-1
) 
kcat/KM (S3P) 
(sec
-1
M
-1
) 
B. subtilis 110 ± 30 800 ± 200 9.0 ± 0.8 1.1 (±0.3)x10
4
 
LCA 90 ± 10 80 ± 10 3.0 ± 0.1 3.8 (±0.7)x10
4
 
The kinetic values were obtained from three technical replicates.  
The errors represent the standard error of the mean 
Wildtype E. coli AroA has a PEP KM (88 M, 140 M) similar to that of the 
measured Bacillus subtilis AroA PEP KM, yet with approximately six fold lower 
S3P KM (120 M, 140 M) and with 3-6 times higher kcat (28.8 sec
-1
, 51 sec
-1
) 
(Eschenburg et al. 2002; Priestman et al. 2005a).  
The enzymatic activity of AroA has been shown to be influenced by monovalent 
cations such as potassium and ammonium ions with increased catalytic turnover 
(Majumder et al. 1995; Priestman et al. 2005a). In the case of AroA assays 
performed in this chapter, it is possible that potassium and ammonium ions are 
present in the assay mixtures (Potassium ions from KCl used in shikimate kinase 
purification buffers and ammonium ions from the NH4HCO3 buffer used in the 
MonoQ purification of S3P).  Such residual amounts of potassium and ammonium 
ions may have been enough to activate the AroA enzymes. The measured Bacillus 
subtilis AroA KM values were more comparable to the ammonium activated 
Bacillus subtilis AroA PEP KM (90 M) and S3P KM (330 M) (Majumder et al. 
1995). Staphylococcus aureus AroA activated by KCl has a comparable kcat 
(4.2 sec
-1
) to the measured kcat of Bacillus subtilis AroA and a comparable PEP 
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KM (180 M), though about six fold lower S3P KM (140 M) (Priestman et al. 
2005a). All these kinetics values from the literature were measured by 
determining the amount of inorganic phosphate produced in the reaction using the 
malachite green assay (Lanzetta et al. 1979) at 20-37 °C. 
Substrate affinity (KM), depends on a variety of factors including temperature, and 
an increase of KM values with increase in temperature has previously been 
reported (Griffith et al. 2001; Barrett 2011). Therefore, the kinetic properties of 
AroA enzymes were measured at the enzymes respective optimum temperature 
(Topt) for accurate comparison. The optimum temperatures for both AroA enzymes 
were measured as described in section 4.2.6. The kinetic parameters for both 
Bacillus AroA LCA and Bacillus subtilis AroA determined at their respective Topt 
are shown in Table 4.4 and Figure 4.10. 
Table 4.4: Kinetic constants for contemporary and ancestral AroA enzymes at their 
respective optimal temperatures (Topt) 
Enzyme PEP KM 
(M) 
S3P KM 
(M) 
kcat 
(sec
-1
) 
kcat/KM (S3P) 
(sec
-1
M
-1
) 
Topt 
(°C) 
B. subtilis 570 ± 90 1500 ± 200 21.0 ± 2.0 1.4 (±0.4)x10
4
 46 
LCA 130 ± 30 340 ± 80 10.0 ± 1.0 3.0 (±1.0)x10
4
 51 
The kinetic values were obtained from three technical replicates.  
The errors represent the standard error of the mean 
As previously seen for B. subtilis AroA at 37 °C, the KM of S3P is more than two 
folds higher than the KM obtained for PEP. While having a lower kcat than 
B. subtilis AroA, it must be noted that AroA LCA exhibits twice the catalytic 
efficiency of contemporary AroA. 
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Figure 4.10: Michaelis-Menten plots for contemporary and ancestral AroA enzymes 
at their respective Topt values. 
Results are the mean of three technical replicates, the error bars representing the SEM. 
Overall, the kinetic parameters determined for Bacillus AroA LCA were 
comparable to the contemporary AroA enzyme kinetic parameters, thus validating 
an accurate reconstruction of AroA LCA enzyme. It must be noted that, although 
PEP KM of B. subtilis AroA and AroA LCA were comparable, the S3P KM of 
B. subtilis AroA is 3-6 folds higher than the S3P KM for AroA LCA (Table 4.4).  
Further information on why the AroA LCA has a higher affinity towards S3P than 
B. subtilis AroA may have to be determined via structural analysis of AroA LCA 
bound to S3P.  
The inhibitory properties of AroA enzymes were also measured in a similar way 
as done for the MurA enzymes in chapter 3. 
4.2.5 Inhibitory properties: IC50  
Multiple studies have focused on the inhibition of AroA, due to the rise in 
tolerance towards its most commonly used inhibitor glyphosate, the prime 
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ingredient of the herbicide Roundup. Inhibition of AroA in pathogenic organisms 
has also been of increased interest as disruption of AroA activity or shikimate 
pathway has been associated with attenuated virulence (McDevitt et al. 2002) and 
viability of microorganisms (Parish & Stoker 2002; Funke et al. 2007). The 
evolution of AroA enzyme may be investigated by determining the inhibitor 
sensitivity of Bacillus AroA LCA in comparison to the contemporary AroA 
enzyme. 
4.2.5.1 Inhibition by glyphosate  
Depending on the resistance of AroA towards its inhibitor glyphosate, AroA 
enzymes are classified into two groups, Class I and Class II. Studying the 
glyphosate sensitivity of AroA LCA may provide information pertinent to the 
evolution of these two classes of AroA enzymes.  
Class I AroA are naturally sensitive to glyphosate, yet they can be modified to 
acquire glyphosate tolerance which comes often at the expense of having a 
decrease in PEP affinity (Sun et al. 2005). From different studies, the IC50 value 
for glyphosate for wild type E. coli, a known class I AroA, may range from as low 
as 8.6 M (Priestman et al. 2005a) to as high as 55 M (Tian et al. 2013). 
Mutagenesis of class I E. coli to P101S conferred glyphosate tolerance exhibiting 
IC50 of 5 mM (Stallings et al. 1991). 
Class II AroA are naturally glyphosate tolerant with high affinity for PEP. Less 
than 30% sequence identity is observed between class I and class II AroA (Sun et 
al. 2005). While the presence or absence of cations was shown to affect the 
property of certain AroA enzymes, Staphylococcus aureus AroA was classified as 
true class II AroA with IC50 of 0.9 mM to 1.6 mM (Priestman et al. 2005a). 
Bacillus cereus AroA was classified as class II AroA with IC50 of 0.5 mM (Tian 
et al. 2013). 
Bacillus subtilis AroA is also classified as class II AroA (Barry et al. 1992; Sun et 
al. 2005). The IC50 values of B. subtilis AroA and AroA LCA were measured as 
explained in section 2.3.7.6. The dose-response curves and the IC50 values are 
given in Figure 4.11 and Table 4.6. The IC50 of B. subtilis AroA was found to be 
very high (4.4 mM), confirming its glyphosate tolerance. B. subtilis AroA also 
showed high affinity to PEP at 37 °C (110±30 M) which agrees with the 
characteristic of class II enzymes. 
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Bacillus AroA LCA, on the other hand, has an IC50 of 0.4 mM, which is in the 
range of class II S. aureus AroA and Bacillus cereus AroA, however, 
approximately 12 fold more sensitive in comparison to B. subtilis AroA (Note that 
fosfomycin sensitivity of MurA obtained by malachite green assay was 0.2-0.3 
mM ). However, AroA LCA exhibits equivalent affinity for PEP as B. subtilis 
AroA at 37 °C and a four fold higher affinity for PEP than B. subtilis AroA at its 
Topt (Table 4.3 and Table 4.4).  
Although the results of assays performed under different experimental conditions 
may vary, comparison to values reported in the literature may provide a range to 
which values may be compared (Table 4.5).  
Table 4.5: Class I and Class II AroA enzymes and their IC50 values   
Enzyme Classification IC50 (mM) Reference 
Wild type E.coli Class I 0.009-0.06 
(Priestman et al. 2005a; 
Tian et al. 2013) 
E.coli P101S 
Class I with 
glyphosate tolerance 
5 (Stallings et al. 1991) 
Staphylococcus 
aureus 
Class II 0.9-1.6 (Priestman et al. 2005a) 
Bacillus cereus Class II 0.5 (Tian et al. 2013) 
Bacillus subtilis Class II 4.4* 
(Barry et al. 1992; Sun et 
al. 2005)** 
Bacillus AroA 
LCA 
- 0.4* - 
*   Measured IC50 values for enzymes 
** Bacillus subtilis classified as class II AroA (Barry et al. 1992; Sun et al. 2005) 
Various mutagenesis studies have identified different amino acid residues which 
affect glyphosate sensitivity. Nevertheless, the specific amino acid residues that 
represent the signature of class I or class II enzymes are not known. Therefore, 
categorization of Bacillus AroA LCA cannot be performed with confidence. From 
the phylogenetic tree used to infer the LCA of Bacillus, B. subtilis and B. cereus 
are classified as class II AroA enzymes. However, the class of the rest of the 
Bacillus species is not known. AroA LCA shows characteristics of class II 
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enzymes in the following ways: 1) Class I and class II AroA share less than 30% 
amino acid identity (Tian et al. 2012), yet Bacillus AroA LCA shares ≥64% 
sequence identity to the Bacillus species (Table 4.1) and only 28.3% sequence 
identity to class I E. coli AroA, 2) AroA LCA exhibits an identical high affinity 
towards PEP as class II B. subtilis AroA, 3) The mutation of Pro101 in E. coli to 
Ser101 confers glyphosate resistance which may be the result of small alterations 
around the binding pocket for glyphosate (Priestman et al. 2005a). Sequence 
alignment revealed that the Pro101 residue of E. coli is substituted by a leucine 
residue in class II S. aureus AroA and all Bacillus AroA sequences used for 
ancestral inference as well as in Bacillus AroA LCA, and 4) All the residues 
identified by Park et al (2004), involved in glyphosate interaction from class II 
S. pneumoniae AroA (K20, S21, R25, G92, T93, R120, R124, S166, A167, Q168, 
D312, K339, E340, R343, H384 and R385) were also conserved in Bacillus AroA 
LCA, suggesting that the difference in sensitivity may not be due to major residue 
differences, but rather subtle changes of the glyphosate binding site caused by 
other amino acid changes. Although the above evidence suggests Bacillus AroA 
LCA to be a class II AroA, the higher glyphosate sensitivity of LCA in 
comparison to B. subtilis AroA does not concur. Therefore, either the present day 
class II Bacillus species with natural glyphosate tolerance evolved from the 
glyphosate sensitive Bacillus AroA LCA; or, if the reconstructed ancestral 
enzyme only represents a snapshot of the evolving host at a given point in time (as 
describe in section 3.2.5), then the LCA may only represent one species with 
glyphosate sensitivity, which is neither class I nor class II. 
  
Figure 4.11: The IC50 dose-response curves obtained for different concentration of 
glyphosate A) Bacillus subtilis AroA B) Bacillus AroA LCA 
Results are the mean of three technical replicates, the error bars representing the SEM 
B) A) 
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4.2.5.2 Inhibition by fosfomycin 
As performed for MurA, the exclusive inhibition of MurA and AroA by 
fosfomycin and glyphosate respectively, was tested on the Bacillus AroA LCA 
enzyme. Inspite of the structural similarity between AroA and MurA, due to the 
spatial arrangement of residues in the enzyme’s active site, the inhibitors are 
specific to contemporary AroA and MurA. Therefore, determining the sensitivity 
of AroA LCA towards the MurA inhibitor fosfomycin, would allow us to find out 
the presence of any structural or mechanistic properties in the ancestor that would 
indicate a similarity in active sites of AroA and MurA. 
The IC50 for fosfomycin measured as explained in section 2.3.7.6 are given in 
Table 4.6 and the corresponding dose-response curves are given in Figure 4.12. 
B. subtilis AroA was found to be resistant to fosfomycin inhibition as expected. 
Bacillus AroA LCA also exhibited a similar non-specific inhibition, thereby 
suggesting the absence of any characteristic changes in LCA that would indicate 
similarity in inhibition to MurA.  
Table 4.6: Glyphosate and fosfomycin IC50 values for Bacillus subtilis AroA and 
Bacillus AroA LCA 
 B.subtilis AroA Bacillus AroA LCA 
Glyphosate 4.4 mM 0.4 mM 
Fosfomycin 55.3 mM 48.4 mM 
 
  
Figure 4.12: The IC50 dose-response curves obtained for different concentration of 
fosfomycin A) Bacillus subtilis AroA B) Bacillus AroA LCA. 
Results are the mean of three technical replicates, the error bars representing the SEM 
A) B) 
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The optimum temperature of enzyme activity and enzyme melting temperature of 
ancestral and contemporary AroA enzymes were also measured for the study of 
the enzyme evolution. 
4.2.6 Thermal properties 
Core metabolic enzymes undergo certain changes to facilitate adaptation of their 
host organisms to the new environments resulting from evolutionary processes 
(Hobbs et al. 2012). Therefore, the thermal characteristics of AroA ancestral 
enzyme would also provide us with key evolutionary information.  
The thermoactivity (Topt) of AroA enzymes were measured over a broad 
temperature range followed by a narrow temperature range as performed for 
MurA enzymes. All the assays were performed by adding the maximum amount 
of substrate possible, considering substrate inhibition and malachite green assay 
sensitivity. Therefore, it was not possible to add ten times the substrate KM and 
hence may have resulted in substrate limitation. The Topt of B. subtilis AroA was 
found to be 46 °C  which could still be considered to be within the mesophilic 
range as it is common for mesophilic organisms to show thermoactivity higher 
than their growth temperature (Georlette et al. 2004; Hobbs et al. 2012). Similarly, 
the Topt of Bacillus AroA LCA was measured to be 51 °C falling within the 
moderately thermophilic range (Figure 4.13, Table 4.4).  
The thermostability (Tm) of AroA enzymes was measured by performing real-time 
protein melt assays as described in section 2.3.8.2. The Tm values determined 
using real-time protein melt method has been shown to be in reasonable 
concordance with values obtained by DSC method (Easter 2010). The Tm of B. 
subtilis AroA was found to be 48 °C and that of Bacillus AroA LCA was found to 
be 62 °C (Figure 4.13).  
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Figure 4.13: Thermoactivity and thermostability profiles for contemporary and 
ancestral AroA enzymes.  
A) Thermoactivity data shown are the mean of at least three replicates and are expressed 
as a proportion of the highest activity (at Topt) B) Thermostability data shown are real-
time melts of B. subtilis AroA and Bacillus AroA LCA at pH 7.5 and pH 7 respectively.  
The Topt and Tm values were found to be consistent with each other. Gromiha et al 
(1999) indicates the correlation between the enzyme thermoactivity (Topt) and 
thermostability (Tm) to the host organism growth temperature, which is hence 
attested by B. subtilis. Therefore, based on this correlation, the thermal properties 
of Bacillus AroA LCA suggest its host to have inhabited a moderately 
thermophilic environment.  
The temperature profile exhibited by B. subtilis AroA (Topt of 46 °C) and 
B. subtilis LeuB (Topt of 53 °C) differ from each other, thus indicating the protein 
dependency of such properties (Hobbs et al. 2012). Similarly Bacillus AroA LCA 
(Topt of 51 °C; Tm of 62 °C) and LeuB ancestor LeuB4 (Topt of 70 °C; Tm of 
65.3 °C), aged 957 myr and 950 myr respectively, differ in the extent of their 
thermophilicity substantially with respect to their Topt, though similar in their Tm 
(Hobbs et al. 2012). Such variation in temperature profiles between enzymes may 
also concur with the hypothesis that the thermal properties are likely to reflect the 
changes in the microenvironment of the organism and does not indicate global 
environmental changes (Hobbs et al. 2012). The difference in thermoactivity 
between Bacillus AroA LCA and Bacillus LeuB4 from the same time period, may 
also point towards the idea that each reconstructed ancestor only represents a 
single candidate from the consortium of Bacillus species present at that particular 
point of time (refer to section 3.2.5).  
A) B) 
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Therefore, thermal characterisation of Bacillus AroA LCA revealed that the 
ancestral AroA enzyme has considerable thermostability. It is however difficult to 
precisely ascertain the amino acids or structural characteristics of Bacillus AroA 
LCA that impart such a thermophilic nature.  
Lastly, the behaviour of Bacillus AroA LCA in vivo in comparison to 
contemporary AroA was investigated.  
4.2.7 In vivo characterisation 
The in vitro parameters of B. subtilis AroA and Bacillus AroA LCA determined in 
section 4.2.4.2, were comparable to each other with two notable characteristics 
being: lower affinity of B. subtilis AroA towards S3P and AroA LCA exhibiting 
twice the catalytic efficiency of B. subtilis AroA. The growth rates of these 
enzymes were used to investigate the effect of the enzyme’s in vitro parameters on 
their fitness in vivo. 
E. coli, with its AroA gene knocked out, fails to grow on M9 minimal media, but 
may be complemented with the help of a plasmid containing the aroA gene 
(Padgette et al. 1987; Jin et al. 2007). Therefore, in vivo characterisation of AroA 
enzymes was carried out using the E. coli ΔaroA from the Keio collection. This 
system was used as a preliminary way of investigating the effect of ancestral 
AroA and contemporary AroA enzymes on growth rate. The parent E. coli cells 
(strain BW25141) comprising of intact aroA gene, was used as a positive control 
and ΔaroA complemented with empty pPROEX HTb plasmid was used as a 
negative control. The AroA fitness study was performed by complementing 
ΔaroA with B. subtilis AroA as well as Bacillus AroA LCA. The relative growth 
rates of complemented cells was determined as explained in section 2.4, by 
growing the cells in M9 minimal media such that the growth of the cells results 
only from the activity of the complemented genes. B. subtilis AroA successfully 
rescued the ΔaroA cells, while Bacillus AroA LCA did not (Figure 4.14). The 
decreased fitness of Bacillus AroA LCA in vivo possibly explains the loss of this 
enzyme over evolutionary time.  
Although, the fitness cost caused by AroA LCA needs to be further confirmed 
with the help of growth experiments and competition assays, Bacillus AroA LCA 
may need to be on the Bacillus chromosome, under the control of Bacillus 
machinery to be able to rescue the cells. Also, the kcat of Bacillus AroA LCA at 
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37 °C (3.0±0.1 sec
-1
) is three times lower than B. subtilis AroA kcat (9.0±0.8 sec
-1
), 
which may not have been sufficient activity for the rescue of the aroA cells. 
Furthermore, if evolutionary changes occurred to all the enzymes in the shikimate 
pathway to adapt to its present evolutionary state, then the insertion of an 
ancestral AroA enzyme within the modern shikimate pathway may result in 
uncoupling, and thereby preventing AroA LCA from rescuing the cells. However, 
further work needs to be done to explore the in vivo fitness cost imposed by AroA 
LCA. 
 
Figure 4.14: Relative growth rate of Keio collection knockout cells complemented 
with contemporary and ancestral aroA genes on M9 agar. 
To summarize, the reconstructed AroA LCA from Bacillus genus, exhibits 
biologically realistic kinetic parameters comparable to the contemporary enzyme 
kinetics. AroA LCA was found to be moderately thermophilic in nature and 
demonstrated more sensitivity towards inhibitor glyphosate in comparison to the 
glyphosate tolerant class II B. subtilis AroA. Although, AroA LCA has twice the 
catalytic efficiency of B. subtilis AroA, unlike the contemporary AroA, AroA 
LCA was not able to rescue aroA E. coli cells. However, further growth 
experiments may need to be performed in order to study the fitness of these 
enzymes more thoroughly. 
The evolution of AroA and MurA enzymes was further explored by their 
structural characterisation as described in chapter 5.  
 
Chapter 5: Structures of Bacillus MurA LCA and Bacillus AroA LCA 
125 
 
5 Chapter 5  
Structures of Bacillus MurA LCA and Bacillus 
AroA LCA  
5.1 Introduction 
The second approach used to study the evolution of the enolpyruvyl transferase 
enzymes MurA and AroA was X-ray crystallography. X-ray crystallography relies 
on the protein to crystallise into a well ordered lattice to determine its 
3-dimensional structure. This technique was used to determine the structures of 
Bacillus MurA LCA and Bacillus AroA LCA for comparison to their respective 
contemporary structures. Such a detailed comparison between the ancestral and 
contemporary enzymes would allow us to identify any structural changes that 
happened over the last 950 myr and whether or not those differences are 
significant enough to affect the enzyme’s functional characteristics. 
5.2 Results and Discussion 
5.2.1 MurA 
5.2.1.1 Crystallisation of Bacillus MurA LCA 
A crystallisation screen of 384 conditions (Hampton Research) was laid down 
with Bacillus MurA LCA as explained in section 2.5.1.  Out of these 384 
crystallization conditions, many conditions proved to be suitable for crystal 
formation, with nine conditions producing crystals overnight and a further 16 
conditions with crystals formed at the end of one month. The conditions with the 
best crystals were advanced through hanging drop crystallisation screens (section 
2.5.2.1). Besides the modifications to the original conditions, fine screens were 
also carried out in the presence of additives. The final condition from which 
crystals gave good diffraction consisted of 0.2 M ammonium acetate, 0.1 M Tris, 
pH 8.5, 25% PEG 3,350 along with the addition of 0.2 M glycine (in the mother 
liquor) as an additive and 1 mM UDP-N-acetylglucosamine (UNAG) (final 
concentration)  in the hanging drop. This condition led to the formation of needle 
like crystals as shown in Figure 5.1. 
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Figure 5.1: Bacillus MurA LCA crystals and their diffraction pattern 
A) The crystals grown in a drop consisting of mother liquor with 0.2 M ammonium 
acetate, 0.1 M Tris, pH 8.5, 25% PEG 3,350 along with glycine and UNAG as additives. 
B) The crystal from which diffraction data was collected. C) X-ray diffraction pattern for 
Bacillus MurA LCA to 2.11 Å resolution. 
5.2.1.2 X-ray Data Collection 
The crystals were sent to the Australian Synchrotron for data collection on the 
MX2 beamline. Data was collected from different spots of the crystal needle. The 
best data was collected to a resolution of 2.11 Å with detector distance of 300 mm 
and 0.5° oscillation angles for a total of 200 frames.  
5.2.1.3 Data Processing 
The data collected was indexed using XDS and scaled using the program Aimless 
(Evans & Murshudov 2013). The space group was found to be P212121 with data 
A) B) 
C) 
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at a resolution of 2.11 Å. ‘Truncate’ (French & Wilson 1978) from the CCP4 suite 
(Winn et al. 2011) was used to ensure unique data and to generate a FreeR set for 
5% of the data. Matthews coefficient analysis (Matthews 1968) predicted the 
presence of four molecules in the asymmetric unit. The data collection statistics 
are given in Table 5.1. 
Table 5.1: Data collection statistics for Bacillus MurA LCA 
Data Statistics Overall Outer Shell 
Space group P212121  
Wavelength (Å) 0.95370  
Cell dimensions 
a b c (Å) 

 
96.06 / 122.85 / 153.53 
90.00 / 90.00 / 90.00 
 
Mosaicity 0.13  
Monomers in asymmetric unit 4  
Resolution range (Å) 48.03-2.11 2.14-2.11 
Number of observations 431273 20057 
Number of unique reflections 105421 5020 
R-merge 0.067 0.636 
Mean I/I 11.8 2.1 
Completeness % 99.8 97.2 
Multiplicity 4.1 4.0 
The structure of Bacillus MurA LCA was solved using molecular replacement 
(using Phaser (McCoy et al. 2007) in CCP4 (Winn et al. 2011)) with the structure 
of Bacillus anthracis MurA (PDB code 3SG1) as the model. Bacillus MurA LCA 
and B. anthracis MurA share 82% sequence identity. The Bacillus MurA LCA 
sequence was then automatically built into the electron density map using 
Buccaneer (Cowtan 2006) in CCP4. The structure was refined multiple times 
using refmac5 (Murshudov et al. 2011) in CCP4, imposing non-crystallographic 
symmetry (NCS) restraints, and manual model building using COOT (Emsley & 
Cowtan 2004). The amino acid residues from 356-363 and 415-418 from all the 
four chains of Bacillus MurA LCA structure were not properly modelled by 
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Buccaneer and hence were built manually in COOT. Each domain of a Bacillus 
MurA LCA monomer was defined as an individual TLS group for the final round 
of refinement  
The Bacillus MurA LCA structure was co-crystallised with the substrate UNAG. 
UNAG is present in the structure, bound to the active site of the enzyme along 
with a phosphate molecule. The refinement statistics are given in Table 5.2. 
Table 5.2: Refinement and model statistics for Bacillus MurA LCA 
Refinement 
R-factor (%) 16.5 
Rfree (%) 21.3 
Total number of atoms 13603 
Total number of protein atoms 12549 
 Chain A 3133 
 Chain B 3133 
 Chain C 3150 
 Chain D 3133 
Total number of ligand atoms 176 
Total number of solvent atoms 878 
RMSD 
Bond lengths (Å) 0.0153 
Bond angles (°) 1.72 
Average B factors (Å
2
) 
Chain A 38.1 
Chain B 43.2 
Chain C 37.09 
Chain D 35.7 
Ramachandran analysis 
Preferred regions  97.8 % (1626 residues) 
Allowed regions  1.9 % (31 residues) 
Outliers  0.3 % (5 residues) 
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5.2.1.4 Overall Structure 
Bacillus MurA LCA enzyme consists of 436 amino acids plus an additional 27 
amino acids including the N-terminal His-tag. There was no electron density for 
the N-terminal His-tag nor for the first amino acid, nor the last 18 amino acids of 
the Bacillus MurA LCA sequence. There are four chains in the asymmetric unit of 
the Bacillus MurA LCA crystal structure. 
The Bacillus MurA LCA monomer consists of two globular domains, with two 
individual strands connecting the two domains. Domain I consists of residues 23-
228 and domain II, containing the N- and C-terminal ends, consists of residues 2-
17 and 234-418. The linker region links the two domains by two strands of five 
amino acids each (residues 18-22 and 229-233). The two domains are also 
connected via a salt bridge between Arg234 and Glu192 (Costantini et al. 2008). 
Each domain is made up of three repetitive subunits with a total of 6 repetitive 
subunits within the monomeric structure (Figure 5.2). Each subunit is typically 
made of four -strands and two -helices with the exception of subunit II which 
has long loop followed by a one turn helix (3) instead of a -strands and subunit 
VI which has its second helix replaced by two 2-turn helices (13 and 14) 
(Figure 5.3). The irregularity of subunits II and VI of Bacillus MurA LCA differs 
from the previously solved structures of MurA (Schönbrunn et al. 1996; 
Skarzynski et al. 1996; Eschenburg & Schönbrunn 2000). Similar to previously 
solved MurA structures, the core of each domain consist of helices surrounded by 
three clusters of  sheets to give the inside out  barrel which is typical of 
enolpyruvyl transferases (Figure 5.2) (Schönbrunn et al. 1996; Skarzynski et al. 
1996; Eschenburg et al. 2003; Oberdorfer et al. 2012). 
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Figure 5.2: Bacillus MurA LCA monomer and its inside out barrel 
conformation 
A) Cartoon representation of monomeric Bacillus MurA LCA bound to its substrate 
UNAG (magenta). B) Cartoon representation of the two domains I and II with its six 
subunits labelled (I-VI). The orientation is chosen to show the inside-out / barrel 
configuration of Bacillus MurA LCA. 
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Figure 5.3: Topology sketch of Bacillus MurA LCA 
The figure displays the two globular domains, domain I and II, each consisting of three subunits (I-VI). Each helix and beta strand is labelled sequentially. 
The twisted loop in subunit II represents the long loop Ala112-Ile124. The components are coloured corresponding to the colouration used in Figure 5.2. 
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The size exclusion chromatography purification of Bacillus MurA LCA protein 
showed two peaks, with the dominant peak corresponding to a dimer (Figure 
3.6 and section 3.2.3.1) used for crystallography. The protein crystallised with 
four molecules in the asymmetric unit. Chain C and chain D form a dimer with 
an interface interaction of 6.6% of the total surface area (1056.3 Å
2
) (Figure 5.4) 
(PDBePISA (Krissinel & Henrick 2007)).  The remaining two molecules (chain 
A and chain B) require symmetry neighbours to form their respective dimers 
with a contact area of 6.7% (1067Å
2
) (PDBePISA (Krissinel & Henrick 2007)). 
Therefore the four chains A, B, C and D form three dimers split between three 
unit cells.  
The presence of UNAG in the crystallisation condition of Bacillus MurA LCA 
allowed the protein to be crystallised in its substrate bound form. It was 
observed that domain I of Bacillus MurA LCA shows a general higher B factor 
than that of domain II, indicating that domain I is less ordered than domain II. It 
was also noted that chain B has a higher average B factor than the remaining 
three chains (Table 5.2).  
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Figure 5.4: Bacillus MurA LCA dimer bound to UNAG 
Cartoon representation of Bacillus MurA LCA dimer bound to UNAG (green). The 
dimer is formed by chain C and D sharing an interface area of 1056.3Å
2
 within the 
same unit cell.  
5.2.1.5 Substrate binding site  
The catalytic site of Bacillus MurA LCA is situated in between the two 
domains. A total of 10 bonds are formed between the substrate UNAG and 
amino acid residues of Bacillus MurA LCA Figure 5.5 (PDBsum (Laskowski 
2001)). Out of these 10 residues involved in ligand interaction, only two 
residues are located within domain II (Asp306 and Val328). The remaining 
eight residues are located on domain I (Asn23, Val165, Ser164, Gln126, 
Asp125, Ser121, Arg122 and Gly166) with residues Ser121 and Arg122 
positioned on the loop between 6 and 5 (Figure 5.3). Asn23, from 
Enterobacter cloacae, was recognised to be an essential active site residue 
involved in the stabilisation of the MurA transition states (Samland et al. 
2001).The second substrate for MurA, phosphoenolpyruvate (PEP), is not 
present in the crystal structure of Bacillus MurA LCA. According to E. cloacae 
and E.coli MurA numbering, the strictly conserved residue Asp305 is essential 
for the addition-elimination reaction of the enzyme. Residues Arg331, Arg371, 
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Lys22 and Arg120 are responsible for PEP binding and the transfer of the 
enolpyruvyl moiety. Other conserved residues such as Arg397 (involved in a 
salt bridge), contribute to the phosphate binding site and Cys115 is involved in 
the protonation of PEP during the reaction (Skarzynski et al. 1996; Eschenburg 
et al. 2003). All the afore mentioned catalytically important active site residues 
correspond to residues Asp306, Arg332, Arg372, Lys22, Arg122, Arg398, 
Cys117 and Asn23 respectively of Bacillus MurA LCA and are illustrated in 
Figure 5.5.  
Residues Cys117, Ser121 and Arg122 are present on the long loop between 6 
and 5 (Ala112-Ile124). The section of this loop from Pro114-Pro123 may 
correspond to the previously identified loop from E.coli and Enterobacter 
cloacae (Pro112 to Pro121) which is believed to have a role in stabilising the 
enzyme in its unliganded form and is known to undergo conformational 
changes upon substrate binding (Schönbrunn et al. 2000). The conformational 
change after substrate binding brings the domains closer together to be in a 
‘closed state’. Skarzynski et al. (1996) describes this loop as a ‘lid’ over the 
catalytic pocket when the enzyme is in its closed state. The loop of Bacillus 
MurA LCA exhibits a similar conformation by forming a lid over the catalytic 
pocket, unlike the orientation of the loop seen in unliganded MurA (PDB 
1NAW) (Figure 5.6).      
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Figure 5.5: Cartoon representation of Bacillus MurA LCA showing the active site 
residues 
The residues interacting with UNAG are shown in red, residues interacting with PEP 
are coloured dark blue and the residues involved in both UNAG and PEP interaction 
are coloured in magenta. UNAG (orange) is bound to the LCA structure and the bonds 
formed between UNAG and residues are shown in dashes. The labels correspond to 
Bacillus MurA LCA structure numbering.  
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Figure 5.6: ‘Lid’-like loop in closed and open conformations 
Bacillus MurA LCA structure (green) is in a closed conformation as it is bound to 
substrate UNAG whereas E.cloacae MurA (PDB 1NAW) (purple) has no substrate 
bound and hence is in an open conformation. The box shows the conformation of the 
‘lid’-like loop in the open and closed states. Domain I of both structures is overlaid and 
shows the unbound structure of E.cloacae MurA (purple) to be more open than 
Bacillus MurA LCA by 10°. 
5.2.1.6 Inhibitor binding in the active site 
In spite of sharing mechanistic and structural similarities, contemporary MurA 
and AroA are exclusively inhibited by fosfomycin and glyphosate respectively. 
However, it is possible that the ancestral enzymes MurA and AroA are more 
similar, which may allow inhibition by glyphosate or fosfomycin 
interchangeably. Eschenburg et al (2003) determined that the reason why 
glyphosate could not inhibit MurA was due to distance clashes of glyphosate to 
the residues Arg120, Arg371 and UNAG as well as the lack of a specific 
residue that could hold glyphosate in place via hydrogen bonds. An alignment 
of contemporary E. cloacae C115D MurA liganded with UNAG (PDB 3V4T) 
with Bacillus MurA LCA shows that the orientation of corresponding residues 
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for Arg120, Arg371 and substrate UNAG remains approximately the same as in 
the ancestral enzyme (Figure 5.7). This suggests that the structural changes 
necessary for glyphosate inhibition of MurA are not present in Bacillus MurA 
LCA, in agreement with the IC50 results obtained in section 3.2.4.2. 
 
Figure 5.7: Orientation of residues Arg120/Arg122 and Arg371/Arg372 and 
UNAG in Enterobacter cloacae MurA and Bacillus MurA LCA respectively 
Residues Arg120, Arg371 (purple) and UNAG (olive green) from Enterobacter 
cloacae MurA (PDB 3V4T) (blue) show similar orientation and positioning as residues 
Arg122, Arg372 (red) and UNAG (orange) from Bacillus MurA LCA (green).   
5.2.1.7 Comparison to contemporary structures 
A structural comparison of Bacillus MurA LCA to the entire PDB archive using 
PDBeFOLD (Krissinel & Henrick 2004) found B. anthracis (PDB 3SG1) to be 
the closest structural homologue with a sequence identity of 82%. Comparing 
the structures of Bacillus MurA LCA and B. anthracis MurA would allow us to 
identify the main differences between contemporary and ancestral MurA 
enzymes within the same genus. The majority of the remaining structures from 
the PDBeFOLD analysis share around 46% to 51% sequence identity to 
Bacillus MurA LCA. To properly analyse the differences between ancestral 
MurA against contemporary MurA, a comparison of the enzymes in their bound 
form to UNAG is also necessary as the enzyme adopts a different conformation 
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upon substrate binding. Table 5.3 gives structural alignment parameters for a 
selection of the structures discussed in this chapter (3SG1 and 1NAW without 
ligand; 3V4T, 2RL1 and 1UAE with UNAG bound). 
Table 5.3: PDBeFOLD structural alignment of PDB structures to Bacillus MurA 
LCA 
Structure RMSD 
% 
seq
1
 
Q-
score 
P-
score 
Z-
score 
% 
sse
2
 
PDB 
code 
Reference 
B. 
anthracis 
0.60 82 0.96 64.0 24.3 95 3SG1 
To be 
published 
E.cloacae 0.89 51 0.89 61.2 23.8 95 3V4T 
(Zhu et al. 
2012) 
E.coli 1.02 50 0.86 64.2 24.2 97 1UAE 
(Skarzynsk
i et al. 
1996) 
H. 
influenzae 
1.06 49 0.86 54.4 22.3 95 2RL1 
(Yoon et 
al. 2008) 
E.cloacae 1.77 48 0.67 38.6 18.9 97 1NAW 
(Schönbru
nn et al. 
1996) 
1%seq: % of sequence identity 
2%sse: % of secondary structure of Bacillus MurA LCA identified in target protein 
 The PDBeFOLD structural alignment of Bacillus MurA LCA to various 
structures in the PDB archive shows an overall high structural similarity 
between ancestral MurA structure to various contemporary MurA enzymes. 
The superposition of Bacillus MurA LCA with unliganded B. anthracis (PDB 
3SG1) and with liganded E. cloacae (PDB 3V4T) and liganded Haemophilus 
influenza (PDB 2RL1) are shown in Figure 5.8. Bacillus MurA LCA differs 
from the three structures in respect to individual -helix and -strand length 
and relative orientation. The length and conformation of loops connecting the 
secondary structures also differ between the structures. Using the topology 
diagram of Bacillus MurA LCA (Figure 5.3) as comparative tool for 
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highlighting structural differences, it was observed that B. anthracis MurA, 
H. influenza MurA and E. cloacae MurA have an additional short -strand in 
front of 3 and have one single long -helix instead of helices 3 and 4. The 
presence of  in subunit VI of Bacillus MurA LCA structure forms the motif 
of Even though the current literature does not describe this 
deviation from the commonly identified repetitive motif , the 
additional short helix in subunit VI is present in all the contemporary MurA 
structures. The positioning and orientation of UNAG is also very similar. Most 
of the noticeable differences of Bacillus MurA LCA and the contemporary 
structures are located on the outer surface of the protein, mostly where the B 
factors are high, leaving the active site very similar to that of the contemporary 
enzymes.  
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Figure 5.8: Secondary structure matching (SSM) overlay of Bacillus MurA LCA 
bound to UNAG with contemporary structures showing the overall structural 
similarity  
Bacillus MurA LCA (green) bound to UNAG (orange) is superimposed onto the 
structures of A) Bacillus anthracis MurA (red) (PDB 3SG1) B) Haemophilus influenza 
MurA (magenta) (PDB 2RL1) bound to UNAG (teal) and C) Enterobacter cloacae 
MurA (blue) (PDB 3V4T) bound to UNAG (olive green). 
The ancestral MurA enzyme was further compared to contemporary 
B. anthracis MurA enzyme by performing a detailed analysis of the amino acid 
differences between them. All the amino acids that differ between Bacillus 
MurA LCA and B. anthracis MurA, which are present in the LCA structure, are 
shown in Figure 5.9. It was observed that majority of the amino acid residues 
identified were present on the surface of the protein. The closest residue to the 
active site was found to be Leu97 with a distance of 4.7 Å from substrate 
UNAG.   
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Bacillus MurA LCA differs significantly from B. anthracis MurA in its 
thermostability. There is a large literature that depicts the contribution of 
protein amino acid composition to thermophily. The most commonly known 
factors responsible for thermophily include: a higher core 
hydrophobicity/number of hydrophobic residues, increase in ion pairs on the 
protein surface/increase in charged residues (Szilágyi & Závodszky 2000; 
Fukuchi & Nishikawa 2001; Zhou et al. 2008; Taylor & Vaisman 2010), 
decrease in polar residues (Fukuchi & Nishikawa 2001) and decrease in Ser 
content (Szilágyi & Závodszky 2000; Fukuchi & Nishikawa 2001). An increase 
in aromatic residues, higher Pro, Arg and Glu content and lower frequency of 
Met has also been reported to be associated with increased thermophily (Zhou 
et al. 2008). The amino acid composition of moderately thermophilic Bacillus 
MurA LCA and mesophilic B. anthracis MurA was compared to identify any 
such trends that could explain the increased thermostability within MurA LCA 
(Table 5.4). This was achieved with the help of EMBOSS (Rice et al. 2000). It 
was observed that there is an increase of seven non polar residues and a 
decrease of five polar residues in MurA LCA in comparison to B. anthracis 
MurA. The decrease of polar residues Ser, Thr, Gln and Asn which is 
asscociated with thermophily (Fukuchi & Nishikawa 2001; Zhou et al. 2008), is 
also observed within MurA LCA except for Thr. 
The amino acid differences between Bacillus MurA LCA and B. anthracis 
MurA are predominantly located on the surface of the protein (Figure 5.9). The 
amino acid composition on the protein surface adapts to the physico-chemical 
environment of the protein (Fukuchi & Nishikawa 2001). Therefore, the 
difference in amino acid composition on the surface of LCA protein in 
comparison to B. anthracis MurA may have resulted from such an adaptation to 
thermophilic and mesophilic environments respectively.  
The increase in charged residues has been reported multiple times as a 
characteristic of increase in thermophily/thermostability (Zhou et al. 2008; 
Taylor & Vaisman 2010). However, such an increase in charged residues has 
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not been observed in Bacillus MurA LCA as both thermophilic LCA and 
mesophilic B. anthracis MurA have an equal number of charged residues 
(Table 5.4). On the other hand, there is a noticeable difference in the Ser 
content between the ancestral and contemporary MurA. An apparent decrease 
in Ser content is associated with increase in thermophily (Szilágyi & 
Závodszky 2000; Fukuchi & Nishikawa 2001) and this trend was observed 
within the moderately thermophilic Bacillus MurA LCA (Table 5.4). With 
regards to other single amino acid trends associated with thermophily, no 
particular trend was observed with Met content and a minor increase of 1-4 
residues of Pro, Arg and Glu was observed in Bacillus MurA LCA in 
comparison to B. anthracis MurA.  
Therefore, the increased thermophily observed in Bacillus MurA LCA might 
have resulted from the decreased serine content, increased hydrophobic 
residues, decreased polar residues and/or due to the amino acid differences on 
the protein surface. A combination of these factors or any of these factors on its 
own may have been responsible for the increase in thermophily as there is no 
specific mechanism to define thermostability and often even subtle 
redistributions of amino acids in the protein may influence thermostability 
(Zhou et al. 2008; Hobbs et al. 2012).    
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Figure 5.9: Amino acid differences between Bacillus MurA LCA and Bacillus 
anthracis MurA 
The cartoon representation of Bacillus MurA LCA structure (green) with a transparent 
surface is shown here. The residues that differ between MurA LCA and B. anthracis 
MurA are highlighted on the MurA LCA structure (magenta). The surface exposed 
residues show magenta colour on the surface. UNAG (orange) is bound to Bacillus 
MurA LCA.  
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Table 5.4: Amino acid composition of Bacillus MurA LCA and Bacillus anthracis 
MurA 
 
1 The amino acid grouping correspond to classification by Zhou et al. (2008) 
2 NP = Non polar residue 
3 P = Polar residue 
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5.2.2 AroA 
5.2.2.1 Crystallisation of Bacillus AroA LCA 
Crystallisation screens were laid down as explained in section 2.5.1 with 
Bacillus AroA LCA protein. Out of the 384 conditions tested (Hampton 
Research), various conditions resulted in the formation of microcrystals and 
one condition, ‘Crystal 14’, formed crystal needles. Further crystallisation 
screen trials (section 2.5.2) were performed on these conditions to improve 
crystal formation. However, none of the microcrystals improved and fine 
screens on ‘Crystal 14’ only resulted in very thin needles originating from a 
single point. Bacillus AroA LCA treated with trypsin (section 2.5.2.3), was 
used to grow a needle crystal in robot screen condition. ‘Crystal 14’ containing 
0.2 M calcium chloride dihydrate, 0.1 M HEPES sodium pH 7.5 and 28% v/v 
PEG 400, was taken to the synchrotron and gave diffraction data at 3Å 
resolution.  
Shikimate has been reported to have been used as an alternative substrate for 
AroA and has also been crystallised in complex with E.coli AroA (Priestman et 
al. 2005b). Therefore, attempts were also made to crystallise Bacillus AroA 
LCA in the presence of shikimate. The drop from which ‘Crystal 14’ crystal 
was taken was used as a seed stock for batch seeding (section 2.5.2.4). Trypsin 
treated protein laid down with 1:100 ratio of the seed stock, in the presence of a 
final concentration of 10 mM shikimate and mother liquor consisting of 
‘Crystal 14’ condition, formed a crystal which diffracted to 2.03 Å (Figure 
5.10). 
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Figure 5.10: Bacillus AroA LCA crystals and diffraction pattern 
A) Crystals grown with trypsin treated protein using batch seeding with mother liquor 
of 0.2 M calcium chloride dihydrate, 0.1 M HEPES sodium pH 7.5 and 28% v/v PEG 
400 in presence of 10 mM final concentration of shikimate. B) Two crystals in the loop. 
The arrow indicates the crystal from which diffraction data was collected. C) X-ray 
diffraction pattern for Bacillus AroA LCA. 
5.2.2.2 X-ray Data Collection 
The MX1 beamline at the Australian synchrotron was used to collect data from 
Bacillus AroA LCA crystals. Two datasets were collected at a resolution of 
3.0 Å and 2.03 Å with detector distance of 199 mm, 50% beam attenuation and 
1° oscillation for 360° with one second exposure per frame. The 2.03 Å dataset 
was used for all further analysis. 
A) B) 
C) 
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5.2.2.3 Data processing 
The data collected from the synchrotron was processed the same way as the 
data for Bacillus MurA LCA. The collected dataset was autoindexed, scaled 
and merged at the Australian synchrotron. The space group was found to be P21 
with data at a resolution  of 2.03 Å. ‘Truncate’ (French & Wilson 1978) was 
used to generate the FreeR for 5% of the data and Matthews coefficient 
(Matthews 1968) predicted the presence of two molecules in the asymmetric 
unit. The data collection statistics are given in Table 5.5. 
Table 5.5: Data collection statistics for Bacillus AroA LCA 
Data Statistics Overall Outer Shell 
Space group P21  
Wavelength (Å) 0.95370  
Cell dimensions 
a b c (Å) 
 (°) 
 
62.83 / 82.64 / 81.22 
90.00 / 99.68 / 90.00 
 
Mosaicity 0.29  
Monomers in asymmetric unit 2  
Resolution range (Å) 45.43-2.03 2.09-2.03 
Number of observations 399780 28517 
Number of unique reflections 52652 3861 
R-merge 0.133 0.895 
Mean I/I 11.1 2.0 
Completeness % 99.9 99.5 
Multiplicity 7.6 7.4 
The structure of Bacillus AroA LCA was solved by molecular replacement 
using Phaser (McCoy et al. 2007) in CCP4 (Winn et al. 2011). The structure of 
Bacillus halodurans AroA (PDB 3RMT) with a sequence identity of 73% was 
used as the model for molecular replacement. Due to the high Rmerge, 
resolution was further truncated to 2.15 Å for all subsequent steps. The Bacillus 
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AroA LCA sequence was built into the electron density map with automated 
model building (Terwilliger et al. 2008) in Phenix (Adams et al. 2010). The 
structure was refined multiple times using Phenix refinement (Afonine et al. 
2012) or refmac5 in CCP4 (Murshudov et al. 2011) with manual model 
building in COOT (Emsley & Cowtan 2004). Amino acid residues with no 
electron density were removed and the ones in poor electron density regions 
were deleted and built back manually, the majority of which were in the second 
half of chain A. Each domain of a Bacillus AroA LCA monomer was defined 
as an individual TLS group for the final refinement. The refinement statistics 
are given in Table 5.6. 
Table 5.6: Refinement and model statistics for Bacillus AroA LCA 
Refinement 
R-factor (%) 17.7 
Rfree (%) 23.4 
Total number of atoms 6355 
Total number of protein atoms 6052 
 Chain A 3019 
 Chain B 3033 
Total number of solvent atoms 303 
RMSD 
Bond lengths (Å) 0.0163 
Bond angles (°) 1.848 
Average B factors (Å
2
) 
Chain A 25.846 
Chain B 31.244 
Ramachandran analysis 
Preferred regions (%) 96.85 % (769 residues) 
Allowed regions (%) 2.52 % (20 residues) 
Outliers (%) 0.63 % (5 residues) 
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5.2.2.4 Overall structure 
Bacillus AroA LCA consists of 430 amino acids with an N-terminal His-tag. As 
mentioned above (section 5.2.2.1), Bacillus AroA LCA was trypsin treated 
prior to crystallisation in the presence of its alternative substrate shikimate. 
However, the crystallised protein does not have shikimate bound to it. There is 
no electron density observed for the N-terminal His-tag and for the first 11 
amino acid residues of Bacillus AroA LCA. Amino acid residues from 337 to 
347 in chain A and 338 to 346 in chain B lack a properly defined electron 
density and hence were deleted from the structure. This may be due to disorder 
in the crystal and/or the flexibility of the loop. Residues corresponding to this 
region are also absent in B. halodurans AroA (PDB 3RMT) and the 
corresponding region is identified as the most flexible area in structures for 
Streptococcus pneumoniae AroA (PDB 1RF5) and Agrobacterium CP4 AroA 
(PDB 2GG4).  
The Bacillus AroA LCA monomer, similar to that of Bacillus MurA LCA, 
consists of two globular domains, domain I (residues 23-230) and domain II 
(residues 12-18 and 235-430) connected together by two strands (residues 19-
22 and 231-234) (Figure 5.11). Bacillus AroA LCA, in its unliganded form, has 
an open configuration similar to that of S. pneumoniae AroA (Park et al. 2004).  
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Figure 5.11: Cartoon representation of monomeric Bacillus AroA LCA showing 
unliganded open conformation 
The colour spectrum from dark blue to red goes from N-terminal to C-terminal.  
The main structural feature shared by AroA and MurA is the six fold repetitive 
motif of  forming an inside-out  barrel (Stallings et al. 1991; 
Schönbrunn et al. 2001; Eschenburg et al. 2003; Park et al. 2004; Oberdorfer et 
al. 2012). It was observed that the overall inside-out  barrel structure is 
maintained by Bacillus AroA LCA (Figure 5.12), however there are minor 
variations to the previously identified repetitive motif due to chain 
differences as further explained below and topology differences as explained in 
section 5.2.2.7 (Figure 5.13).  
The Bacillus AroA LCA structure consists of two monomers in the asymmetric 
unit, chain A and chain B, with an RMSD of 1.57 Å indicating significant 
differences between the two chains (potentially imposed by crystal 
development). The differences between the two chains lie in their secondary 
structure elements (their lengths and orientation), which is a result of chain B 
being more open than chain A by approximately an angle of 8 ° (Figure 5.12). 
Such differences in orientation between the chains have resulted in the 
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disruption of the hydrogen bonds responsible in defining a few short  helices 
and  strands in certain regions of chain B.  
The two globular domains of Bacillus AroA LCA structure consists of three 
subdomains each (Figure 5.13). Subunits III and IV form the previously 
described repetitive  motif. Subunit I in chain A also forms a 
configuration; however a  strand is missing in chain B. All the 
remaining subunits typically consist of three strands and two  helices. The 
residues of the N-terminal region of the protein usually form a  strand in 
subunit VI. However, density for this region is missing; hence the presence of 
this  strand is unconfirmed. An additional short  helix was observed in 
subunits II and VI (consisting of four and six residues respectively), which 
corresponds to the extra 310-helices in the structure of unliganded 
S. pneumoniae AroA (Park et al. 2004). 
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Figure 5.12: Conformational differences between chain A and chain B of Bacillus 
AroA LCA and the two domains forming the inside-out  barrel configuration 
within an individual AroA LCA monomer 
A) Overlay of Bacillus AroA LCA chain A (blue) and chain B (magenta). Chain B is 
in a more open state than chain A by an angle of approximately 8 °. B) Cartoon 
representation of domain I and II of chain B with the six subunits labelled (I-VI). The 
orientation chosen shows the inside-out  barrel configuration of Bacillus AroA 
LCA. 
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Figure 5.13: Topology sketch of Bacillus AroA LCA (Chain B) 
The figure displays the two globular domains I and II, each consisting of three subunits (I-VI). Each  helix and  strand is labelled sequentially. The 
components are coloured corresponding to the colouration used in Figure 5.11. The missing regions in the structure are indicated in red lines.   
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Bacillus AroA LCA protein was purified using size exclusion chromatography 
and showed two peaks with the dominant peak corresponding to a dimer. The 
dimer of Bacillus AroA LCA was used for crystallography and the protein 
crystallised as a dimer (Figure 5.14) as Bacillus MurA LCA did. The dimer is 
formed between the chains from adjacent unit cells sharing a contact area of 725.4 
Å
2
 as calculated by PDBePISA (Krissinel & Henrick 2007). PyMOL was used to 
generate the symmetry mates for Bacillus AroA LCA (Figure 5.14) and this 
confirmed the formation of dimer.  
 
 
Figure 5.14: Bacillus AroA LCA dimer 
A) Cartoon representation of Bacillus AroA LCA dimer formed by chains from adjacent 
unit cells. B) Cartoon representation of Bacillus AroA LCA dimer formed from symmetry 
mates generated by PyMOL. 
 
A) 
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5.2.2.5 Substrate binding site 
Similar to that of MurA, the two domains of AroA approach each other in a screw 
like movement to form the active site in the interdomain cleft (Skarzynski et al. 
1996; Schönbrunn et al. 2001). Many residues have been identified in different 
structures as residues involved in the catalytic activity. However a few residues 
have been specifically identified as universal active site residues and they are 
Asp313, Arg386, Arg344, Glu341, Lys411, Arg124 and Lys22 (E.coli  
numbering)(Eschenburg et al. 2003). The residue Asp313 plays an important role 
in the addition-elimination reaction of the enzyme. In the absence of the aspartate 
side chain, the reaction will stop after the addition step (Eschenburg et al. 2003). 
It was proposed by Schönbrunn et al. (2001) that Glu341 acts as a proton donor to 
the substrate PEP. The remaining residues have been implicated to be taking part 
in PEP binding (Shuttleworth et al. 1999; Schönbrunn et al. 2001; Eschenburg et 
al. 2003). It has also been reported that mutagenesis of Lys411 and His385 results 
in inactive enzymes or drastic decreases in catalytic efficiency (Schönbrunn et al. 
2001; Park et al. 2004). The above mentioned catalytically important residues 
correspond to Asp316, Arg390, Arg347, Glu344, Val416 (instead of Lys), Arg123, 
Lys23, and His389 respectively in the Bacillus AroA LCA structure. These 
residues are illustrated in Figure 5.15, however residues Arg347 and Glu344, 
which are part of the highly flexible loop missing in the Bacillus AroA LCA 
structure, are unable to be shown. Residue Lys411 from E.coli was found to be 
involved in the binding of PEP, however, the corresponding residue Thr412 in 
S. pneumoniae AroA does not interact with the substrates (Park et al. 2004). The 
corresponding residue in Bacillus AroA LCA is Val416 which is conserved in 
Bacillus species and may also not interact with PEP. An overlay of Bacillus AroA 
LCA with contemporary B. halodurans AroA (PDB 3RMT) (both unliganded), 
shows the orientation and positioning of the mentioned catalytically important 
residues (Figure 5.15). The slight differences observed in the orientation of the 
residues may indicate a possible effect on the catalytic mechanism. However, 
further comparisons with a structure of Bacillus AroA LCA bound to its substrate 
would need to be performed before any conclusions may be drawn.  
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Figure 5.15: Overlay of Bacillus AroA LCA and Bacillus halodurans AroA showing 
the active site residues of the enzymes 
Bacillus AroA LCA (blue) is overlaid onto B. halodurans AroA (yellow) (PDB 3RMT). 
The figure shows the differences in positioning and orientation of AroA active site 
residues from B. AroA LCA (red) and B. halodurans AroA (dark blue). Labels 
correspond to Bacillus AroA LCA numbering only. 
5.2.2.6 Inhibitor binding in the active site 
Bacillus AroA LCA shows many characteristics similar to class II AroA, yet its 
sensitivity towards glyphosate in comparison to class II B. subtilis AroA has led 
us to the hypothesis that AroA LCA may be neither from class I nor class II 
(section 4.2.5.1). For a comprehensive analysis of the AroA LCA structure to 
verify this hypothesis, it may be necessary to obtain the AroA LCA structure 
bound to its inhibitor. However, currently this may only be explored using the 
unliganded AroA LCA structure in comparison to unliganded class II 
S. pneumoniae AroA structure. Comparison to inhibitor bound AroA structures 
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will not provide the necessary information as unliganded AroA adopts an open 
conformation whereas liganded AroA adopts a closed conformation (Schönbrunn 
et al. 2001).  
Glyphosate was found to interact with amino acid residues Lys20, Ser21, Arg25, 
Gly92, Thr93, Arg120, Arg124, Ser166, Ala167, Gln168, Asp312, Lys339, 
Glu340, Arg343, His384 and Arg385 within class II S. pneumoniae AroA 
structure (Park et al. 2004). These amino acid residues are conserved within the 
AroA LCA structure with minor changes in the position and orientation of the 
residues (Figure 5.16) (Numbering of the above residues in B. AroA LCA: Lys23, 
Ser24, Arg28, Gly95, Thr96, Arg123, Arg127, Ser168, Ala169, Gln170, Asp316, 
Lys343, Glu344, Arg347, His389 and Arg390). The residues Lys343, Glu344 and 
Arg347 cannot be shown in Figure 5.16 as they are absent from the structure due 
to lack of electron density. Similar to that of E. coli  AroA which shows a 
difference in glyphosate sensitivity due to steric hindrances upon Gly96Ala 
mutation (Priestman et al. 2005b), the difference in sensitivity between AroA 
LCA from contemporary class II AroA enzymes may be explained to be the result 
of mere rearrangements of amino acids within the AroA LCA structure. 
 
 
Figure 5.16: Overlay of Bacillus AroA LCA with Streptococcus pneumoniae AroA 
showing the residues involved in glyphosate interaction 
S. pneumoniae AroA (red) and its residues (yellow); B. AroA LCA (blue) and its residues 
(green). The residue numbering corresponds to B. AroA LCA. 
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5.2.2.7 Comparison to contemporary structures 
The structural comparison of Bacillus AroA LCA against the entire PDB archive 
was performed using PDBeFOLD (Krissinel & Henrick 2004) which found the 
structure of B. halodurans AroA (PDB 3RMT) to be the closest structural 
homologue with a sequence identity of 71%. Table 5.7 gives the structural 
alignment parameters for a selection of structures discussed in this chapter (3RMT, 
1RF5 and 2GG4 are unliganded and 1G6S is bound glyphosate and shikimate-3-
phosphate). It is clear from the table that the structure of Bacillus AroA LCA has 
an overall high structural similarity to the different contemporary AroA enzymes 
as indicated by the %sse. E.coli shares the lowest sequence identity of 28% and 
still identified 79% of secondary structures of Bacillus AroA LCA.  
Table 5.7: PDBeFOLD structural alignment of PDB structures 
Structure RMSD 
% 
seq
1
 
Q-
score 
P-
score 
Z-
score 
% 
sse
2
 
PDB 
code 
Reference 
B. 
halodurans 
1.56 71 0.73 44.1 20.1 100 3RMT --- 
S. 
pneumoniae 
2.13 52 0.60 22.0 14.9 85 1RF5 
(Park et al. 
2004) 
Agrobacte-
rium Cp4 
2.15 43 0.55 24.1 15.4 86 2GG4 
(Funke et 
al. 2006) 
E. coli 1.92 28 0.58 17.7 13.4 79 1G6S 
(Schönbrun
n et al. 
2001) 
1 %seq : % of sequence identity 
2%sse: % of secondary structure of Bacillus AroA LCA identified in target protein 
The structure overlays of Bacillus AroA LCA in its unliganded form with 
unliganded B. halodurans AroA (PDB 3RMT) and S. pneumoniae AroA also 
unliganded (PDB 1RF5) are shown in Figure 5.17. The general fold of the 
structures are very similar. The topology Figure 5.13 was used to identify the 
differences between Bacillus AroA LCA and contemporary AroA structures from 
Table 5.7. It was observed that, in comparison to Bacillus AroA LCA structure, 
the structures of contemporary AroA have an extra  strand in subunits I, II, V 
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and VI positioned beside 1, 3, 10 and 19 respectively, thus generating the 
repetitive motif of  in all the subunits except for subunit VI 
(Agrobacterium CP4 is the only one to form the  in subunit VI). It is 
possible that the additional  strand in subunit VI may be present in Bacillus 
AroA LCA, however this density is missing in the structure. Detailed analysis of 
the contemporary structures reveals an additional short  helix in subdomains II 
and VI, corresponding to 4 and 13 in Bacillus AroA LCA. These additional  
helices are not usually mentioned in the broad topological descriptions in the 
current literature. Other differences between the ancestral AroA structure and the 
contemporary AroA structures lie in the lengths and orientations of  helices,  
strands and loops. 
 
 
Figure 5.17: Secondary structure matching (SSM) overlay of Bacillus AroA LCA 
with contemporary structures showing the overall structural similarity 
Bacillus AroA LCA (blue) overlaid with A) B. halodurans AroA (PDB 3RMT) (yellow) 
and B) S. pneumoniae AroA (PDB 1RF5) (red). 
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The overall structure of Bacillus AroA LCA appears to be similar to that of 
contemporary AroA. The active site residues of the ancestral enzyme are in a 
similar position to the corresponding residues in its closest structural homologue 
B. halodurans AroA. However, it should be noted that both structures are in their 
unliganded forms. In order to properly analyse the catalytic site residues and 
inhibitor interactions, it is necessary to have a Bacillus AroA LCA structure in its 
bound form to its substrates and/or glyphosate.  
Further comparison between ancestral AroA enzyme and contemporary 
B. halodurans AroA enzyme was achieved by a detailed analysis of their amino 
acid compositions (Table 5.8). All the amino acid differences between Bacillus 
AroA LCA and B. halodurans AroA that are present on the LCA structure are 
shown in Figure 5.18. Majority of the amino acid differences are located on the 
surface of the AroA LCA protein structure with no amino acid closer than 6Å to 
the substrate binding site.  
The thermostability of Bacillus AroA LCA was found to differ from that of 
contemporary B. halodurans AroA, in a similar way as Bacillus MurA LCA. 
Therefore, an attempt to find out the factors responsible for thermophily in 
ancestral AroA was performed as was done for MurA in section 5.2.1.7. The 
amino acid composition of moderately thermophilic Bacillus AroA LCA and 
mesophilic B. halodurans AroA were analysed to identify any trends which could 
explain the increase in thermostability in ancestral AroA.  
The increase in hydrophobic residues and a decrease in polar residues are 
commonly associated to increased thermophily (Szilágyi & Závodszky 2000; 
Fukuchi & Nishikawa 2001; Zhou et al. 2008; Taylor & Vaisman 2010). However, 
it must be noted that in the case of Bacillus AroA LCA, there is an apparent 
decrease in total number of non polar residues (Table 5.8). Furthermore, there is 
an increase in the number of polar residues in AroA LCA in comparison to 
B. halodurans AroA, which is the opposite of the trend generally observed in 
thermophilic proteins. 
The amino acid differences between Bacillus AroA LCA and B. halodurans AroA 
are mostly located on the surface of the protein (Figure 5.18). Therefore, these 
surface amino acid residues may be responsible for the increased thermophily in 
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Bacillus AroA LCA as the amino acid composition on the protein surface is 
known to adapt to the physico-chemical environment of the protein (Fukuchi & 
Nishikawa 2001).  
Another major feature associated with increase in thermophily is the presence of 
increased ionic interactions on the protein surface/increased charged residues 
(Szilágyi & Závodszky 2000; Fukuchi & Nishikawa 2001; Zhou et al. 2008; 
Taylor & Vaisman 2010). In contrary to Bacillus MurA LCA, which failed to 
show any trend with regards to charged residues, Bacillus AroA LCA has an 
apparent increase in number of charged residues in comparison to B. halodurans 
AroA (Table 5.8). This may have contributed to the increase in thermophily in 
AroA LCA. 
Similarly to Bacillus MurA LCA, AroA LCA also shows a decrease in Ser content 
which is also known to be a trend observed in thermophiles (Table 5.8) (Szilágyi 
& Závodszky 2000; Fukuchi & Nishikawa 2001). Other singular amino acid 
residue trends observed in thermophily such as lower Met, higher Glu, Arg and 
Pro content were also analysed (Zhou et al. 2008). Although there is a decrease in 
Met content in Bacillus AroA LCA, it only differs by three residues in comparison 
to B. halodurans AroA. An increase in Glu content is observed, however, this was 
not observed for Arg and Pro residues. 
Therefore, themophily in Bacillus AroA LCA might be a consequence of 
increased number of charged residues or trends observed in individual amino 
acids such as Ser, Glu or Met. However, it is not possible to find the exact factor 
responsible for thermophily as a universal mechanism for thermostability has not 
been identified yet (Yano & Poulos 2003). It must be noted that some of the 
trends observed in AroA LCA differ from the trends observed in MurA LCA. 
Therefore, the factors responsible for thermophily may be different in different 
proteins and/or any of the identified factors singularly or in combination may have 
influenced thermophily, as even subtle redistributions can affect thermostability 
(Zhou et al. 2008; Hobbs et al. 2012) 
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Figure 5.18: Amino acid differences between Bacillus AroA LCA and Bacillus 
halodurans AroA 
The cartoon representation of Bacillus AroA LCA structure (blue) with a transparent 
surface is shown here. The residues that differ between AroA LCA and B. halodurans 
AroA are highlighted on the AroA LCA structure (magenta). The surface exposed 
residues show magenta colour on the surface. The active site is shown by placing S3P 
(green) and glyphosate (orange) from S. pneumoniae AroA structure (1RF6). 
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Table 5.8: Amino acid composition of Bacillus AroA LCA and Bacillus halodurans 
AroA 
 
1 The amino acid grouping correspond to classification by Zhou et al. (2008) 
2 NP = Non polar residue 
3 P = Polar residue 
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5.2.3 Conclusion 
Many studies have identified the structural similarities and differences of MurA 
and AroA (Schönbrunn et al. 1996; Skarzynski et al. 1996). Therefore, a 
comparison between the Bacillus LCA of MurA and AroA would provide us with 
insight into the evolution of these enolpyruvyl transferase enzymes. However, an 
accurate comparison is not possible with the currently obtained structures as 
Bacillus MurA LCA is in its bound form (closed conformation) and Bacillus 
AroA LCA is in its unbound form (open conformation).  
The overall enzyme structure consisting of two globular domains built by a 6-fold 
repetition of  motif to give an inside out  barrel configuration is the 
unique protein architecture shared by MurA and AroA enzymes (Eschenburg et al. 
2003; Oberdorfer et al. 2012). From the description of Bacillus MurA LCA and 
Bacillus AroA LCA in section 5.2.1 and section 5.2.2 respectively, it is clear that 
both ancestral enzymes share a similar protein fold made of two globular domains 
consisting of a total of six individual subunits, maintaining the inside out  
barrel configuration. While some of the subunits within MurA LCA and AroA 
LCA retained the commonly described  motif, some of the subunits 
showed deviations from this. The structure of Bacillus AroA LCA showed more 
such deviations in comparison to the contemporary AroA enzymes than the 
deviations observed between Bacillus MurA LCA and contemporary MurA 
enzymes. It has also been noted that there is an additional  helix in subunit VI in 
Bacillus MurA and AroA LCA as well as in all contemporary MurA and AroA 
enzymes discussed in this chapter. Overall, both MurA and AroA LCA maintain a 
high structural similarity with contemporary enzymes, with the differences 
between LCA enzyme and contemporary enzymes predominantly present on the 
protein surface leaving the active site intact. 
The active site of MurA and AroA LCA is situated in the interdomain pocket, 
similar to that of contemporary MurA and AroA enzymes. Strictly conserved and 
catalytically important residues of MurA and AroA enzymes are also conserved 
within the LCA enzymes. However, upon comparison of unliganded AroA LCA 
with unliganded B. halodurans AroA, the orientation and positioning of some of 
these residues were found to differ. The impact of such changes in the catalytic 
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properties of AroA could be further investigated after obtaining the structure of 
AroA bound to its substrate.  
The position and orientation of amino acid residues and UNAG in contemporary 
MurA that are believed to prevent inhibition by the AroA inhibitor glyphosate, 
remains the same within MurA LCA, suggesting that the LCA also do not support 
inhibition by glyphosate. The residues involved in the interaction with glyphosate 
in class II AroA are conserved within AroA LCA with minor variations in 
position and orientation. However, an inhibitor bound structure of AroA LCA 
would provide more information on the inhibitory mechanism of AroA LCA. 
MurA LCA and AroA LCA are moderately thermophilic and both enzymes show 
different trends which are attributed to increase in thermophily. While MurA LCA 
shows an increase in hydrophobic residues, a decrease in polar residues and a 
decrease in Ser residues, AroA LCA shows an increase in charged residues, 
decrease in Ser residues and the opposite trend with respect to hydrophobic and 
polar residues. Therefore, it is difficult to ascertain the exact factors contributing 
to the increased thermostability in MurA and AroA LCA, in comparison to their 
mesophilic counterparts. Any of these factors alone or in combination or, any of 
the differences present on the protein surface, may have been responsible for the 
increased thermostability.          
It would be of further interest to obtain the structure of Bacillus AroA LCA bound 
to its substrate for detailed analysis of its active site. The structures of MurA and 
AroA LCA bound to their respective inhibitors would also provide a more 
detailed understanding of inhibitory site of the enzymes. 
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6 Chapter 6 
Discussion 
6.1 General background 
The two enolpyruvyl transferase enzymes, AroA and MurA, from the shikimate 
pathway and peptidoglycan synthesis pathway respectively, have been extensively 
studied as they are attractive targets for the development of antimicrobial drugs 
due to the absence of these pathways in mammals, as well as their essentiality to 
the survival of microorganisms (Eschenburg et al. 2003). Information available in 
the literature ranges from the enzyme mechanism, enzyme kinetic characteristics, 
structural properties, inhibitory mechanism and possible new inhibitor designs. 
The functional and structural similarities of AroA and MurA known to date also 
leads us to believe that AroA and MurA may have originated from a common 
ancestor, making the study of their evolution all the more interesting. 
Ancestral sequence reconstruction (ASR) was chosen as the tool to study the 
evolution of AroA and MurA enzymes. The methodology of ancestral sequence 
reconstruction used in this study has been used for various evolutionary studies, 
including the study of thermophily within the Bacillus genus (Hobbs et al. 2012), 
reconstruction of ancestral -lactamases (Risso et al. 2013), and studies on the 
mechanism of gene duplication (Voordeckers et al. 2012). In this research, ASR 
was used to resurrect ancestral enzymes of AroA and MurA from the Bacillus 
genus.  
AroA and MurA are exclusively inhibited by glyphosate and fosfomycin 
respectively (Skarzynski et al. 1996; Eschenburg et al. 2003). Hence 
characterisation of ancestral enzymes with respect to their inhibitor specificity, as 
well as their inhibitor promiscuity, will provide us with evolutionary information 
on these enzymes as well as allow us to explore the hypothesis of AroA and 
MurA originating from a common ancestor. 
The aim of this study was to reconstruct ancestral AroA and MurA enzymes from 
the Bacillus genus and compare their kinetic, inhibitory, thermal and structural 
properties to contemporary Bacillus species in order to attain knowledge 
pertaining to the evolution of AroA and MurA. This study also focussed on 
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assessing the robustness of the ASR technique in the study of evolution of 
thermophily. 
6.1.1 Functional Evolution of MurA and AroA 
Four ancestral MurA enzymes, estimated to be between 550 myr and 950 myr old, 
were reconstructed to study the evolution of MurA enzymes, and concurrently 
investigate the evolution of thermophily using these ancestral enzymes. The 
inferred ancestral sequences have a 76-90% sequence identity to the contemporary 
sequences used for the inference. The four MurA ancestral enzymes were 
catalytically active presenting comparable kinetic parameters to those of 
contemporary Bacillus subtilis and Bacillus coagulans MurA enzymes at their 
optimum temperature of activity (Topt).  MurA ANC1 and MurA LCA have very 
similar kinetic properties only differing in their Topt by 4 °C. Out of all the 
characterised ancestral MurA and contemporary MurA enzymes, MurA ANC2 
shows the highest catalytic efficiency. Inhibition of MurA LCA by the MurA 
inhibitor fosfomycin does not differ substantially from the inhibition exhibited by 
B. subtilis MurA. It is also clear MurA LCA cannot be specifically inhibited by 
the AroA inhibitor glyphosate. The thermoactivity (Topt) and thermostability (Tm) 
of B. subtilis and B. coagulans MurA enzymes confirmed the thermal adaptation 
of their host organisms, thus confirming the correlation between organism growth 
temperature and enzyme Topt and Tm. All four MurA ancestors exhibited similar 
Topt and Tm profiles, all being moderately thermophilic.  
In a similar way to MurA, AroA from the LCA of Bacillus genus was 
reconstructed using ASR. The sequence of the resurrected AroA ancestor, aged 
957 myr old, has a 64-82% sequence identity to the contemporary Bacillus species 
used for the inference. Shikimate-3-phosphate (S3P), substrate of AroA enzyme 
reaction, was synthesised and purified to 12.7% purity for the characterisation of 
the AroA enzyme. The catalytically active AroA LCA showed comparable kinetic 
parameters to B. subtilis AroA, with AroA LCA showing more than twice the 
catalytic efficiency (kcat/KM) of B. subtilis AroA at the enzyme’s Topt. 
Contemporary B. subtilis AroA, classified as a class II AroA, concurred with the 
class II AroA characteristics of having very high tolerance to glyphosate as well 
as high affinity towards PEP. AroA LCA, on the other hand, is considerably more 
sensitive towards glyphosate than B. subtilis AroA by approximately 12 fold, yet 
exhibits high affinity towards PEP. As expected, similar to that of MurA, AroA 
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LCA does not show sensitivity toward the MurA inhibitor fosfomycin. Thermal 
characterisation of AroA LCA resulted in moderately thermophilic properties. 
Ancestral enzymes reconstructed via ASR may also be used to study the 
relationship between its biochemical properties and the organismal fitness (Hobbs 
et al. 2015 ). Unlike B. subtilis AroA, AroA LCA failed to rescue the aroA E. 
coli cells in spite of having favourable biochemical properties such as 
thermostability, increased affinity towards its substrates, as well as greater 
catalytic efficiency than its contemporary counterpart. 
6.1.2 Structural evolution of MurA and AroA 
The structure of Bacillus MurA LCA was solved at a resolution of 2.11Å at 
spacegroup P212121. MurA LCA crystallised bound to its substrate UNAG and a 
phosphate molecule. The structure of Bacillus AroA LCA, in the apo-form, was 
solved to a resolution of 2.15Å with P21 space group. 
The overall structure of Bacillus MurA LCA and Bacillus AroA LCA consists of 
two globular domains connected via a double stranded linker. The entire structure 
consists of six very similar motifs, many of them comprising typically of four -
strands and two -helices, giving an overall inside out  barrel structure, which 
is a characteristic feature of enolpyruvyl transferase enzymes.  
MurA shows variation from the characteristic repetitive motif in its 
subunits II and VI (Figure 5.3). However, subunit VI in MurA LCA is consistent 
with that of contemporary MurA structures, as it was observed that the additional 
short  helix in subunit VI constitutingmotif is a common feature 
among contemporary MurA structures, inspite of not being specifically mentioned 
in the literature. UNAG was situated in the catalytic site of MurA, in the 
interdomain cleft, with the enzyme in its ‘closed state’ with the loop from Pro114-
Pro123 forming a lid over the catalytic site. The most commonly recognized 
catalytically important and conserved residues in MurA enzymes were also 
identified in MurA LCA. The AroA inhibitor glyphosate does not specifically 
inhibit MurA LCA. The structure of MurA LCA confirmed that the distance 
clashes associated with the inability of glyphosate to inhibit MurA enzymes 
(Eschenburg et al. 2003) were also present within MurA LCA, hence confirming 
that no structural changes have occurred to allow inhibition by glyphosate. The 
structure of MurA LCA shows an overall high structural similarity to 
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contemporary MurA enzymes, the closest being to Bacillus anthracis MurA (PDB 
3SG1), differing mainly with respect to the relative orientation and length of 
individual loops,  strands and  helices. Such structural differences were 
observed on the protein surface, leaving the active site very similar to that of 
contemporary MurA enzymes.  
Bacillus AroA LCA was crystallised with two chains in the asymmetric unit, with 
one chain more open than the other by approximately 8 °. This resulted in 
topological differences between both chains caused by disruptions in hydrogen 
bonds defining  helices and  strands. AroA LCA shows deviations from the 
repetitive  motif in all subunits except for III and IV (Figure 5.13). The 
additional short  helix in subdomains II and VI is consistent with contemporary 
AroA enzymes. AroA LCA, crystallised in its unliganded form, displayed the 
‘open’ state conformation with its active site in the interdomain cleft. Conserved 
and universal active site residues are also conserved within the LCA structure, 
however the orientation and positioning of these residues differ slightly from that 
of the contemporary Bacillus halodurans, the closest contemporary structure 
(Figure 5.15). However, the effect of these differences on the catalytic mechanism 
can only be determined by comparing AroA LCA and contemporary AroA 
structures bound to its substrates.  
The thermal stability of the ancestral enzymes in comparison to the contemporary 
enzymes was investigated via comparison of the enzyme’s amino acid 
composition and structure. The literature provides a variety of factors attributed to 
thermostability (Szilágyi & Závodszky 2000; Fukuchi & Nishikawa 2001; Zhou et 
al. 2008; Taylor & Vaisman 2010), for which Bacillus MurA LCA and AroA 
LCA, both moderately thermophilic, exhibit different trends. Bacillus MurA LCA 
in comparison to B. anthracis MurA showed a decrease in Serine content, increase 
in hydrophobic residues and decrease in polar residues. On the other hand, 
Bacillus AroA LCA shows an apparent decrease in total number of nonpolar 
residues and an increase in the number of polar residues in comparison to 
B. halodurans AroA, which is opposite to the trend generally observed in 
thermophilic proteins. Additionally, Bacillus AroA LCA has an apparent increase 
in number of charged residues in comparison to B. halodurans AroA as well as a 
decrease in Serine content which are known to be trends observed in thermophiles 
(Szilágyi & Závodszky 2000; Fukuchi & Nishikawa 2001; Zhou et al. 2008; 
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Taylor & Vaisman 2010). The majority of the amino acid differences between 
MurA LCA and B. anthracis MurA, and between Bacillus AroA LCA and 
B. halodurans AroA, were present on the surface of the protein structure. The 
amino acid composition on a protein surface adapts to its physico-chemical 
environment, thus displaying the differences in amino acid composition between 
proteins of thermophilic bacteria and mesophilic bacteria to be predominantly on 
the protein surface (Fukuchi & Nishikawa 2001).  
Despite all the changes observed on the ancestral MurA and AroA enzymes, it is 
suspected that 1-3 critical mutations may have been responsible for the exhibited 
thermal properties. However, the exact mutations responsible for this are 
unknown. Moreover, subtle global redistributions of amino acids in the protein 
structure may also have influenced thermostability (Hobbs et al. 2012). 
6.1.3 Stability of ancestral enzymes and ASR as a tool to study 
evolution of thermophily 
Ancestral enzymes resurrected using ASR were reported to exhibit high 
thermostability, kinetic stability, and high catalytic activity in comparison to 
modern enzymes (Perez-Jimenez et al. 2011; Hobbs et al. 2012; Akanuma et al. 
2013; Risso et al. 2013; Groussin et al. 2015; Hobbs et al. 2015 ). However, there 
are also reconstructed ancestral enzymes that do not agree with this, such as LeuB 
ANC2 (Hobbs et al. 2012). In regards to AroA and MurA enzymes, due to their 
lack of tryptophan residues, kinetic stability which is measured as the free energy 
for unfolding G‡, could not be determined.  
Considering the catalytic properties of AroA and MurA ancestral enzymes, not all 
the reconstructed enzymes showed higher catalytic activity/catalytic efficiency 
than modern enzymes. MurA ANC2, ANC3 and AroA LCA showed higher 
catalytic efficiency than contemporary enzymes, while MurA ANC1 and MurA 
LCA only showed higher catalytic efficiency to B. subtilis MurA (but similar kcat), 
but lower catalytic efficiency than B. coagulans MurA. Therefore, no specific 
pattern or trend of increasing catalytic activity/efficiency with evolutionary time 
was observed.  
While a broad trend of increasing thermophily has been reported with 
evolutionary time (Gaucher et al. 2008; Perez-Jimenez et al. 2011; Akanuma et al. 
2013), Hobbs et al. (2012), albeit at different timescales, reported fluctuations 
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within this broad thermal trend, with thermophily evolving twice via independent 
evolutionary paths. Bacillus AroA LCA and all Bacillus MurA ancestral enzymes 
are moderately thermophilic with a constant temporal trend of thermophily 
(Figure 6.1). The temporal trend in thermophily obtained from Bacillus MurA 
ancestors cannot be compared with the trend showed by LeuB due to the 
difference in timescale of the reconstructed ancestors. The only enzymes that are 
possible to compare are AroA and MurA LCA, aged 957 and 950 myr old, which 
is the same age as the LeuB LCA LeuB4 (950 myr). However the thermal 
properties of the Bacillus LCA shown by AroA, MurA and LeuB enzymes differ 
significantly from each other, with Topt of 51 °C, 58 °C and 70 °C respectively, 
and Tm of 62 °C, 59.7 °C and 65.3 °C respectively. This implies that the LCA of 
the Bacillus genus, aged ~950 myr old exhibits different thermal properties at the 
same point of time, which is not realistic.  
 
Figure 6.1: Temperature profile displayed by ancestral AroA, MurA and LeuB 
enzymes 
The data shows the age estimates for ancestral nodes against their Topt values for each 
ancestral enzyme. Data for LeuB is taken from Hobbs et al. (2012). The Topt values for 
contemporary enzymes are shown at age 0 Myr. Colour and symbol key: LeuB enzymes 
(green), LeuB ancestors (triangle), MurA enzymes (red), MurA ancestors (diamond), 
AroA enzymes (blue), AroA ancestor (square) and all contemporary enzymes (circle). 
The figure also shows that the Topt values obtained for B. subtilis enzymes differs beween 
enzymes. 
The occurrence of different temperature profiles by the Bacillus LCA from three 
different enzymes inferred using the same ASR methodology, (considering the 
absolute thermal values measured here), may be explained three ways: 1) The 
ancestral inference is protein dependent and depends on the species chosen for the 
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phylogenetic tree. AroA, MurA and LeuB differ in their inference primarily in the 
fact that both have different contemporary species and tree topologies; 2) The 
absolute Topt or Tm values are protein dependant. This is suggested by the 
difference in Topt or Tm values obtained for B. subtilis AroA, MurA and LeuB 
enzymes (Figure 6.1); 3) As proposed by Woese et al. (1998), the universal 
ancestor is not a discrete entity but a community. Hence the concept that a group 
of contemporary species evolved from a single common ancestor may be an 
oversimplification of the true evolutionary events. Therefore the ancestral 
enzymes reconstructed here may in fact represent a consortium of species that 
existed during a particular time point. The present day Bacillus species inhabit 
multiple environments. Similarly, the data obtained here for the reconstructed 
ancestor may represent a single candidate from the consortium, ie., each 
reconstructed ancestor only represents a snapshot of the evolving host.   
ASR remains useful in the study of thermophily, however, the biological 
conclusions and thermal trends inferred from resurrected ancestors needs to be 
treated with caution as, even after surpassing biases associated with ancestral 
inference, the reconstructed ancestral protein may still only be a representative 
from a consortium of species present at that point of time and the ancestor with 
the respective biochemical and biophysical properties may not even have existed. 
6.1.4 Evolution of Enzyme inhibition 
The specific inhibition of AroA and MurA LCA, by their inhibitors glyphosate 
and fosfomycin respectively, was explored to evaluate the effect of evolution on 
the enzyme’s inhibitory properties. While MurA LCA showed very similar 
inhibitor specificity to fosfomycin in comparison to its contemporary enzyme, the 
inhibition of AroA LCA in comparison to B. subtilis AroA by glyphosate showed 
interesting characteristics. AroA LCA showed approximately 12 fold more 
sensitivity towards glyphosate in comparison to the naturally tolerant class II 
B. subtilis AroA. Yet AroA LCA maintains high affinity to PEP, similar to 
B. subtilis AroA, a characteristic of class II enzymes. AroA LCA also shares a 
sequence identity of 76-77% with class II Bacillus cereus AroA and B. subtilis 
AroA. The residues involved in glyphosate binding in class II Streptococcus 
pneumoniae AroA, were also identified within the AroA LCA structure, with 
minor variations in their position and orientation. This evidence indicates AroA 
LCA to be intermediate between class I and class II AroA and the present day 
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class II Bacillus species evolved from a glyphosate sensitive enzyme. It also 
agrees with the hypothesis that reconstructed ancestors only represent the 
properties of a candidate from a consortium of species present at a particular time 
point. Therefore it is possible that the LCA is only a representative candidate with 
different properties to the typical class I and class II enzymes.  
A phylogenetic analysis demonstrates that class I and class II AroA are distinctly 
grouped together (Figure 6.2) (previous studies have also shown this phylogenetic 
distinction between class I and class II (Tian et al. 2012; Zhang et al. 2014)). This 
sets the question as to which among these two classes would have been the LCA 
of both classes. The preliminary data obtained from AroA LCA suggests that the 
ancestor would have been class I AroA as AroA LCA is observed to become more 
sensitive as it goes back in time.  
An alternative reasoning for inhibitory features exhibited by AroA LCA is that the 
characteristics defining a class I and II AroA may be easily obtainable subjected 
to appropriate selection pressures. This is exemplified by Pseudomonas genus 
within which some species are tolerant to inhibition by glyphosate while some are 
sensitive to inhibition by glyphosate (Schulz et al. 1985).  
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Figure 6.2: Phylogenetic tree analysis of selected class I and class II AroA species 
The unrooted phylogenetic tree was generated using GARLI 1.0. The scale for 
substitution rate per site per unit time is indicated at the bottom of the tree. I and II 
next to the species indicate the class of each species. The accession numbers for 
the species used in the phylogenetic tree are given in Table A.3 in Appendix A.    
The promiscuity of the inhibitors was also explored to ascertain any evolutionary 
changes that may allow specific inhibition of AroA and MurA LCA by 
fosfomycin and glyphosate respectively. If we assume that AroA and MurA 
enzymes originated from a common ancestor, this implies that going back in 
evolutionary time, at a certain point both enzymes would show more similarities 
structurally and functionally to each other. Therefore it is possible that at a 
particular evolutionary time, both AroA and MurA had biochemical and 
biophysical characteristics allowing their inhibition by fosfomycin and glyphosate 
interchangeably. However, upon exploring such inhibitor promiscuity, it was 
observed that AroA LCA did not show specific inhibition with the MurA inhibitor 
fosfomycin and vice versa. Hence, it is clear that the LCA of AroA and MurA 
only possessed structural and functional characteristics to allow exclusive 
inhibition by glyphosate and fosfomycin respectively at this point of time.  
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6.1.5 In vivo fitness of reconstructed AroA ancestor 
Reconstructed ancestral proteins provide a unique opportunity to study the 
relationship between the protein’s biochemical and biophysical properties and 
organismal fitness in vivo (Hobbs et al. 2015 ). Such a test was possible for AroA. 
AroA LCA has twice the catalytic efficiency and higher affinity to PEP and S3P 
than B. subtilis AroA, and lower kcat than B. subtilis AroA both at 37 °C and at 
their respective Topt. Upon studying the fitness of these enzymes using aroA E. 
coli cells, AroA LCA failed to rescue the cells at 37 °C inspite of the efficient 
enzyme properties, in comparison to the contemporary enzyme. However, it has 
been shown that improved properties such as protein stability and higher catalytic 
efficiency does not correlate to organismal fitness (Hobbs et al. 2015 ). There are 
many possible reasons for the fitness cost observed here. For example, AroA LCA 
has a three times lower kcat than B. subtilis AroA at 37 °C which may also have 
affected the fitness in vivo. Another reasoning for the fitness cost may be 
associated with an increase in uncoupling between ancestral AroA LCA enzyme 
and the other enzymes of the shikimate pathway (Hobbs et al. 2015 ). The 
regulation of the shikimate pathway in microorganisms is by feedback inhibition 
and by repression of the first enzyme (Fischer et al. 1986; Herrmann & Weaver 
1999). The insertion of ancestral Bacillus AroA LCA enzyme in modern E. coli 
cells, may have caused improper regulation of the other enzymes present in the 
pathway. This in turn may result in the accumulation of different pathway 
intermediates (Hobbs et al. 2015 ). The improper regulation of enzymes of the 
shikimate pathway may lead to an inability to synthesise the aromatic amino acids, 
or a decrease in end product molecules of the shikimate pathway, resulting in 
failure of feedback inhibition and repression of the first enzyme DAHP synthase 
(Fischer et al. 1986). There is also the possibility for toxicity of accumulated 
intermediate metabolites, especially DAHP or S3P (Fischer et al. 1986). 
Furthermore, organismal fitness also depends on inter- and intra-molecular 
interactions such as interaction of the protein with individual components within 
the cellular network (Kaçar & Gaucher 2013). Differences between interactions 
exhibited by the contemporary AroA protein within the cellular network in 
comparison to the ancestral AroA may have also been responsible for the fitness 
cost imposed by AroA LCA. However, the exact molecular basis is unknown. 
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6.1.6 Robustness and implications of ASR in study of evolution  
The robustness of ancestral inference is fundamental to this study. All the data 
presented here is in context of this ASR method. Therefore, a discussion of its 
strengths and weaknesses is important. 
The LCA of Bacillus genus using AroA and MurA were reconstructed using the 
Maximum Likelihood criterion (ML). At a given position and at a given internal 
node, ML inference assigns the ancestral state with the highest posterior 
probability (Yang 2006). The ML method tends to choose the most frequently 
observed amino acids at a given site, eliminating the less frequent amino acids 
that may even be slightly detrimental to structural stability. This in turn leads to 
the well-known inference bias, overestimation of thermal stability (Williams et al. 
2006). An alternative and possible solution to such a bias is the Bayesian 
inference method which chooses the amino acid residues from the posterior 
probability distribution instead of choosing the one with the maximum probability 
(Williams et al. 2006). However, Hobbs et al. (2012) observed a greater number 
of errors in the ancestral sequence inferred using Bayesian method over ML 
(Hobbs et al. 2012). Another bias associated with the ancestral inference is the 
predominance of hydrophobic amino acids in the ancestral sequence (Gaucher et 
al. 2008). 
The data from reconstructed Bacillus AroA and MurA ancestral enzymes does not 
support bias in their reconstruction. Evidence for unbiased reconstruction is 
detailed below: 
(i) Phylogenetic robustness 
The phylogenetic trees for the ancestral inference of AroA, MurA and LeuB 
enzymes all employed extant protein sequences from the Bacillus genus. While 
AroA and MurA employed the same set of 20 Bacillus sequences, the LeuB 
phylogenetic tree differed in that it included psychrophilic (20 °C) and 
thermophilic (60–80 °C) sequences (Hobbs et al. 2012). The three 
phylogenetically conserved clades identified by Alcaraz et al (2010), the 
pathogenic clade, the soil clade, and halophile clade are conserved within the 
three phylogenetic trees. The relationship between the species described by their 
grouping within the phylogenetic tree is consistent with each other, and with 
previous literature. For instance, the pathogenic clade, also referred to as Bacillus 
cereus group, comprises of primarily six species, B. pseudomycoides, B. mycoides, 
Chapter 6: Discussion 
177 
B. weihenstephanensis, B. cereus, B. thuringiensis and B. anthracis; to which B. 
cytotoxicus is closely related (Guinebretière et al. 2013). Similarly, the grouping 
of species within the soil and halophile clades are consistent with the literature 
(Alcaraz et al. 2010; Hobbs et al. 2012; Guinebretière et al. 2013), suggesting 
confidence in the phylogenetic relationship between species. The robustness of 
the phylogenies of AroA and MurA are also validated by the high bootstrap 
percentage, including a 100% bootstrap value for the LCA of the Bacillus genus. 
However, it was observed that these three phylogenetic trees differ from each 
other in their overall topology. The pathogenic and soil clades are grouped 
together within MurA (with MurA ANC2 as common ancestor) and LeuB (with 
LeuB3 as common ancestor), with the halophile clade branching from them, while 
the soil and halophile clades are grouped together within AroA phylogeny.  
 (ii) Sequence identity and posterior probability 
There is high sequence identity between the species used for the inference. The 
sequence alignment of Bacillus species for MurA has 50.2% identical sites while 
AroA alignment has 35% identical sites. The fact that there is more difference 
between the AroA sequences than the MurA sequences may be due to greater rate 
of evolution as observed from the phylograms (data not shown). This may also 
explain some of the minor differences in topology between AroA, MurA and 
LeuB phylogenies. 
The reconstructed ancestral sequences show high similarity towards the 
contemporary sequences, (MurA LCA: 76-90% and AroA LCA 64-82%). 
However the ancestral enzymes do not show a significantly higher identity to one 
contemporary sequence than the others, suggesting that there is no bias posed on 
the ancestral nodes by extant sequences. The high sequence identity between the 
Bacillus sequences implies a higher accuracy for the phylogeny inferred from 
them (Kumar & Filipski 2007) and will result in a biologically relevant 
phylogenetic tree (Brown 2002). 
All the reconstructed ancestral nodes had high posterior probability given the 
model of evolution used and low number ambiguous sites. 
(iii) Functionality of reconstructed enzymes 
The ancestral enzymes show comparable kinetic characteristics to the 
contemporary enzymes, and the structure of LCA is highly similar to the 
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contemporary structure. This suggests that the enzymes have been accurately 
reconstructed, as any error in ancestral inference would have resulted in inactive 
or biologically unrealistic enzymes. 
(iv) Thermal properties 
Williams et al (2006) suggested that the ancestral enzymes reconstructed by the 
ML method tend to overestimate protein thermostability. However, considering 
the thermal properties of MurA ancestors, although all ancestors were consistently 
moderately thermophilic, there is a gradual decrease in the thermal properties of 
the ancestors with evolutionary time, therefore not supporting a bias towards 
thermostability. The ML method assigns the ancestral sequence with the amino 
acid residues present in the majority of sequences known to be stabilizing, thus 
conferring the predicted ancestor a thermostability higher than contemporary 
orgainsms. However, the AroA and MurA ancestors do not show considerably 
much higher thermostability than the contemporary sequences such as Bacillus 
coagulans, thereby suggesting no overestimation of thermostability. At the same 
time, it must be noted that the reconstructed ancestors are not an average of the 
extant species thermostabilities as shown by LeuB ancestral enzymes (Hobbs et al. 
2012). The sequences of the inferred ancestors for AroA and MurA show highest 
pairwise identity to sequences from different thermal environments: MurA ANC1 
to Bacillus megaterium (25-30 °C), MurA ANC2 to Bacillus cytotoxicus (45-
50 °C), MurA ANC3 to Bacillus cellulosyliticus (37 °C), MurA LCA to Bacillus 
cellulosyliticus (37 °C), and AroA LCA to Bacillus cytotoxicus (45-50 °C) then to 
Bacillus pumilus (25-30 °C) (Table 3.1 and Table 4.1). Therefore there is no 
specific similarity to contemporary sequences from a specific thermal habitat, 
suggesting that contemporary sequences do not bias the thermal properties of 
ancestral sequences and hence they are more likely to exhibit their true thermal 
properties.  
(v) Hydrophobicity 
An increase of seven hydrophobic residues was observed within MurA LCA, 
which accounts for only a 1% increase in hydrophobic residues in comparison to 
contemporary mesophilic B. anthracis MurA (Table 5.4), while on the contrary, 
Bacillus AroA LCA has a decrease of ~4% in hydrophobic residues compared to 
its contemporary mesophilic B. halodurans AroA (Table 5.8), and yet AroA LCA 
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shows a higher Tm than MurA LCA, hence ruling out bias associated to 
hydrophobic residues. 
Although we cannot completely rule out the possibility of bias or errors in the 
ancestral inference, this evidence provides a strong confidence in the validity of 
the resurrected ancestors, hence there is no reason to doubt the validity of the data 
measured for the reconstructed enzymes. 
It is however acknowledged that a variety of assumptions are associated with this 
study. We assume that the resurrected ancestral enzyme is a representation of the 
true ancestral state. However, ancestral sequence inference identifies the best 
approximation of the ancestral state and is not the true ancestor (Thornton 2004).  
The ancestral reconstruction by ML uses a set model of evolution, alignment and 
tree topology for inference. We assume confidence in these parameters upon 
which the ancestral inference depends. It is also assumed that the properties 
exhibited by the ancestral enzymes were not affected by its expression and 
characterisation within extant cell systems (Thornton 2004). The absolute values 
for the thermal properties as well as ancestral evolutionary ages were taken for 
this study.        
In spite of these, this data provides ample information on the structural and 
functional aspects of AroA and MurA enzyme evolution. There is no specific 
trend observed with respect to thermal stability and catalytic activity/efficiency 
with evolutionary time. Such an exhibit of distinct properties by the ancestors 
suggests that the inference does not show any bias. Furthermore, the mechanistic 
and structural similarities between AroA and MurA led us to hypothesis that 
AroA and MurA originated from a common ancestor. Upon analysing the 
chronogram of prokaryotic evolution generated by Battistuzzi et al. (2004), it is 
observed that the evolution of MurA may have succeeded AroA, as indicated by 
the presence of AroA enzyme within archaea, while peptidoglycan is absent from 
archaea cell wall and hence MurA enzyme. This suggests that the LCA of AroA 
and MurA may possibly be the LUCA. Therefore, it is only natural that the 
reconstruction of AroA and MurA ancestral enzymes that date back to only 950 
myr old would not show characteristic features differing from contemporary AroA 
and MurA. Therefore, the results obtained in this study concur with the expected 
evolutionary behavior.   
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6.1.7 Implications of ASR  
The use of this ASR technique, most certainly has a significant implication in the 
study of functional and structural protein evolution. However, certain aspects of 
this ASR technique, such as possible bias due to taxon sampling, and error in 
inferences due to external factors such as horizontal gene transfer, insertions and 
deletions, may be addressed with the use of a reconciled tree (Groussin et al. 
2015). Reconciled trees (S-aware trees) encompass a phylogeny based on protein 
sequences (gene tree) as well as a species tree. Incorporating a species tree along 
with a gene tree, would allow factoring in genetic events such as duplications, 
deletions and lateral gene transfers, which may otherwise affect the phylogeny 
based on protein sequences alone. The use of a reconciled tree was shown to 
improve the accuracy of ancestral inference in silico as well as in vitro (Groussin 
et al. 2015). Accurate phylogeny translates into accurate ancestral inference and 
resurrection of more evolutionarily realistic ancestors (Groussin et al. 2015). 
Therefore using a reconciled tree for Bacillus species with a species tree involving 
only species that are fully genome sequenced, would account for any genetic 
events and would standardise the contemporary species used for ancestral 
inference. This is more likely to result in more consistent phylogenies between 
proteins. This would also provide further confidence in the node age estimations. 
The use of a reconciled tree may or may not cause uniformity in the thermal 
trends exhibited by the ancestors from the same time point. However, this must be 
confirmed by experimentally testing AroA, MurA and LeuB LCA of the Bacillus 
genus reconstructed using reconciled trees. The current reconstruction method 
utilises a site-homogenous LG model (Le & Gascuel 2008) which uses only a 
single substitution matrix for a given phylogenetic tree. On the other hand a site-
heterogeneous model utilises several such matrices and helps decrease bias in the 
estimation of model parameters (Groussin et al. 2013). However, results obtained 
from trees reconstructed by both site-homogenous model and site-heterogeneous 
were very similar (Groussin et al. 2015). 
Therefore, incorporating the use of a reconciled tree to the current ASR 
methodology could improve the overall robustness of ancestral inference and 
hence the biological conclusions drawn from them. 
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6.2 Future Work 
As previously discussed, the use of a reconciled tree for the ancestral inference 
procedure would result in more accurate phylogenies which in turn would 
resurrect more evolutionarily accurate ancestral enzymes. Therefore, AroA and 
MurA ancestral enzymes from the Bacillus genus could be reconstructed using a 
reconciled tree and the enzymes characterised, to see whether the measured 
properties differ from those observed in this study.  
It would be of further interest to obtain the structure of Bacillus AroA LCA bound 
to its substrate for detailed analysis of its active site. This may also help in 
identifying the structural factors responsible for 3-6 fold higher affinity of 
Bacillus AroA LCA in comparison to B. subtilis AroA. The structure of Bacillus 
AroA LCA bound to its inhibitor glyphosate would be necessary to structurally 
evaluate the reasons for its increased sensitivity towards glyphosate in comparison 
to B. subtilis AroA. The structural comparison between AroA LCA and MurA 
LCA could not be performed as MurA LCA bound to UNAG was in its ‘closed’ 
state and unliganded AroA LCA was in its ‘open’ state. Therefore, the structure of 
AroA LCA bound to its substrate or unliganded MurA LCA could be used for 
such a comparative study.   
The in vivo fitness cost posed by AroA LCA needs to be investigated further. To 
achieve this, the following experiments could be carried out (Hobbs et al. 2015 ): 
1) To have the ancestral AroA on the chromosome of contemporary B. subtilis, or 
cloning the genes encoding for B. subtilis AroA and Bacillus AroA LCA such that 
they come under the control of the same promoter; 2) growth experiments of 
aroA cells complemented with AroA LCA and B. subtilis AroA in M9 media 
and sampling periodically to determine the growth rates; 3) competition assays 
may also be performed by growing the two strains in the same culture and 
estimating the relative fitness of AroA LCA in comparison to the contemporary 
AroA; and 4) placing the AroA LCA onto the Bacillus chromosome and forward 
evolving the strain until fitness improves. The resulting mutations unique to AroA 
could then be studied in vitro (Hobbs et al. 2015 ).  
As explained in this study, the exact factors involved in the characterisation of 
class I and class II AroA are unknown. However, it would be of further interest to 
reconstruct ancestral enzymes that go further back to the LCA of class I and 
class II AroA and thus gain more insight into the evolution of these two classes of 
Chapter 6: Discussion 
182 
AroA. Taking the reconstruction process further back in evolutionary time would 
also allow us further study the evolution of AroA and MurA enzymes. To further 
explore the hypothesis that AroA and MurA originated from a common ancestor, 
reconstructing older ancestors may allow us to observe convergence between 
AroA and MurA enzymes. With the help of new ancestral inference procedures 
with reconciled trees, there is greater potential for successful reconstruction of 
ancestral enzymes that are much further back in evolutionary time.  
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Appendix A: Accession Numbers and species details 
Table A.1: Bacterial strains and accession numbers of MurA used in ancestral 
inference 
Organism  Strain/serovar Accession number 
Bacillus amyloliquefaciens  DSM 7 NC_014551 
Bacillus anthracis  Sterne NC_005945 
Bacillus atrophaeus  1942 NC_014639 
Bacillus cellulosilyticus  DSM 2522 NC_014829 
Bacillus cereus  ATCC 14579 AE016877 
Bacillus clausii  KSM-K16 NC_006582 
Bacillus coagulans  36D1 NC_016023 
Bacillus coahuilensis  m4-4 NZ_ABFU01000064 
Bacillus cytotoxicus  NVH 391-98 NC_009674 
Bacillus halodurans  C-125 NC_002570 
Bacillus licheniformis  ATCC 14580 NC_006270 
Bacillus megaterium  DSM 319 CP001982 
Bacillus mycoides  Rock3-17 NZ_ACMW01000102 
Bacillus pseudofirmus  OF4 NC_013791 
Bacillus pseudomycoides  DSM 12442 NZ_ACMX01000083 
Bacillus pumilus  ATCC 7061 NZ_ABRX01000004 
Bacillus selenitireducens  MLS10 NC_014219 
Bacillus subtilis  168 This study 
Bacillus thuringiensis  97-27 NC_005957 
Bacillus weihenstephanensis  KBAB4 NC_010184 
Clostridium acetobutylicum  ATCC 824 NC_003030 
Clostridium butyricum  5521 NZ_ABDT01000114 
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Table A.2: Bacterial strains and accession numbers of AroA used in ancestral 
inference 
Organism  Strain/serovar  Accession number 
Bacillus amyloliquefaciens  DSM7 NC_014551 
Bacillus anthracis  Ames NC_003997 
Bacillus atrophaeus  1942 NC_014639 
Bacillus cellulosilyticus  DSM 2522 NC_014829 
Bacillus cereus  ATCC 14579 NC_004722 
Bacillus clausii  KSM-K16 NC_006582 
Bacillus coagulans  36D1 NC_016023 
Bacillus coahuilensis  m4-4 NZ_ABFU01000037 
Bacillus cytotoxicus  NVH 391-98 NC_009674 
Bacillus halodurans  C-125 NC_002570 
Bacillus licheniformis  ATCC 14580 NC_006322 
Bacillus megaterium  DSM319 NC_014103 
Bacillus mycoides  Rock3-17 NZ_ACMW01000069 
Bacillus pseudofirmus  OF4 NC_013791 
Bacillus pseudomycoides  DSM 12442 NZ_ACMX01000055 
Bacillus pumilus  ATCC 7061 NZ_ABRX01000005 
Bacillus selenitireducens  MLS10 NC_014219 
Bacillus subtilis  168 This study 
Bacillus thuringiensis  Al Hakam NC_008600 
Bacillus weihenstephanensis  KBAB4 NC_010184 
Clostridium acetobutylicum  ATCC 824 NC_003030 
Clostridium butyricum  5521 NZ_ABDT01000092 
 
Table A.3: Bacterial species and accession numbers of class I and class II AroA  
Class Organism Accession number 
I Aeromonas salmonicida Q03321 
II Agrobacterium tumefaciens. CP4 Q9R4E4 
II Bacillus cereus NP_832685 
II Bacillus subtilis P20691 
I Bordetella pertussis P12421 
I Escherichia coli P0A6D3 
II Halothermothrix orenii. H168 ACL69793 
II Pseudomonas sp. PG2982 P0A2Y4 
I Salmonella typhimurium CAA71382 
II Staphylococcus aureus Q05615 
II Streptococcus pneumoniae Q9S400 
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Appendix B: Protein sequence alignment for Bacillus MurA and 
Bacillus AroA 
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Figure A.1: Bacillus MurA protein sequence alignment 
The different shades indicate the percentage similarity at each position in the alignment. 
Black = 100% similar, dark grey = 80 to 100% similar, light grey = 60 to 80% similar and 
white = less than 60% similar. Alignment was generated with ClustalW {Larkin, 2007 
#222} in Geneious {Kearse, 2012 #221}. Conserved residues mentioned in section 
3.2.1.1 are shown in red boxes. 
 
 
Appendices 
206 
 
Appendices 
207 
 
Figure A.2: Bacillus AroA protein sequence alignment 
The different shades indicate the percentage similarity at each position in the alignment. 
Black = 100% similar, dark grey = 80 to 100% similar, light grey = 60 to 80% similar and 
white = less than 60% similar. Alignment was generated with ClustalW {Larkin, 2007 
#222} in Geneious {Kearse, 2012 #221}. Conserved residues mentioned in section 
4.2.1.1 are shown in red boxes. 
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Appendix C: Nucleotide and amino acid sequence information 
Bacillus subtilis murA (1311 bp) 
TTGGAAAAAATCATCGTCCGCGGCGGTCAGAAGTTAAACGGCACAGTCAAAGTTG
AAGGCGCTAAAAATGCCGTTTTACCTGTTATCGCTGCATCTTTATTAGCAAGTGA
AGAAAAAAGCGTAATTTGTGATGTACCTACGCTCTCCGATGTATATACAATTAAC
GAAGTGTTGCGTCATTTAGGAGCAGATGTGCATTTTGAAAATAATGAAGTGACTG
TAAATGCTTCATACGCTTTGCAAACTGAAGCACCTTTTGAATATGTTCGTAAAAT
GCGTGCGTCTGTGCTTGTCATGGGGCCGCTTCTTGCGCGTACAGGTCATGCAAGA
GTTGCACTTCCGGGCGGATGCGCAATTGGTTCCAGACCGATTGATCAGCATTTAA
AAGGTTTTGAAGCAATGGGCGCAGAAATCAAAGTCGGTAATGGCTTCATTGAAGC
TGAAGTAAAAGGCCGACTGCAAGGCGCAAAAATTTATCTGGACTTCCCAAGTGTA
GGAGCTACAGAGAACCTGATTATGGCAGCCGCTCTAGCTGAAGGAACAACAACGC
TGGAAAACGTGGCAAAAGAACCCGAAATCGTTGATTTAGCAAACTATATCAACGG
CATGGGCGGAAAAATCCGCGGAGCTGGCACCGGCACCATCAAAATTGAAGGAGTC
GAAAAGCTTCACGGCGTAAAACACCATATTATTCCTGACCGTATTGAAGCGGGCA
CATTTATGGTTGCTGCTGCAATCACTGAAGGAAACGTATTAGTAAAAGGAGCGGT
TCCTGAGCACCTCACCTCTTTAATTGCAAAAATGGAAGAGATGGGTGTAACAATT
AAGGATGAAGGTGAAGGTCTGCGTGTCATCGGCCCGAAAGAGCTTAAACCGATTG
ACATCAAAACAATGCCTCACCCGGGCTTCCCGACTGATATGCAGTCACAAATGAT
GGCGCTTCTGCTTCGTGCAAGCGGCACAAGCATGATTACAGAAACCGTTTTTGAA
AACCGTTTTATGCATGCGGAAGAATTCCGCCGTATGAATGGTGATATCAAGATTG
AAGGACGTTCTGTCATCATTAACGGTCCTGTACAGCTTCAGGGAGCTGAAGTTGC
AGCGACTGATTTGCGTGCAGGTGCAGCGCTGATTCTTGCGGGGTTAGTGGCTGAA
GGTCACACACGTGTTACTGAATTGAAGCACTTAGACCGCGGTTACGTTGATTTCC
ATCAGAAGCTTGCCGCTCTGGGCGCAGACATCGAACGTGTAAATGATGAGTCTGC
TTCTGAGCAAGAGAATAAAGAAGTCGTTTCTGACTTAAATGCATAA 
Bacillus subtilis MurA  
MEKIIVRGGQKLNGTVKVEGAKNAVLPVIAASLLASEEKSVICDVPTLSDVYTIN
EVLRHLGADVHFENNEVTVNASYALQTEAPFEYVRKMRASVLVMGPLLARTGHAR
VALPGGCAIGSRPIDQHLKGFEAMGAEIKVGNGFIEAEVKGRLQGAKIYLDFPSV
GATENLIMAAALAEGTTTLENVAKEPEIVDLANYINGMGGKIRGAGTGTIKIEGV
EKLHGVKHHIIPDRIEAGTFMVAAAITEGNVLVKGAVPEHLTSLIAKMEEMGVTI
KDEGEGLRVIGPKELKPIDIKTMPHPGFPTDMQSQMMALLLRASGTSMITETVFE
NRFMHAEEFRRMNGDIKIEGRSVIINGPVQLQGAEVAATDLRAGAALILAGLVAE
GHTRVTELKHLDRGYVDFHQKLAALGADIERVNDESASEQENKEVVSDLNA 
436 amino acids  
Predicted molecular weight: 46701 Da  
Theoretical pI: 5.55 
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Bacillus coagulans murA (1314 bp) 
ATGGAAAAAATCATTGTGCGTGGTGGTAATCGTCTGCAGGGTGCAGTTCAGGTTG
AAGGTGCAAAAAATGCAGTTCTGCCGGTTATTGCAGCAAGCCTGCTGGCAAGCGA
AGGTAAAAGCATTATTCGTGATGTTCCGCAGCTGAGTGATGTTTTTACCATTAGC
GAAGTTCTGCGTCATCTGAATGCAGAAGTTACCTTTCTGGAAAACGAAATCACCG
TTGATGCAAGCCGTGAACTGAGCATTGAAACCCCGTTTGAATATGTTCGTAAAAT
GCGTGCAAGCTTTCTGGTTCTGGGTCCGCTGCTGGCACGTACCGGTAAAGCACGT
GTTGCACTGCCTGGTGGTTGTGCAATTGGTAGCCGTCCGATTGATCTGCATCTGA
AAGGTTTTGAAGCAATGGGTGCAAAAGTTGATGTGGGCAATGGTTTTATTGAAGC
CAGCGTTAGCGGTCGCCTGCATGGTGCCAAAATTTACATGGATTTTCCGAGCGTT
GGTGCCACCCAGAATATTATGATGGCAGCCAGCCTGGCAGATGGTCAGACCGTTA
TTGAAAATTGTGCAAAAGAACCGGAAATTGTGGATCTGGCCAATTTTCTGAATGA
AATGGGTGCCAATGTTAAAGGTGCAGGCACCGGCACCATTAAAATCGAAGGTGTT
GAAAAACTGCATGCCGCAGATCATACCATTATTCCGGATCGTATTGAAGCAGGCA
CCTTTATGGTTGCAGCAGCAATTACCAAAGGTAATGTTCTGGTGAAAGGTGCCGT
GCCGGAACATATTAGCAGCCTGATTGCAAAACTGGAAGAAATGGGCGTGACCATT
ATTGAAGAAGAAAACGGCGTTCGCGTTATTGGTCCGGAAACCCTGAAAGCAGTGG
ATATCAAAACCATGCCGTATCCGGGTTTTCCGACCGATATGCAGAGCCAGATGAT
GGCACTGCTGCTGTGTGCAGAAGGCACCAGCGTTATTACCGAAACCGTGTTTGAA
AATCGCTTTATGCACGTGGAAGAATTTCGTCGTATGAATGCCGATCTGAAAATTG
AAGGTCGTAGCGTTATTGTTAATGGTCCGTGTAATCTGCAAGGTGCCGAAGTTGC
AGCAACCGATCTGCGTGCAGCAGCCGCACTGATTATTGCAGGTCTGGCAGCAAAA
GGTATTACCCGTGTTACCGAACTGAAACATCTGGATCGTGGTTATCTGAACTTTC
ATCTGAAACTGGCAGCACTGGGTGCGAATATTGAACGTGTTGATGATGAAGCGGA
AGTTGCACCGGCAAAACAGGATCAGCTGCTGGCCGATGCAAATCTGTAA 
Bacillus coagulans MurA 
MEKIIVRGGNRLQGAVQVEGAKNAVLPVIAASLLASEGKSIIRDVPQLSDVFTIS
EVLRHLNAEVTFLENEITVDASRELSIETPFEYVRKMRASFLVLGPLLARTGKAR
VALPGGCAIGSRPIDLHLKGFEAMGAKVDVGNGFIEASVSGRLHGAKIYMDFPSV
GATQNIMMAASLADGQTVIENCAKEPEIVDLANFLNEMGANVKGAGTGTIKIEGV
EKLHAADHTIIPDRIEAGTFMVAAAITKGNVLVKGAVPEHISSLIAKLEEMGVTI
IEEENGVRVIGPETLKAVDIKTMPYPGFPTDMQSQMMALLLCAEGTSVITETVFE
NRFMHVEEFRRMNADLKIEGRSVIVNGPCNLQGAEVAATDLRAAAALIIAGLAAK
GITRVTELKHLDRGYLNFHLKLAALGANIERVDDEAEVAPAKQDQLLADANL 
437 amino acids  
Predicted molecular weight: 46649 Da  
Theoretical pI: 5.30 
Bacillus murA ANC1 (1311 bp) 
ATGGAAAAAATCATTGTGCGTGGTGGTAAACGTCTGAATGGCACCGTTAAAGTTG
AAGGTGCAAAAAATGCAGTTCTGCCGGTTATTGCAGCAAGCCTGCTGGCAAGCGA
AGGTAAAAGCGTTATTTATGATGTTCCGGCACTGAGTGATGTGTATACCATTAAT
GAAGTTCTGCGTCATCTGAATGCCGAAGTGGAATTTGAAAATAATCAGGTTACCG
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TTGATGCAAGCCGTGAACTGAAAACCGAAGCACCGTTTGAATATGTTCGTAAAAT
GCGTGCAAGCGTTCTGGTTATGGGTCCGCTGCTGGCACGTACCGGTCATGCACGT
GTTGCACTGCCTGGTGGTTGTGCAATTGGTAGCCGTCCGATTGATCAGCATCTGA
AAGGTTTTGAAGCAATGGGTGCCAAAGTTAAAGTGGGCAATGGTTTTATTGAAGC
CAAAGTGGAAGGTCGTCTGCAGGGTGCGAAAATCTATCTGGATTTTCCGAGCGTT
GGTGCAACCGAAAACATTATGATGGCAGCAGCACTGGCAGAAGGCACCACCATTA
TTGAAAATGTTGCAAAAGAACCGGAAATCGTGGATCTGGCAAATTTTCTGAACGC
CATGGGAGCAAAAGTTCGTGGTGCAGGCACCGGCACCATTCGTATTGAAGGTGTT
GATAAACTGTATGGTGCCGAACATACCATTATTCCGGATCGCATTGAAGCAGGCA
CCTTTATGGTTGCAGCAGCAATTACCGGTGGTAATGTTCTGGTGAAAGGTGCAGT
TCCTGAACATCTGAGCAGCCTGATTGCAAAAATGGAAGAAATGGGCGTGGAAATT
ATTGAAGAGGGTGATGGTCTGCGTGTTATTGGTCCGGAAAAACTGAAAGCAGTGG
ATATCAAAACCATGCCGCATCCGGGTTTTCCGACCGATATGCAGAGCCAGATGAT
GGCACTGCTGCTGCGTGCCGAAGGTACAAGCATGATTACCGAAACCGTTTTTGAA
AACCGCTTTATGCACGTGGAAGAATTTCGTCGTATGAACGCAGACATTAAAATCG
AAGGTCGTAGCGTGATTATTAACGGTCCGAATAAACTGCAAGGTGCAGAAGTTGC
AGCAACCGATCTGCGTGCAGCAGCCGCACTGATTCTGGCAGGTCTGGTTGCGGAA
GGTTATACCCGTGTTACCGAACTGAAACATCTGGATCGTGGTTATGTGAACTTCC
ACAAAAAACTGGCAGCCCTGGGTGCAGATATTGAACGTGTTAATGATGAAGCCGA
AGAAGAAGAGGAAAACAAACAAGAGGTTAGCGATCTGAACGCGTAA 
Bacillus MurA ANC1 
MEKIIVRGGKRLNGTVKVEGAKNAVLPVIAASLLASEGKSVIYDVPALSDVYTIN
EVLRHLNAEVEFENNQVTVDASRELKTEAPFEYVRKMRASVLVMGPLLARTGHAR
VALPGGCAIGSRPIDQHLKGFEAMGAKVKVGNGFIEAKVEGRLQGAKIYLDFPSV
GATENIMMAAALAEGTTIIENVAKEPEIVDLANFLNAMGAKVRGAGTGTIRIEGV
DKLYGAEHTIIPDRIEAGTFMVAAAITGGNVLVKGAVPEHLSSLIAKMEEMGVEI
IEEGDGLRVIGPEKLKAVDIKTMPHPGFPTDMQSQMMALLLRAEGTSMITETVFE
NRFMHVEEFRRMNADIKIEGRSVIINGPNKLQGAEVAATDLRAAAALILAGLVAE
GYTRVTELKHLDRGYVNFHKKLAALGADIERVNDEAEEEEENKQEVSDLNA 
436 amino acids  
Predicted molecular weight: 46930 Da  
Theoretical pI: 5.36 
Bacillus murA ANC2 (1311 bp) 
ATGGAAAAAATCATTGTGCGTGGTGGTAAACGTCTGAATGGCACCGTTCGTGTTG
AAGGTGCAAAAAATGCAGTTCTGCCGGTTATTGCAGCAAGCCTGCTGGCAAGCGA
AGGTAAAAGCGTTATTTATGATGTTCCGGCACTGAGTGATGTGTATACCATTAAT
GAAGTTCTGCGTCATCTGAATGCCGAAGTGGAATTTGAAAATAATCAGGTTACCG
TGGATGCCAGCAAAGAACTGAAAACCGAAGCACCGTTTGAATATGTTCGTAAAAT
GCGTGCAAGCGTTCTGGTTATGGGTCCGCTGCTGGCACGTACCGGTCATGCACGT
ATTGCACTGCCTGGTGGTTGTGCAATTGGTAGCCGTCCGATTGATCAGCATCTGA
AAGGTTTTGAAGCAATGGGTGCCAAAGTTAAAGTGGGCAATGGTTTTATTGAAGC
CAAAGTTGAAGGTCGTCTGCAGGGTGCGAAAATCTATCTGGATTTTCCGAGCGTT
GGTGCAACCGAAAACATTATGATGGCAGCAGCACTGGCAGAAGGCACCACCATTA
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TTGAAAATGCAGCAAAAGAACCGGAAATTGTGGATCTGGCAAATTTTCTGAACGC
CATGGGAGCAAAAGTTCGTGGTGCAGGCACCGGCACCATTCGCATTGAAGGCGTT
GATAAACTGTATGGTGCAGAACATACCATTATTCCGGATCGTATTGAAGCAGGCA
CCTTTATGGTTGCAGCAGCAATTACCGGTGGTAATGTTCTGGTGGAAAATGCCGT
TCCTGAACATATCCGTAGCCTGATTGCAAAAATGGAAGAAATGGGCGTGGAAATT
ATTGAAGAGGGTGATGGTCTGCGTGTTATTGGTCCGGAAAAACTGAAAGCAGTGG
ATATCAAAACCATGCCGCATCCGGGTTTTCCGACCGATATGCAGAGCCAGATGAT
GGCACTGCTGCTGCGTGCCGAAGGTACAAGCATGATTACCGAAACCGTTTTTGAA
AACCGCTTTATGCACGTGGAAGAATTTCGTCGTATGAACGCAGACATTAAAATCG
AAGGTCGTAGCGTGATTATTAACGGTCCGAATAAACTGCAAGGTGCCGAAGTTGC
AGCAACCGATCTGCGTGCAGCAGCCGCACTGATTCTGGCAGGTCTGGTTGCGGAA
GGTTATACCCGTGTTACCGAACTGAAACATCTGGATCGTGGTTATGTGAACTTCC
ACAAAAAACTGGCAGCCCTGGGTGCAGATATTGAACGTGTTAATGAAGAAGCCGA
AGAAGAAGAGGAAAACAAACAAGAGGTTAGCGATCTGAACGCGTAA 
Bacillus MurA ANC2 
MEKIIVRGGKRLNGTVRVEGAKNAVLPVIAASLLASEGKSVIYDVPALSDVYTIN
EVLRHLNAEVEFENNQVTVDASKELKTEAPFEYVRKMRASVLVMGPLLARTGHAR
IALPGGCAIGSRPIDQHLKGFEAMGAKVKVGNGFIEAKVEGRLQGAKIYLDFPSV
GATENIMMAAALAEGTTIIENAAKEPEIVDLANFLNAMGAKVRGAGTGTIRIEGV
DKLYGAEHTIIPDRIEAGTFMVAAAITGGNVLVENAVPEHIRSLIAKMEEMGVEI
IEEGDGLRVIGPEKLKAVDIKTMPHPGFPTDMQSQMMALLLRAEGTSMITETVFE
NRFMHVEEFRRMNADIKIEGRSVIINGPNKLQGAEVAATDLRAAAALILAGLVAE
GYTRVTELKHLDRGYVNFHKKLAALGADIERVNEEAEEEEENKQEVSDLNA 
436 amino acids  
Predicted molecular weight: 47057 Da  
Theoretical pI: 5.31 
Bacillus murA ANC3 (1311 bp) 
ATGGAAAAAATCATTGTGCGTGGTGGTAAACGTCTGAATGGCACCGTTCGTGTTG
AAGGTGCAAAAAATGCAGTTCTGCCGGTTATTGCAGCAAGCCTGCTGGCAAGCAA
AGGCACCAGCGTTATTTATGATGTTCCGGCACTGGCAGATGTGTATACCATTAAT
GAAGTTCTGCGTAATCTGAACGCCGAGGTGGAATATGATAATGGTCAGATTACCG
TTGATGCCGAGAAAGAACTGAAAACCGAAGCACCGTTTGAATATGTTCGTAAAAT
GCGTGCAAGCTTTCTGGTTATGGGTCCGCTGCTGGCACGTATTGGTCATGCCCGT
ATTGCACTGCCTGGTGGTTGTGCAATTGGTAGCCGTCCGATTGATCAGCATCTGA
AAGGTTTTGAAGCAATGGGTGCCAAAGTGGAAATTGGCAATGGTTTTATTGAAGC
GAAAGTTGAAGGTCGTCTGCAGGGTGCGAAAATCTATCTGGATTTTCCGAGCGTT
GGTGCAACCGAAAACATTATGATGGCAGCAGCACTGGCCGAAGGCACCACCATTA
TTGAAAATGCAGCACAAGAACCGGAAATTGTTGATCTGGCAAATTATCTGAATGC
CATGGGAGCAAAAGTTCGTGGTGCAGGCACCGGCACCATTCGCATTGAAGGCGTT
GATGAACTGAATGGTGCAGAACATACCATTATTCCGGATCGTATTGAAGCAGGCA
CCTTTATGGTTGCAGCAGCAATTACCGGTGGTAATGTTCTGGTTGAAAATGTTGT
GCCTGAACATATCCGTCCGCTGATTGCAAAAATGACCGAAATGGGTGTGAAAATC
ATCGAAGAAGAAAACGGTCTGCGCGTTATTGGTCCGGAAAAACTGAAAGCAGTGG
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ATATCAAAACCATGCCGCATCCGGGTTTTCCGACCGATATGCAGAGCCAGATGAT
GGCACTGCTGCTGCGTGCAGAAGGTACAAGCGTTATTACCGAAACCGTTTTTGAA
AACCGCTTTATGCACGTGGAAGAATTTCGTCGTATGAATGCCGACATTAAAATCG
AAGGTCGTAGCGCAATTGTTAACGGTCCGAATAAACTGCAAGGTGCCGAAGTTGC
AGCAACCGATCTGCGTGCGGGTGCAGCACTGATTCTGGCAGGTCTGGTTGCAGAT
GGTTATACCCGTGTTACCGAACTGAAACATATTGATCGTGGCTATGTTGACTTTG
CCGGTAAACTGAAAGCCCTGGGTGCAGATATTGAACGTGTTAATGAAAAAGCCGA
AGAAGAGGAAGAGAACAAAGAAGAAGCCGCACCGCTGAAAGCATAA 
Bacillus MurA ANC3 
MEKIIVRGGKRLNGTVRVEGAKNAVLPVIAASLLASKGTSVIYDVPALADVYTIN
EVLRNLNAEVEYDNGQITVDAEKELKTEAPFEYVRKMRASFLVMGPLLARIGHAR
IALPGGCAIGSRPIDQHLKGFEAMGAKVEIGNGFIEAKVEGRLQGAKIYLDFPSV
GATENIMMAAALAEGTTIIENAAQEPEIVDLANYLNAMGAKVRGAGTGTIRIEGV
DELNGAEHTIIPDRIEAGTFMVAAAITGGNVLVENVVPEHIRPLIAKMTEMGVKI
IEEENGLRVIGPEKLKAVDIKTMPHPGFPTDMQSQMMALLLRAEGTSVITETVFE
NRFMHVEEFRRMNADIKIEGRSAIVNGPNKLQGAEVAATDLRAGAALILAGLVAD
GYTRVTELKHIDRGYVDFAGKLKALGADIERVNEKAEEEEENKEEAAPLKA 
436 amino acids  
Predicted molecular weight: 46885 Da  
Theoretical pI: 5.20 
Bacillus murA LCA (1311 bp) 
ATGGAAAAAATCATTGTGCGTGGTGGTAAACGTCTGAATGGCACCGTTCGTGTTG
AAGGTGCAAAAAATGCAGTTCTGCCGGTTATTGCAGCAAGCATTCTGGCAAGCAA
AGGCACCAGCACCATTTATGATGTTCCGGCACTGGCAGATGTGTATACCATTAAT
GAAGTTCTGCGTAATCTGAACGCCGAGGTGGAATATGATAATGGTCAGATTACCG
TTGATGCCGAGAAAACCCTGAAAACCGAAGCACCGTTTGAATATGTTCGTAAAAT
GCGTGCAAGCTTTCTGGTTATGGGTCCGCTGCTGGCACGTATTGGTCATGCCCGT
ATTGCACTGCCTGGTGGTTGTGCAATTGGTAGCCGTCCGATTGATCAGCATCTGA
AAGGTTTTGAAGCAATGGGTGCCAAAGTGGAAATTGGCAATGGTTTTATTGAAGC
GAAAGTTGAAGGTCGTCTGCAGGGTGCGAAAATCTATCTGGATTTTCCGAGCGTT
GGTGCAACCGAAAACATTATGATGGCAGCAGCAATGGCAGAAGGCACCACCATTA
TTGAAAATGCAGCACAAGAACCGGAAATTGTTGATCTGGCAAATTATCTGAATGC
CATGGGAGCAAAAGTTCGTGGTGCAGGTACAGGCACCATTCGCATTGAAGGCGTT
GATGAACTGAATGGTGCAGAACATACCATTATTCCGGATCGTATTGAAGCAGGCA
CCTTTATGGTTGCAGCAGCCATTACCGGTGGTAATGTTCTGGTTGAAAATGTTGT
GCCTGAACATATCCGTCCGCTGATTGCAAAAATGACCGAAATGGGTGTGAAAATC
ATCGAAGAAGAAAACGGTCTGCGCGTTATTGGTCCGGAAAAACTGAAAGCAGTGG
ATATCAAAACCATGCCGCATCCGGGTTTTCCGACCGATATGCAGAGCCAGATGAT
GGCACTGCTGCTGCGTGCAGAAGGTACAAGCGTTATTACCGAAACCGTTTTTGAA
AACCGCTTTATGCACGTGGAAGAATTTCGTCGTATGAACGCCAACATTAAAATCG
AAGGTCGTAGCGCAATTGTTACCGGTCCGAATAAACTGCAAGGTGCCGAAGTTGC
AGCAACCGATCTGCGTGCCGGTGCAGCACTGATTCTGGCAGGTCTGGTTGCAGAT
GGTTATACCCGTGTTACCGAACTGAAACATATTGATCGTGGCTATGTTGACTTTG
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CCGGTAAACTGAAAGCCCTGGGTGCAGATATTGAACGTGTTAATGAAAAAGCCGA
AGAAGAGGAAGAAAATCTGGAAGCAGCAGCACCGCTGAAAGTTTAA 
Bacillus MurA LCA 
MEKIIVRGGKRLNGTVRVEGAKNAVLPVIAASILASKGTSTIYDVPALADVYTIN
EVLRNLNAEVEYDNGQITVDAEKTLKTEAPFEYVRKMRASFLVMGPLLARIGHAR
IALPGGCAIGSRPIDQHLKGFEAMGAKVEIGNGFIEAKVEGRLQGAKIYLDFPSV
GATENIMMAAAMAEGTTIIENAAQEPEIVDLANYLNAMGAKVRGAGTGTIRIEGV
DELNGAEHTIIPDRIEAGTFMVAAAITGGNVLVENVVPEHIRPLIAKMTEMGVKI
IEEENGLRVIGPEKLKAVDIKTMPHPGFPTDMQSQMMALLLRAEGTSVITETVFE
NRFMHVEEFRRMNANIKIEGRSAIVTGPNKLQGAEVAATDLRAGAALILAGLVAD
GYTRVTELKHIDRGYVDFAGKLKALGADIERVNEKAEEEEENLEAAAPLKV 
436 amino acids  
Predicted molecular weight: 46818 Da  
Theoretical pI: 5.31 
Bacillus subtilis aroA (1287 bp) 
ATGAAACGAGATAAGGTGCAGACCTTACATGGAGAAATACATATTCCCGGTGATA
AATCCATTTCTCACCGCTCTGTTATGTTTGGCGCGCTAGCGGCAGGCACAACAAC
AGTTAAAAACTTTCTGCCGGGAGCAGATTGTCTGAGCACGATCGATTGCTTTAGA
AAAATGGGTGTTCACATTGAGCAAAGCAGCAGCGATGTCGTGATTCACGGAAAAG
GAATCGATGCCCTGAAAGAGCCAGAAAGCCTTTTAGATGTCGGAAATTCAGGTAC
AACGATTCGCCTGATGCTCGGAATATTGGCGGGCCGTCCTTTTTACAGCGCGGTA
GCCGGAGATGAGAGCATTGCGAAACGCCCAATGAAGCGTGTGACTGAGCCTTTGA
AAAAAATGGGGGCTAAAATCGACGGCAGAGCCGGCGGAGAGTTTACACCGCTGTC
AGTGAGCGGCGCTTCATTAAAAGGAATTGATTATGTATCACCTGTTGCAAGCGCG
CAAATTAAATCTGCTGTTTTGCTGGCCGGATTACAGGCTGAGGGCACAACAACTG
TAACAGAGCCCCATAAATCTCGGGACCACACTGAGCGGATGCTTTCTGCTTTTGG
CGTTAAGCTTTCTGAAGATCAAACGAGTGTTTCCATTGCTGGTGGCCAGAAACTG
ACAGCTGCTGATATTTTTGTTCCTGGAGACATTTCTTCAGCCGCGTTTTTCCTTG
CTGCTGGCGCGATGGTTCCAAACAGCAGAATTGTATTGAAAAACGTAGGTTTAAA
TCCGACTCGGACAGGTATTATTGATGTCCTTCAAAACATGGGGGCAAAACTTGAA
ATCAAACCATCTGCTGATAGCGGTGCAGAGCCTTATGGAGATTTGATTATAGAAA
CGTCATCTCTAAAGGCAGTTGAAATCGGAGGAGATATCATTCCGCGTTTAATTGA
TGAGATCCCTATCATCGCGCTTCTTGCGACTCAGGCGGAAGGAACCACCGTTATT
AAGGACGCGGCAGAGCTAAAAGTGAAAGAAACAAACCGTATTGATACTGTTGTTT
CTGAGCTTCGCAAGCTGGGTGCTGAAATTGAACCGACAGCAGATGGAATGAAGGT
TTATGGCAAACAAACGTTGAAAGGCGGCGCTGCAGTGTCCAGCCACGGAGATCAT
CGAATCGGAATGATGCTTGGTATTGCTTCCTGTATAACGGAGGAGCCGATTGAAA
TCGAGCACACGGATGCCATTCACGTTTCTTATCCAACCTTCTTCGAGCATTTAAA
TAAGCTTTCGAAAAAATCCTGA 
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Bacillus subtilis AroA 
MKRDKVQTLHGEIHIPGDKSISHRSVMFGALAAGTTTVKNFLPGADCLSTIDCFR
KMGVHIEQSSSDVVIHGKGIDALKEPESLLDVGNSGTTIRLMLGILAGRPFYSAV
AGDESIAKRPMKRVTEPLKKMGAKIDGRAGGEFTPLSVSGASLKGIDYVSPVASA
QIKSAVLLAGLQAEGTTTVTEPHKSRDHTERMLSAFGVKLSEDQTSVSIAGGQKL
TAADIFVPGDISSAAFFLAAGAMVPNSRIVLKNVGLNPTRTGIIDVLQNMGAKLE
IKPSADSGAEPYGDLIIETSSLKAVEIGGDIIPRLIDEIPIIALLATQAEGTTVI
KDAAELKVKETNRIDTVVSELRKLGAEIEPTADGMKVYGKQTLKGGAAVSSHGDH
RIGMMLGIASCITEEPIEIEHTDAIHVSYPTFFEHLNKLSKKS 
428 amino acids  
Predicted molecular weight: 45240 Da  
Theoretical pI: 6.33 
Bacillus aroA LCA (1293 bp) 
ATGAAAGAGAAAACCATTAACACCGCAGAAAAAGGTCTGAATGGCACCATTCGTA
TTCCGGGTGATAAAAGCATTAGCCATCGTGCAGTTATGTTTGGTGCAATTGCCGA
AGGCACCACCACCGTTAAAAACTTTCTGCCTGGTGAAGATTGTCTGAGCACCATT
GCATGTTTTCGTAAACTGGGTGTTGAAATCGAACAGAATGGTGATGATGTTACCA
TTAACGGTAAAGGCCTGGATGGTCTGAAAGAACCGAAAGATGTTCTGGATGTTGG
TAATAGCGGTACAACCATTCGTCTGATGCTGGGTATTCTGGCAAATCGTCCGTTT
CATAGCACCATTATTGGTGATGAAAGTATTGCAAAACGTCCGATGAAACGTGTTA
CCGATCCGCTGCGTGAAATGGGTGCACAGATTGATGGTCGTGAAGATGGCAAATT
TACACCGCTGAGCATTCGTGGTGGTAATCTGAAAGGTATCGATTATAACAGTCCG
GTTGCAAGCGCACAGGTTAAAAGCGCAATTCTGCTGGCAGGTCTGCAGGCAGAAG
GTACAACAACCGTTACCGAACCGCATAAAAGCCGTGATCATACCGAACGTATGCT
GGAAGCATTTGGTGTTAAAGTTGAAGAAGAAGGTCAGACCGTTAGCATTGAAGGT
GGTCAGACCCTGAAAGGCACCGATATTGAAGTTCCAGGTGATATTAGCAGCGCAG
CATTTTTTCTGGTTGCCGGTGCCATTGTTCCGAATAGCCGTATTGTTCTGAAAAA
TGTTGGTCTGAATCCGACCCGTACCGGTATTATTGATGTGCTGAAAAAAATGGGA
GCCAACCTGGAAATTGATCAGGTTCGTGAAGAGGGTGCAGAACCGTATGGTGATC
TGACCATTGAAACCAGCAGTCTGAAAGGGATTGAAATTGGTGGCGATCTGATTCC
GCGTCTGATTGATGAAATTCCGATTATTGCACTGCTGGCAACCCAGGCGGAAGGC
ACAACCGTGATTAAAGATGCAGAAGAACTGAAAGTTAAAGAAACCAACCGTATTG
ATACCGTTGTGAGCGAACTGAAAAAACTGGGTGCAAATATTGAAGCAACCGATGA
TGGCATGATTATCCATGGTAAAACCACACTGAAAGGTGGTGCAACCGTTGATAGC
CATGGTGATCATCGTATTGGTATGATGCTGGCCATTGCAAGCTGTATTGCAGAAG
GTGAAGTTGAAATTGAAGATACCGATGCAGTTAGCGTTAGCTATCCGAAATTTTT
CGAACATCTGGAAAGCCTGAAAAAATGA 
Bacillus AroA LCA 
MKEKTINTAEKGLNGTIRIPGDKSISHRAVMFGAIAEGTTTVKNFLPGEDCLSTI
ACFRKLGVEIEQNGDDVTINGKGLDGLKEPKDVLDVGNSGTTIRLMLGILANRPF
HSTIIGDESIAKRPMKRVTDPLREMGAQIDGREDGKFTPLSIRGGNLKGIDYNSP
VASAQVKSAILLAGLQAEGTTTVTEPHKSRDHTERMLEAFGVKVEEEGQTVSIEG
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GQTLKGTDIEVPGDISSAAFFLVAGAIVPNSRIVLKNVGLNPTRTGIIDVLKKMG
ANLEIDQVREEGAEPYGDLTIETSSLKGIEIGGDLIPRLIDEIPIIALLATQAEG
TTVIKDAEELKVKETNRIDTVVSELKKLGANIEATDDGMIIHGKTTLKGGATVDS
HGDHRIGMMLAIASCIAEGEVEIEDTDAVSVSYPKFFEHLESLKK 
430 amino acids  
Predicted molecular weight: 45930 Da  
Theoretical pI: 5.07 
Escherichia coli shikimate kinase (aroL) (525 bp) 
ATGACACAACCTCTTTTTCTGATCGGGCCTCGGGGCTGTGGTAAAACAACGGTCG
GAATGGCCCTTGCCGATTCGCTTAACCGTCGGTTTGTCGATACCGATCAGTGGTT
GCAATCACAGCTCAATATGACGGTCGCGGAGATCGTCGAAAGGGAAGAGTGGGCG
GGATTTCGCGCCAGAGAAACGGCGGCGCTGGAAGCGGTAACTGCGCCATCCACCG
TTATCGCTACAGGCGGCGGCATTATTCTGACGGAATTTAATCGTCACTTCATGCA
AAATAACGGGATCGTGGTTTATTTGTGTGCGCCAGTATCAGTCCTGGTTAACCGA
CTGCAAGCTGCACCGGAAGAAGATTTACGGCCAACCTTAACGGGAAAACCGCTGA
GCGAAGAAGTTCAGGAAGTGCTGGAAGAACGCGATGCGCTATATCGCGAAGTTGC
GCATATTATCATCGACGCAACAAACGAACCCAGCCAGGTGATTTCTGAAATTCGC
AGCGCCCTGGCACAGACGATCAATTGTTGA 
Escherichia coli shikimate kinase  
MTQPLFLIGPRGCGKTTVGMALADSLNRRFVDTDQWLQSQLNMTVAEIVEREEWA
GFRARETAALEAVTAPSTVIATGGGIILTEFNRHFMQNNGIVVYLCAPVSVLVNR
LQAAPEEDLRPTLTGKPLSEEVQEVLEERDALYREVAHIIIDATNEPSQVISEIR
SALAQTINC 
174 amino acids  
Predicted molecular weight: 19151 Da  
Theoretical pI: 4.72 
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Appendix D: Bacterial strains and Plasmids 
D1: Plasmids and cell strains 
Table A.4: Plasmids used in this study 
Plasmid Description His Tag used 
pPROEX HTb 
E. coli expression vector. Trc promoter. 
Encodes an N-terminal 6 x histidine tag with 
an rTEV protease cleavage site. Ampicillin 
resistance 
N-terminal 
pET28b-PstI 
 
Bacterial expression vector with T7 promoter; 
Modified pET28b where the NcoI sites have 
been replaced with PstI sites; C- or N-
terminal His-tags; Kanamycin resistance 
C-terminal 
Table A.5: Bacterial strains used in the study 
Cell strain  Description 
DH5α  fhuA2 Δ(argF-lacZ)U169 phoA glnV44 
Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 
endA1 thi-1 hsdR17 
BL21 (DE3)  F- ompT hsdSB (rB-mB-) gal dcm (DE3)  
Keio collection – parent strain:  
E. coli BW25141  
 
rrnB3 DElacZ4787 DEphoBR580hsdR514 
DE(araBAD)567DE(rhaBAD)568galU95 
DEendA9::FRT DEuidA3::pir(wt) recA1 
rph-1  
E. coli BW25141 – aroA KO  
 
rrnB3 DElacZ4787 DEphoBR580hsdR514 
DE(araBAD)567DE(rhaBAD)568galU95 
DEendA9::FRT DEuidA3::pir(wt) recA1 
rph-1 ΔaroA 
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D2: Genetically modified organisms (GMOs) used in this study 
Table A.6: Transformants generated in this study 
Cell strain Plasmid 
E. coli DH5α pPROEX HtB- Bacillus AroA LCA 
 pPROEX HtB- Bacillus MurA LCA 
 pPROEX HtB- Bacillus MurA ANC1 
 pPROEX HtB- Bacillus MurA ANC2 
 pPROEX HtB- Bacillus MurA ANC3 
 pPROEX HtB- Bacillus subtilis MurA 
 pPROEX HtB- Bacillus coagulans 
MurA 
E.. coli BL21 pPROEX HtB- Bacillus subtilis AroA 
 pET28b-pstI- Shikimate kinase 
E. coli BW25141 pPROEX HtB 
E. coli BW25141 – aroA KO pPROEX HtB 
 pPROEX HtB- Bacillus subtilis AroA 
 pPROEX HtB- Bacillus AroA LCA 
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Appendix E: Reagents, Buffers, Growth Media and Gels 
E1: Reagents and buffers 
Coomassie stain 0.05 % w/v coomassie blue R-250, 25 % v/v 
isopropanol, 10% v/v acetic acid 
Destain solution 10% v/v acetic acid 
10x DNA loading dye 0.4 % w/v bromophenol blue, 0.4 % w/v 
xylene, 50 % v/v glycerol 
4x SDS loading dye  200 mM Tris-HCl pH 6.8, 8% (w/v) SDS, 
40% (v/v) glycerol, 0.4% (w/v) 
bromophenol blue, 400 mM β-
mercaptoethanol 
1x SDS-PAGE running buffer 25 mM Tris-HCl pH 8.3, 250 mM glycine, 
0.1% (w/v) SDS 
1x TAE buffer 40 mM Tris-acetate, 1 mM EDTA  
E2: Buffers used in lysis buffer screen and Protein Melt Analysis 
pH 4.0 :  50 mM sodium acetate + 300 mM NaCl 
pH 5.0 : 50 mM sodium acetate + 300 mM NaCl 
pH 6.0 : 50 mM citrate + 300 mM NaCl 
pH 7.0 : 50 mM sodium phosphate + 300 mM NaCl 
pH 7.5 : 50 mM Tris + 300 mM NaCl 
pH 8.0 : 50 mM sodium phosphate + 300 mM NaCl 
pH 9.0 : 50 mM glycine + 300 mM NaCl 
pH 10.0 : 50 mM glycine + 300 mM NaCl 
 
Appendices 
219 
E3: Growth media 
LB broth  1 % (w/v) bactotryptone, 0.5 % (w/v) yeast 
extract, 1 % (w/v) NaCl pH 8  
LB agar 1 % (w/v) bactotryptone, 0.5 % (w/v) yeast 
extract, 1 % (w/v) NaCl, 15 g/L agar pH 8  
M9 minimal media  5 x M9 salts:  64 g/L Na2HPO4.7H20  
 15 g/L KH2PO4  
2.5 g/L NaCl  
5.0 g/L NH4Cl  
 M9 media:  200 ml/L 5x M9 salts  
2 ml/L 1 M MgSO4  
20 ml/L carbon source (0.2 
μm filter sterilised)  
0.1 ml/L CaCl2  
780 ml/L H2O  
M9 agar  200 ml/L 5x M9 salts  
2 ml/L 1 M MgSO4  
20 ml/L carbon source (0.2 μm filter 
sterilised)  
0.1 ml/L CaCl2  
780 ml/L H2O with 15 g agar  
Terrific Broth  Solution A  12 g tryptone  
24 g yeast extract  
4 ml glycerol  
Made up to 900 ml with H2O  
 Solution B  2.31 g KH2PO4  
 12.54 g K2HPO4  
 Made up to 100 ml with H20 
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E4: Gels 
Agarose gel 1 % w/v agarose in TAE buffer and 2-5 μL 
SYBR safe DNA gel stain (Invitrogen) per 
gel 
15% SDS-PAGE gel recipe  
SDS-PAGE gels were made up of a resolving gel layer overlaid with a stacking 
gel layer 
Resolving gel layer: 15% acrylamide 
 375 mM Tris (pH 8.8)  
 0.1% (w/v) SDS  
 0.05% (w/v) ammonium persulphate  
 0.05 % (v/v) TEMED 
Stacking gel layer: 5% acrylamide 
 128 mM Tris (pH 6.8) 
 0.1% (w/v) SDS 
 0.05% (w/v) ammonium persulphate  
 0.05 % (v/v) TEMED 
 
 
 
